EOS Med Chem Impurity Stock 20201029-20

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

Sulfamethoxazole-d4 N4-glucoside, CAS: /, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₄N₃O₈S.

Sulfatroxazole, CAS: 23256-23-7, stock: 9.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₃S.

Sulfatroxazole-d4, CAS: /, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₄N₃O₃S.

Sulfisoxazole, CAS: 127-69-5, stock: 7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₃S.

Sulfisoxazole Acetyl, CAS: 80-74-0, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₄S.

Sulfisoxazole Acetyl-d4, CAS: /, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₄N₃O₄S.

Sulfisoxazole-d4, CAS: 1388717-81-4, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₄N₃O₃S.

N-Desmethyl 4-Hydroxy Toremifene Hydrochloride, CAS: /, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇Cl₂NO₂.

Suvorexant, CAS: 1030377-33-3, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃ClN₆O₂.

Suvorexant-d6, CAS: /, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₇D₆ClN₆O₂.

T 5601640, CAS: 924473-59-6, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄F₃N₃O₃.

TASP 0433864, CAS: 1431980-60-7, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₃O₃.

Telithromycin 90%, CAS: 191114-48-4, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₅N₅O₁₀.

tert-Butyldiphenylchlorosilane, CAS: 58479-61-1, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉ClSi.

trans-4-Amino-1-methylcyclohexanol, CAS: 177908-37-1, stock: 1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO.

n-Hexyl 4-Hydroxybenzoate-2,3,5,6-d4, CAS: /, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄D₄O₃.

UK-1, CAS: 151271-53-3, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄N₂O₅.

Vapendavir, CAS: 439085-51-5, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆N₄O₃.

N-Hydroxy Metaraminol, CAS: /, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO₃.

Vapendavir-d5, CAS: /, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₅N₄O₃.

VER-50589, CAS: 747413-08-7, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇ClN₂O₅.

N-Methyl-p-tyramine, CAS: 370-98-9, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO.

N-tert-Butoxycarbonyl Tyramine, CAS: 64318-28-1, stock: 5.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₃.

N-[3’,4’-Dihydroxy-(E)-cinnamoyl]-3-hydroxy-L-tyrosine, CAS: 53755-02-5, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₇.

Zoxazolamine-d2, CAS: 24160-33-6, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃D₂ClN₂O.

[[4-[2-[[(5-Methyl-3-isoxazolyl)carbonyl]amino]ethyl]phenyl]sulfonyl]-carbamic Acid, CAS: 24489-02-9, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₆S.

N-[3’,4’-Dihydroxy-(E)-cinnamoyl]-L-tyrosine, CAS: 124027-56-1, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₆.

N-[6-(Dimethylamino)-3-pyridinyl]-3-fluorobenzenesulfonamide, CAS: 1356647-38-5, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄FN₃O₂S.

N’-Demethyldauricine Iodide, CAS: 1134729-98-8, stock: 6.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂N₂O₆.

Nectandrin B, CAS: 74683-16-2, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄O₅.

Nitroxinil, CAS: 1689-89-0, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃IN₂O₃.

Nitroxinil-13C6, CAS: 1325559-31-6, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₆H₃IN₂O₃.

Nordihydro Guaiaretic Acid (mixture of diastereomers), CAS: 500-38-9, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O₄.

Nordihydro Guaiaretic Acid-d6, CAS: 1346600-58-5, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₆O₄.

NSC-33994, CAS: 82058-16-0, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂N₂O₂.

NSC-33994-d4, CAS: 1795134-33-6, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈D₄N₂O₂.

Nutmeg Neolignan, CAS: /, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₆₀O₁₂.

O-(2,4-Dinitrophenyl)hydroxylamine, CAS: 17508-17-7, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃O₅.

O-AMINOPHENOL SULFATE, CAS: 67845-79-8, stock: 8.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₆H₇NO) •  H₂SO₄.

O-Desmethyl Mycophenolate Mofetil(Impurity A), CAS: 1322681-36-6, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉NO₇.

O-Desmethyl Tramadol-d6, CAS: 873928-73-5, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇D₆NO₂.

O-Desmethyl Tramadol-d6 Hydrochloride, CAS: 1261393-87-6, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₆ClNO₂.

O-Desmethyl Venlafaxine Cyclic Impurity, CAS: 1346601-55-5, stock: 9.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₂.

O-Desmethyl Venlafaxine Cyclic Impurity-d5, CAS: 1346598-83-1, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₅NO₂.

O-Desmethyl Venlafaxine Dimer, CAS: 1187545-62-5, stock: 5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₀N₂O₄.

O-t-Butyldimethylsilyl 3-bromo-4-methoxyphenol, CAS: 1133116-37-6, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁BrO₂Si.

o-Tyramine, CAS: 2039-66-9, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO.

Octafluoro-4,4’-biphenol, CAS: 2200-70-6, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂O₂F₈.

Oleacein, 90%, CAS: 149183-75-5, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₆.

Oleuropein Aglycone, CAS: 31773-95-2, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂O₈.

Oleuropein, 75%, CAS: 32619-42-4, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂O₁₃.

Oleuropein, >95%, CAS: 32619-42-4, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂O₁₃.

Orsellinic Acid-13C6, CAS: /, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₈O₄.

ortho-Topolin 9-Glucoside, CAS: 160299-96-7, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁N₅O₆.

Oxymetazoline Hydrochloride, CAS: 08/02/2315, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅ClN₂O.

Oxymetazoline-d4, CAS: 1262053-60-0, stock: 4.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀D₄N₂O.

p-(1-Benzyl-2-benzimidazolyl)phenol, CAS: 10206-01-6, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆N₂O.

p-Coumaric Acid 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: 866417-47-2, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆O₁₂.

p-Coumaric Acid 4-O-β-D-Glucuronide, CAS: 214689-30-2, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₉.

p-Coumaric Acid 4-O-Sulfate Disodium Salt, CAS: 308338-96-7, stock: 1.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆Na₂O₆S.

p-Coumaric Acid-d4 4-O-Sulfate, CAS: 1795140-39-4, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄D₄O₆S.

p-Coumaric Acid-d5 4-O-β-D-Glucuronide, CAS: /, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₄O₉.

p-Ethylphenol, CAS: 123-07-9, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O.

p-Ethylphenol-d10, CAS: 352431-18-6, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈D₁₀O.

p-Hydroxypropiophenone, CAS: 70-70-2, stock: 7.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₂.

p-Hydroxypropiophenone-d2, CAS: /, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₂O₂.

p-Nitrophenyl Acetate-13C,d3, CAS: 1794766-80-5, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³CH₄D₃NO₄.

p-Nitrophenyl α-D-Glucopyranoside, CAS: 3767-28-0, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₈.

p-t-Butylphenyl Diphenyl Phosphate, CAS: 981-40-8, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃O₄P.

p-t-Butylphenyl Diphenyl Phosphate-d10, CAS: /, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃D₁₀O₄P.

p-Tyramine, CAS: 51-67-2, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO.

p-Tyramine-d4 Hydrochloride, CAS: 1189884-47-6, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈D₄ClNO.

p-Tyramine-d4 Hydrochloride, CAS: 1188266-06-9, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈D₄ClNO.

p38 MAP Kinase Inhibitor IV, CAS: 1638-41-1, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄Cl₆O₄S.

para-Topolin, CAS: 80054-30-4, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₅O.

para-Topolin-9-Glucoside, CAS: 1046433-04-8, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁N₅O₆.

Pelargonidin 3-Rutinoside, CAS: 33978-17-5, stock: 1.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁ClO₁₄.

Pentabromopseudilin, CAS: 10245-81-5, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄Br₅NO.

Pentachlorophenol, CAS: 87-86-5, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HCl₅O.

Pentachlorophenol Sodium Salt, CAS: 131-52-2, stock: 6.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆Cl₅NaO.

Pentachlorophenol Sodium Salt Hydrate, CAS: 123333-54-0, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆OCl₅-.Na+ • H₂O.

Pentachlorophenol-13C6, CAS: 85380-74-1, stock: 5.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆HCl₅O.

Pentachloropseudilin, CAS: 69640-38-6, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄Cl₅NO.

Pentachlorothiophenol, CAS: 133-49-3, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HCl₅S.

Pentafluorothiophenol, CAS: 771-62-0, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HF₅S.

Perfluorophenol, CAS: 771-61-9, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HF₅O.

PFTU, Pentafluorphenol-tetramethyluronium Hexafluorophosphate, CAS: 206190-14-9, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂F₅N₂O  •  PF₆.

Phenofluor(TM) Mix, CAS: 1648825-53-9, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆Cl₂N₂ • xCsF.

Phenol, CAS: 108-95-2, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O.

Phenol Red, CAS: 143-74-8, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₅S.

Phenol Red Sodium Salt, CAS: 34487-61-1, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄O₅S  • Na.

Phenol, Glass Distilled Under Argon, CAS: 108-95-2, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O.

Phenol-13C6, CAS: 89059-34-7, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₆O.

Phenol-2,4,6-d3, CAS: 7329-50-2, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₃H₃O.

Phenol-d5, CAS: 4165-62-2, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₅O.

Phenolphthalein Disodium Salt, CAS: 518-51-4, stock: 5.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂Na₂O₄.

Phenolphthalin, CAS: 81-90-3, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O₄.

Phentolamine Hydrochloride, CAS: 73-05-2, stock: 8.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClN₃O.

Phentolamine-d4 Hydrochloride, CAS: 1346599-65-2, stock: 6.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₄ClN₃O.

Phenyl Acetate, CAS: 122-79-2, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₂.

Phenyl Acetate-13C6, CAS: /, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₈O₂.

Phenyl Acetate-d5, CAS: 22705-26-6, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃D₅O₂.

Phenyl Di-p-tert-butylphenyl Phosphate, CAS: 115-87-7, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁O₄P.

Phenyl β-D-Glucuronide, CAS: 17685-05-1, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄O₇.

Phenyl β-D-Thioglucopyranoside, CAS: 2936-70-1, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₅S.

Phenyl Salicylate, CAS: 118-55-8, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀O₃.

Phenyl-d5 β-D-Glucuronide, CAS: /, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉D₅O₇.

PHTPP, CAS: 805239-56-9, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₁F₆N₃O.

PI 103 Hydrochloride, CAS: 371935-79-4, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₄O₃ • HCl.

PI 103-D8, CAS: /, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₈D₈N₄O₃.

Platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane Complex Solution, CAS: 68478-92-2, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈OPtSi₂.

PNPP, Disodium Hexahydrate, CAS: 4264-83-9, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄NNa₂O₆P  • 6(H ₂O).

Poly(4-vinylphenol), CAS: 24979-70-2, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O.

Potassium p-Aminophenyl Sulphate, CAS: 37763-28-3, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆KNO₄S.

Potassium Phenolate, CAS: 100-67-4, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅KO.

Prenalterol, CAS: 57526-81-5, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₃.

Prenalterol-d7, CAS: /, stock: 8.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₇NO₃.

Probucol, CAS: 23288-49-5, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₈O₂S₂.

Promecarb, CAS: 2631-37-0, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

Promecarb-d3, CAS: 1219799-11-7, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄D₃NO₂.

Propofol, CAS: 2078-54-8, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O.

Propofol-d14, CAS: /, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄D₁₄O.

Propofol-d17, CAS: 1261393-54-7, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂HD₁₇O.

Pterostilbene, CAS: 537-42-8, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₃.

Pyrogallol, CAS: 87-66-1, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₃.

Pyronaridine Tetraphosphate, CAS: 76748-86-2, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₄ClN₅O₁₈P₄.

Pyronaridine-13C2 , d4, CAS: 1261393-31-0, stock: 7.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇¹³C₂H₂₈D₄ClN₅O₂.

Quininib, CAS: 143816-42-6, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃NO.

R 112, CAS: 575474-82-7, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃FN₄O₂.

R(+)-3-(3-Hydroxyphenyl)-N-propylpiperidine Hydrochloride, CAS: 89874-80-6, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO •HCl.

R-(+)-Tolterodine, CAS: 124937-51-5, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁NO.

rac Dehydro-O-desmethyl Venlafaxine, CAS: 1346600-38-1, stock: 3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO.

rac Dehydro-O-desmethyl Venlafaxine-d6, CAS: 1346598-00-2, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₆NO.

rac Deoxy-O-desmethyl Venlafaxine, CAS: 1346605-18-2, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO.

rac Deoxy-O-desmethyl Venlafaxine-d6, CAS: 1346600-06-3, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉D₆NO.

rac Desisopropyl Tolterodine, CAS: 480432-14-2, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅NO.

rac Desisopropyl Tolterodine-d7, CAS: 1346600-20-1, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₇NO.

rac Didesisopropyl Tolterodine, CAS: 1189501-90-3, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉NO.

rac N,N-Didesmethyl-N-(4-hydroxyphenethyl)-O-desmethyl Venlafaxine, CAS: 1346601-21-5, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉NO₃.

rac N,N-Didesmethyl-N-(4-hydroxyphenethyl)-O-desmethyl Venlafaxine-d11, CAS: 1346598-87-5, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₁₁NO₃.

rac N,N-Didesmethyl-O-desmethyl Venlafaxine 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇NO₁₁.

rac N,O-Didesmethyl Tramadol, CAS: 138853-73-3, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₂.

rac N,O-Didesmethyl Tramadol Hydrochloride, CAS: 333364-41-3, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂ClNO₂.

rac N,O-Didesmethyl Tramadol O-Sulfate, CAS: 480452-78-6, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₅S.

rac N,O-Didesmethyl Tramadol-d3, CAS: 1261398-22-4, stock: 7.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈D₃NO₂.

rac O-Desmethyl Venlafaxine 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₁NO₁₁.

rac Tolterodine-d14 Hydrochloride, CAS: 1246816-99-8, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₁₄ClNO.

rac Tolterodine-d6 Hydrochloride, CAS: 1330076-60-2, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆D₆ClNO.

rac-1-Benzyl-3,4-dimethylpiperidin-4-yl)phenol Hydrochloride, CAS: /, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆ClNO.

rac-1-Benzyl-4-(3-isopropoxyphenyl)-3,4-dimethylpiperidine Hydrobromide, CAS: /, stock: 4.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₂BrNO.

rac-1-Ethyl-4-(3-isopropoxyphenyl)-3-methylpiperidin-4-ol, CAS: /, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO₂.

rac-Rhododendrol, CAS: 69617-84-1, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O₂.

rel-4-[(2R,3R)-4-(1,3-Benzodioxol-5-yl)-2,3-dimethylbutyl]-2-methoxyphenol, CAS: 130008-79-6, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄O₄.

rel-4-[(2R,3R)-4-(1,3-Benzodioxol-5-yl)-2,3-dimethylbutyl]-2-methoxyphenol-d3, CAS: /, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃O₄.

Resorcinol Monoacetate(Resorcin Monoacetate), CAS: 102-29-4, stock: 9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈O₃.

Resorcinol Monoacetate-d4(Resorcin Monoacetate-d4), CAS: /, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄D₄O₃.

Resorcinol-1,2,3-13C3, CAS: 1185048-67-2, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₆O₂.

Ro 25-6981 Maleate, CAS: 1312991-76-6, stock: 3.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉NO₂ •  C₄H₄O₄.

S-(-)-Tolterodine D-Tartrate, CAS: 124937-54-8, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇NO₇.

Salvianolic Acid A, CAS: 96574-01-5, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂O₁₀.

SB 202190, CAS: 152121-30-7, stock: 7.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄FN₃O.

SB 202190 Hydrochloride, CAS: 350228-36-3, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅ClFN₃O.

SB 269970, CAS: 201038-74-6, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O₃S.

SB 269970A Hydrochloride, CAS: 261901-57-9, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₉ClN₂O₃S.

Secophenol, CAS: 2394-69-6, stock: 6.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₃.

SEN 1269, CAS: 956128-01-1, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₄O₂.

Sesamol, CAS: 533-31-3, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₃.

Sesamol-d2, CAS: 923932-05-2, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄D₂O₃.

SKI II, CAS: 312636-16-1, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁ClN₂OS.

Sodium 2,2’-Methylene-bis(4,6-di-tert-butylphenyl)phosphate, CAS: 85209-91-2, stock: 5.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₂NaO₄P.

Sodium 2-Nitrophenolate, CAS: 824-39-5, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄NNaO₃.

Sodium Benzenethiolate (technical grade, 90%), CAS: 930-69-8, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NaS.

Sodium Phenoxide Trihydrate, CAS: 156150-40-2, stock: 5.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NaO•3[H₂O].

Sphingosine Kinase Inhibitor, CAS: 1177741-83-1, stock: 1.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁ClN₂OS•HCl.

Syringoyl Methyl Ketone, CAS: 6925-65-1, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₅.

T2AA, CAS: 1380782-27-3, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅I₂NO₃.

Tannic Acid, CAS: 1401-55-4, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₆H₅₂O₄₆.

(5Z)-5,11-Dihydro-5-(3-hydroxypropylidene)-10H-dibenzo[a,d]cyclohepten-10-one, CAS: 156458-89-8, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O₂.

(5Z)-5-(3-Bromopropylidene)-5,11-dihydro-10H-dibenzo[a,d]cyclohepten-10-ol, CAS: 156458-91-2, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇BrO.

(5Z)-5-(3-Bromopropylidene)-5,11-dihydro-10H-dibenzo[a,d]cyclohepten-10-one, CAS: 156458-92-3, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅BrO.

TC-G 1003, CAS: 1021912-42-4, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅ClN₂O₂.

Tea Polyphenol (TP98), CAS: 84650-60-2, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

10-Hydroxy Nortriptyline Maleate, CAS: 74853-74-0, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₅.

Temephos, CAS: 3383-96-8, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀O₆P₂S₃.

Temoporfin, ~ 90%, CAS: 122341-38-2, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₃₂N₄O₄.

4-Bromo-5H-dibenzo[a,d]cyclohepten-5-one, CAS: 17044-50-7, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉BrO.

cis-10-Hydroxy Nortriptyline, CAS: 47132-19-4, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO.

cis-10-Hydroxy Nortriptyline-D3, CAS: /, stock: 5.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₃NO.

Tetrabromobisphenol S, CAS: 39635-79-5, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Br₄O₄S.

Tetrabromophenol Blue, CAS: 4430-25-5, stock: 5.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₆Br₈O₅S.

Nortriptyline N-Ethyl Carbamate, CAS: 16234-88-1, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅NO₂.

Nortriptyline N-β-Glucuronide, CAS: /, stock: 2.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉NO₆.

Nortriptyline-d3 Hydrochloride, CAS: 203784-52-5, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉D₃ClN.

Nortriptyline-d3 N-β-Glucuronide, CAS: /, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆D₃NO₆.

TG 100572, CAS: 867334-05-2, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆ClN₅O₂.

TG 100713, CAS: 925705-73-3, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₆O.

TG100-115, CAS: 677297-51-7, stock: 3.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄N₆O₂.

Theaflavin, CAS: 07/05/4670, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄O₁₂.

Thiophenol, CAS: 108-98-5, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆S.

Thymol Blue, CAS: 76-61-9, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₅S.

Thymol Blue Sodium Salt, CAS: 62625-21-2, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉NaO₅S.

Tilfrinib, CAS: 1600515-49-8, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃N₃O.

Tolcide 2230 (90%), CAS: 21564-17-0, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆N₂S₃.

Tolterodine Dimer, CAS: 854306-72-2, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₁NO₂.

Tolterodine Dimer-D7, CAS: /, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₄D₇NO₂.

trans-4,4’-Azodiphenol, CAS: 51437-66-2, stock: 6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₂.

trans-4,4’-Azodiphenol-d8, CAS: /, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂D₈N₂O₂.

trans-Diethyl Stilbestrol, CAS: 56-53-1, stock: 7.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀O₂.

trans-Diethyl Stilbestrol Acetate, CAS: 66320-32-9, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₃.

trans-Diethyl-1,1,1’,1’-stilbestrol-3,3’,5,5’-d8, CAS: 91318-10-4, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₈O₂.

trans-Zeatin-O-glucoside Riboside, CAS: 62512-97-4, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₅O₁₀.

Tributylhexadecylphosphonium Bromide, CAS: 14937-45-2, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₆₀BrP.

Trichloroacetyl Isocyanate, CAS: 3019-71-4, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃Cl₃NO₂.

Triclosan (3’,5’,6’-d3) O-Sulfate Sodium Salt, CAS: /, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₃D₃Cl₃NaO₅S.

Triclosan O-Sulfate Sodium Salt, CAS: 68508-18-9, stock: 6.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Cl₃NaO₅S.

Tris(1-chloro-2-propyl) Phosphate, CAS: 13674-84-5, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈Cl₃O₄P.

Tris(1-chloro-2-propyl) Phosphate-d18, CAS: 1447569-78-9, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉D₁₈Cl₃O₄P.

Tris(2,4-di-tert-butylphenyl)phosphate, CAS: 95906-11-9, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₃O₄P.

Tris(2,4-di-tert-butylphenyl)phosphate-d54, CAS: /, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₉D₅₄O₄P.

Tris(2,4-tert-butylphenyl) Phosphite, CAS: 31570-04-4, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₃O₃P.

Tris(2-isopropylphenyl) Phosphate, CAS: 64532-95-2, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃O₄P.

Tris(2-isopropylphenyl) Phosphate-d21, CAS: /, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₁₂D₂₁O₄P.

Tris(p-tert-butylphenyl) Phosphate, CAS: 78-33-1, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₉O₄P.

Tris(p-tert-butylphenyl) Phosphate-d27, CAS: /, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₁₂D₂₇O₄P.

Tropolone, CAS: 533-75-5, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆O₂.

Tropolone 1,2-13C2, CAS: /, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₂H₆O₂.

TWS 119, CAS: 1507095-58-0, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆F₆N₄O₆.

Tyramine Hydrochloride, CAS: 60-19-5, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO • HCl.

Tyrosol, CAS: 501-94-0, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₂.

Tyrosol Glucuronide, CAS: 28116-28-1, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈O₈.

Tyrosol Sulfate Sodium Salt, CAS: /, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NaO₅S.

Tyrosol-d4, CAS: /, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₄O₂.

Tyrphostin RG 14620, CAS: 136831-49-7, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈Cl₂N₂.

Urea-urethane Compound, CAS: 321860-75-7, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₃₆N₆O₈S.

Vanillic-d3 Acid, CAS: /, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₃O₄.

Vanillylacetone, CAS: 122-48-5, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

Vanillylmethanol, CAS: 2380-78-1, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂O₃.

Verbascoside, CAS: 61276-17-3, stock: 8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₆O₁₅.

Vilanterol Acetate, CAS: 503068-35-7, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇Cl₂NO₇.

Vilanterol Dimer, CAS: /, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₆₄Cl₄N₂O₉.

Vilanterol Trifenatate, CAS: 503070-58-4, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₉Cl₂NO₇.

Vilanterol Trifenatate-d4, CAS: /, stock: 7.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₅D₄Cl₂NO₇.

Vitexin-2-O-Rhamnoside, CAS: 64820-99-1, stock: 5.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₁₄.

Vitisin B Chloride, CAS: 312297-86-2, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇ClO₁₂.

VP 14637, CAS: 235106-62-4, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂N₁₀O₃.

(17α)-13-Ethyl-18,19-dinorpregna-3,5(10)-dien-20-yne-3,17-diol Diacetate, CAS: 62855-59-8, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂O₄.

VP 14637-13C3, CAS: 1331665-99-6, stock: 3.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₃H₂₂N₁₀O₃.

WAY 200070, CAS: 440122-66-7, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈BrNO₃.

WHI-P154, CAS: 211555-04-3, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄BrN₃O₃.

WY 45233 Succinate, CAS: 448904-47-0, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₁NO₆.

17α-Ethynyl-18-methylestra-3,5-diene-3,17β-diol Diacetate, CAS: 13635-15-9, stock: 4.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂O₄.

∆-6,7-Norgestimate, CAS: /, stock: 2.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉NO₃.

XMC (pesticide), CAS: 2655-14-3, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

Delta 6(7)-Norelgestromin, CAS: /, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₂.

N-Acetyl Norgestimate-d6, CAS: 1263195-02-3, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇D₆NO₄.

Z,Z-Dienestrol, CAS: 35495-11-5, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₂.

Z,Z-Dienestrol Diacetate, CAS: 24705-62-2, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₄.

Norgestimate, CAS: 35189-28-7, stock: 2.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₃.

Norgestimate-d3 (major), CAS: /, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆D₅NO₃.

Z,Z-Dienestrol-d2, CAS: 1346606-45-8, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₂O₂.

Z,Z-Dienestrol-d4, CAS: /, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₄O₂.

Norgestimate-d6 (major), CAS: 1263194-12-2, stock: 2.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅D₆NO₃.

syn/anti-6α-Hydroxy Desacetyl Norgestimate, CAS: /, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉NO₃.

Z,Z-Dienestrol-d6, CAS: 91297-99-3, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₆O₂.

ZM 241385, CAS: 139180-30-6, stock: 6.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₇O₂.

ZM 323881 Hydrochloride, CAS: 193000-39-4, stock: 8.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉ClFN₃O₂.

[R,R-(E)]-4-Methoxy-2,3,6-trimethyl-5-(3,7,11,15-tetramethyl-2-hexadecenyl)phenol, CAS: 86993-71-7, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₂.

1-Desmethyl-7-depyrazine-7-chloro Norfloxacin, CAS: 70032-16-5, stock: 8.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇ClFNO₃.

4-Oxo Norfloxacin, CAS: 74011-42-0, stock: 4.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆FN₃O₄.

6,7-Dichloro-1-ethyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester, CAS: 122224-56-0, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃Cl₂NO₃.

6-((2-((tert-Butoxycarbonyl)amino)ethyl)amino)-7-chloro-1-ethyl-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid, CAS: /, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄ClN₃O₅.

6-Defluoro-(ethoxycarbonyl)piperazinyl-7-depiperazinyl-chloro Norfloxacin, CAS: /, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇ClN₃O₄.

6-Defluoro-(ethoxycarbonyl)piperazinyl-7-N-ethoxycarbonyl Norfloxacin, CAS: /, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅N₅O₇.

7-​Chloro-​1-​ethyl-​6-​fluoro-​1,​4-​dihydro-​4-​oxo-3-​quinolinecarboxylic Acid Ethyl Ester, CAS: 70458-94-5, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃ClFNO₃.

7-​Chloro-​1-​ethyl-​6-​fluoro-​1,​4-​dihydro-​4-​oxo-3-​quinolinecarboxylic Acid Ethyl-d5 Ester, CAS: /, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈D₅ClFNO₃.

7-Chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid, 90%, CAS: 68077-26-9, stock: 2.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉ClFNO₃.

7-Chloro-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester Potassium Salt, CAS: 126357-59-3, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClFKNO₃.

Benzyl 4-Nitrophenyl Carbonate, CAS: 13795-24-9, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₅.

Defluoro-6-chloro Norfloxacin Hydrochloride, CAS: 67681-86-1, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈ClN₃O₃•HCl.

Desethylene N-Boc Norfloxacin Hydrochloride, CAS: 2222290-73-3, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄FN₃O₅.

Desethylene Norfloxacin Hydrochloride, CAS: 1797116-86-9, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇ClFN₃O₃.

Diacetyl (6,7-Dichloro-1-ethyl-1,4-dihydro-4-oxo-3-quinolinecarboxy Borate), CAS: /, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄BCl₂NO₇.

Diacetyl (6-Chloro 7-Piperazinyl 1-Ethyl-1,4-dihydro-4-oxo-3-quinolinecarboxy Borate), CAS: /, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃BClN₃O₇.

Difloxacin Hydrochloride Salt, CAS: 91296-86-5, stock: 5.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀ClF₂N₃O₃.

Difloxacin-d3 Hydrochloride Salt, CAS: 1173021-89-0, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆D₃F₂N₃O₃ • HCl.

Ethyl 7-Chloro-4-ethoxy-6-fluoro-3,4-dihydroquinoline-3-carboxylate, CAS: 125292-94-6, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃ClFNO₃.

N-(3-Oxobutyl) Norfloxacin, CAS: 103240-27-3, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄FN₃O₄.

N-Demethyl Norfloxacin Hydrochloride, CAS: 74011-48-6, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆FN₃O₃•HCl.

N-Ethoxycarbonyl Norfloxacin, CAS: 105440-01-5, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂FN₃O₅.

N-Formyl Norfloxacin, CAS: 70459-04-0, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈FN₃O₄.

N-Hydroxy Norfloxacin, CAS: 109142-49-6, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈FN₃O₄.

Norfloxacin, CAS: 70458-96-7, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈FN₃O₃.

Norfloxacin Nicotinate, CAS: 118803-81-9, stock: 4.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈FN₃O₃ •C₆H₅NO₂.

Norfloxacin Piperazinyl-1-Oxide, CAS: 1796931-70-8, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈FN₃O₄.

Norfloxacin-acyl-β-glucuronide, CAS: 1260617-45-5, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆FN₃O₉.

Norfloxacin-d5, CAS: 1015856-57-1, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₅FN₃O₃.

Norfloxacin-d8, CAS: 1216601-32-9, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₀D₈FN₃O₃.

Pefloxacin-d3, CAS: /, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₃FN₃O₃.

((1S,2S)-2-(Diethylcarbamoyl)-2-phenylcyclopropyl)methyl Acetate, CAS: /, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₃.

(1R,1’R,2S,2’S)-2,2’-(((2-Aminopropane-1,3-diyl)bis(oxy))bis(methylene))bis(phenylcyclopropanecarboxamide), CAS: /, stock: 5.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁N₃O₄.

(1R,2R)-2-(Hydroxymethyl)-1-phenylcyclopropanecarboxylic Acid, CAS: /, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

(1R,2R)-rel-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenyl-cyclopropanecarboxamide, CAS: 907205-34-9, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₃.

(1R,2R)-rel-N,N-Diethyl-2-(hydroxymethyl)-1-phenyl-cyclopropanecarboxamide, CAS: 1797131-72-6, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₂.

(1R,2S)-rel-N,N-Diethyl-2-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-1-phenyl-cyclopropanecarboxamide, CAS: 923037-67-6, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇NO₄S.

(1R-cis)-Milnacipran Hydrochloride, CAS: 175131-61-0, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃ClN₂O.

(1R-cis)-Milnacipran-d10 Hydrochloride, CAS: 1217774-40-7, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₁₀ClN₂O.

(1S,2S)-2-(Acetoxymethyl)-1-phenylcyclopropanecarboxylic Acid, CAS: /, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₄.

(1S,2S)-2-(Hydroxymethyl)-1-phenylcyclopropanecarboxylic Acid, CAS: /, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

(1S-cis)-Milnacipran Hydrochloride, CAS: 175131-60-9, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃ClN₂O.

(2S,3R)-2-Amino-3-(3-(benzoyloxy)-4-hydroxyphenyl)-3-hydroxypropanoic Acid, CAS: /, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₆.

(βR)-Ethyl β-Hydroxy-3-(phenylmethoxy)-O-(phenylmethyl)-L-tyrosine Ester-D3, CAS: /, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄D₃NO₅.

(βS)-rel-Ethyl N-(Diphenylmethylene)-3-(phenylmethoxy)-O-(phenylmethyl)-β-[(trimethylsilyl)oxy]-D-tyrosine Ester-D3, CAS: /, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₀D₃NO₅Si.

(R)-3-Methylamino-1-(2-thienyl)-1-propanol, CAS: 116539-57-2, stock: 4.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NOS.

(R)-Duloxetine Hydrochloride, CAS: 910138-96-4, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀ClNOS.

(R)-α,α-Diphenylprolinol Hydrochloride, CAS: 172152-19-1, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClNO.

(R)-α,α-Diphenylprolinol-d10 Hydrochloride, CAS: /, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₁₀ClNO.

(S)-α,α-Diphenylprolinol Hydrochloride, CAS: 148719-90-8, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClNO.

(S)-α,α-Diphenylprolinol-d10 Hydrochloride, CAS: /, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₁₀ClNO.

(S)-N-Desmethyl Duloxetine Hydrochloride, CAS: 1798887-69-0, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClNOS.

(S)-[[(Methylsulfonyl)oxy]methyl]piperidine-1-carboxylic Acid tert-Butyl Ester, CAS: 364356-44-5, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃NO₅S.

1,3-Benzodioxole-N-phthalimido DL-threo-Droxidopa-d3, CAS: /, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₀D₃NO₇.

1-phenyl-3-azabicyclo[3.1.0]hexan-2-one, CAS: 153275-06-0, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO.

1-Phenyl-3-oxabicyclo[3.1.0]hexan-2-one, CAS: 63106-93-4, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₂.

10,10’-Oxybis(5-methyl-10,11-dihydro-5H-dibenzo[b,f]azepine), CAS: /, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₈N₂O.

10,11-Dihydro-5-methyl-5H-dibenz[b,f]azepine-10-carbamic Acid Ethyl Ester, CAS: 30761-57-0, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O₂.

2,5-Dimethoxy-4-iodophenethylamine Hydrochloride, CAS: 64584-32-3, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅ClINO₂.

2,6-Dichloroiodobenzene, CAS: 19230-28-5, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂I.

2-(Hydroxymethyl)-1-phenylcyclopropanecarbonitrile, CAS: 60788-55-8, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO.

2-Acetoxymethylphenol, CAS: 6161-96-2, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O₃.

2-Aminoindan Hydrochloride, CAS: 2338-18-3, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClN.

2-Hydroxydesipramine Dihydrochloride, CAS: /, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂N₂O  •2HCl.

2-Hydroxymethyl Atomoxetiene, CAS: 299435-92-0, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₂.

2-Hydroxymethyl Atomoxetiene-d3, CAS: /, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₂.

2-[3-(Methylamino)-1-(2-thienyl)propyl]-1-naphthalenol Hydrochloride, CAS: 1033719-36-6, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀ClNOS.

2C-C-NBOMe Hydrochloride, CAS: 1539266-19-7, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃Cl₂NO₃.

2C-C-NBOMe-d6 Hydrochloride, CAS: /, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₆Cl₂NO₃.

3,3’-(Methylimino)bis[1-(2-thienyl)-1-propanone Hydrochloride, CAS: 494221-37-3, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈ClNO₂S₂.

3-(3,4-Dichlorophenyl)-3-(2-hydroxyethyl)-1-piperidinecarboxylic Acid tert-Butyl Ester, CAS: /, stock: 6.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅Cl₂NO₃.

3-(3,4-Dichlorophenyl)-3-(2-hydroxymethyl)-1-piperidinecarboxylic Acid tert-Butyl Ester, CAS: /, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃Cl₂NO₃.

3-(Methylamino)-1-(thiophen-3-yl)propane-1-ol, CAS: /, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NOS.

3-Methoxyamphetamine Hydrochloride, CAS: 35294-10-1, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClNO.

3’,4’-Dibenzyloxy-1-phenyl-2-butanone, CAS: 24538-59-8, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄O₃.

4-(2-Methyl-2-nitropropyl)phenol, CAS: 16066-97-0, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

5,11-Dihydro-5-methyl-10H-dibenz[b,f]azepin-10-one, CAS: 4904-83-0, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO.

5-Hydroxy Duloxetine, CAS: 741693-77-6, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₂S.

5-Hydroxy Duloxetine-d3, CAS: /, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₃NO₂S.

6-​chloro-​4-​phenyl-​2-​(1-​piperazinyl)​-Quinazoline, CAS: 313398-51-5, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇ClN₄.

6-Hydroxy Duloxetine, CAS: 741693-76-5, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₂S.

3-Methylnonane-2,4-dione, CAS: 113486-29-6, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈O₂.

6-Hydroxy Duloxetine-d3, CAS: /, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₃NO₂S.

3-Methylnonane-2,4-dione-D3 (Mixture of isomers), CAS: 1335436-44-6, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅D₃O₂.

5,5,6,6,7,7,8,8,9,9,9-Undecafluoro-2,4-nonanedione, CAS: 75824-01-0, stock: 2.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅F₁₁O₂.

Aconitine, CAS: 302-27-2, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₇NO₁₁.

ARC 239 Dihydrochloride, CAS: 55974-42-0, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉N₃O₃ • 2(HCl).

Bicyclo[4.2.0]octa-1,3,5-trien-7-amine, CAS: 61599-85-7, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N.

Centanafadine Hydrochloride, CAS: 923981-14-0, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N  •HCl.

Centanafadine Lactam, CAS: /, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO.

Centanafadine-d7 Hydrochloride, CAS: /, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₇N  •HCl.

Centanafadine-d7 Lactam, CAS: /, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₆D₇NO.

cis-N-Ethyl-2-(hydroxymethyl)-1-phenylcyclopropanecarboxamide, CAS: 69160-65-2, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₂.

Cyclopentamine Hydrochloride, CAS: 538-02-3, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClN.

Cyclopentamine Hydrochloride-d3, CAS: /, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇D₃ClN.

Cyclopentylacetic Acid, CAS: 1123-00-8, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₂.

D,L-threo-Droxidopa-13C2,15N Hydrochloride, CAS: 1329556-63-9, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₂H₁₂Cl¹⁵NO₅.

3α,5α-Tetrahydronorethisterone, CAS: 16392-60-2, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₂.

3α,5α-Tetrahydronorethisterone-d5, CAS: 122605-87-2, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₅O₂.

3β,5α-Tetrahydronorethisterone, CAS: 01/05/6424, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₂.

Dehydronitroso Nifedipine, CAS: 50428-14-3, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₅.

Desipramine Hydrochloride, CAS: 58-28-6, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃ClN₂.

3β,5α-Tetrahydronorethisterone-d5, CAS: 122605-89-4, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₅O₂.

4,5α-Dihydronorethisterone, CAS: 52-79-9, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

Desipramine Hydrochloride (1.0 mg/mL in Methanol), CAS: 58-28-6, stock: 7.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃ClN₂.

Desipramine-2,4,6,8-d4 Hydrochloride, CAS: 61361-34-0, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₄ClN₂.

Δ-5(10)-Norethindrone Acetate, CAS: 19637-28-6, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈O₃.

Desipramine-d3, CAS: 65100-49-4, stock: 6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₃N₂.

Δ-5(6)-Norethindrone, CAS: 22933-71-7, stock: 5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₂.

Desoxypipradrol, CAS: 519-74-4, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₁N.

Desoxypipradrol (1mg/mL in Methanol), CAS: 519-74-4, stock: 1.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₁N.

DL-β-O-Methylnorepinephrine Hydrochloride, CAS: 02/01/3770, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄ClNO₃.

DL-Norepinephrine 3-Sulfate, CAS: 112346-92-6, stock: 6.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO₆S.

DL-Norepinephrine 4-Sulfate, CAS: 35538-87-5, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO₆S.

DL-threo-Droxidopa, CAS: 3916-18-5, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₅.

DL-threo-Droxidopa-d3, CAS: 1643953-83-6, stock: 1.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₃NO₅.

DL-threo-Droxidopa-d3 Hydrochloride Salt Hydrate, CAS: /, stock: 2.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₃NO₅  • HCl • x(H ₂O).

Duloxetine Hydrochloride, CAS: 136434-34-9, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀ClNOS.

Duloxetine Hydrochloride (1.0 mg/mL in Methanol), CAS: 136434-34-9, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀ClNOS.

Duloxetine Maleate, CAS: 116817-86-8, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃NO₅S.

Duloxetine-d3 Maleate, CAS: /, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₃NO₅S.

Duloxetine-d7, CAS: 919514-01-5, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₇NOS.

Duloxetine-d7 Maleate, CAS: /, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆D₇NO₅S.

Edivoxetine Hydrochloride, CAS: 1194374-05-4, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇ClFNO₄.

Erythro-β,3-dihydroxy-DL-tyrosine, CAS: 16322-99-9, stock: 5.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₅.

Fenozolone, CAS: 15302-16-6, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₂.

GBR-12909 Dihydrochloride, CAS: 67469-78-7, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂F₂N₂O  • 2(HCl).

Isothiochromanone, CAS: 4426-76-0, stock: 3.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C9H8OS.

α-Ethyl Norepinephrine Hydrochloride(Mixture of Diastereomers), CAS: 3198-07-0, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClNO₃.

L-threo-Droxidopa, CAS: 23651-95-8, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₅.

L-threo-Droxidopa-13C2,15N, CAS: 1276295-04-5, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₂H₁₁¹⁵NO₅.

L-threo-β-(3,4-Methylenedioxyphenyl)serine, CAS: 84129-64-6, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₅.

L-threo-β-(3,4-Methylenedioxyphenyl)serine-d3, CAS: /, stock: 5.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₃NO₅.

L-Tyrosine tert-Butyl Ester, CAS: 16874-12-7, stock: 5.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₃.

Metapramine, CAS: 21730-16-5, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂.

Metapramine-d3, CAS: 1794942-17-8, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅D₃N₂.

Milnacipran Dimer Impurity B, CAS: /, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁N₃O₄.

N,N-Diethyl-2-methylene-1-phenyl-cyclopropanecarboxamide, CAS: 1418000-38-0, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO.

N,N-Dimethylamphetamine, CAS: 17279-39-9, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N.

N,N-Dimethylamphetamine-d6, CAS: 786580-21-0, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₆N.

N-(1-Naphthyl) Duloxetine, CAS: /, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₅NOS.

N-Benzyl-2-formyl Desipramine, CAS: 134150-70-2, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈N₂O.

N-Boc-L-tyrosine, CAS: 3978-80-1, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₅.

N-Cbz-L-tyrosine, CAS: 1164-16-5, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₅.

N-Ethylpropargylamine Hydrochloride, CAS: 53227-33-1, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀ClN.

N-Fmoc-5-fluoro-L-tryptophan, CAS: 908846-88-8, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₁FN₂O₄.

N-Fmoc-6-fluoro-L-tryptophan, CAS: 908847-01-8, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₁FN₂O₄.

N-Fmoc-L-tyrosine, CAS: 92954-90-0, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁NO₅.

Nisoxetine Hydrochloride, CAS: 57754-86-6, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₂ • HCl.

O-Denaphthyl N-(1-Naphthyl) Duloxetine, CAS: /, stock: 2.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NOS.

p-Hydroxy Levomilnacipran Hydrochloride, CAS: 688320-03-8, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₂•HCl.

p-Hydroxy-Levomilnacipran Carbamoyl-β-D-glucuronide, CAS: /, stock: 8.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀N₂O₁₀.

Prolintane, CAS: 493-92-5, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N.

Prolintane-d5, CAS: /, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₅N.

rac 2-Desaminomethyl-2-chloromethyl Milnacipran, CAS: 1353644-50-4, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀ClNO.

4-Acetoxynisoldipine, CAS: 106666-00-6, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₈.

4-Acetoxynisoldipine-d6, CAS: 1189672-21-6, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀D₆N₂O8.

4-Hydroxy Nisoldipine, CAS: 106685-70-5, stock: 5.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₇.

rac,cis-Milnacipran Hydrochloride, CAS: 165259-91-6, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅ClN₂O.

4-Hydroxy Nisoldipine-d6, CAS: 1189945-12-7, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈D₆N₂O₇.

Dehydro Nisoldipine, CAS: 103026-83-1, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₆.

rac,trans-Milnacipran Hydrochloride, CAS: 105310-47-2, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃ClN₂O.

rac-3-Thienyl-duloxetine, CAS: 116817-26-6, stock: 3.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NOS  •C₂H₂O₄.

Dehydro Nisoldipine-d7, CAS: 1329836-20-5, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅D₇N₂O₆.

Isobutyl 2-(2-Nitrobenzylidene)acetoacetate, CAS: 61312-59-2, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₅.

rac-Duloxetine Hydrochloride (1:1 R:S Mixtures), CAS: 947316-47-4, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀ClNOS.

rac-Milnacipran Hydrochloride, CAS: 101152-94-7, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃ClN₂O.

rac-Milnacipran-d10 Hydrochloride, CAS: 1217774-40-7, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₁₀ClN₂O.

rac-trans-Sertraline, CAS: 79836-45-6, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇Cl₂N.

RTI-112, CAS: 150653-92-2, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃Cl₂NO₂.

RTI-112-d3, CAS: /, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₃Cl₂NO₂.

t-Butylnorsynephrine, CAS: 96948-64-0, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₂.

Thozalinone, CAS: 655-05-0, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₂.

Thozalinone-d5, CAS: /, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₅N₂O₂.

[4-Hydroxy-1-methyl-4-(2-thienyl)-3-piperidinyl]-2-thienylmethanone Hydrochloride, CAS: 494221-40-8, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₂S₂ • HCl.

1,4-O-Didesmethyl rac-Niranthin, CAS: 81263-83-4, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈O₇.

1,4-O-Didesmethyl rac-Niranthin-d4, CAS: /, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄D₄O₇.

rac-Niranthin, CAS: 50656-77-4, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂O₇.

rac-Niranthin-d4, CAS: /, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈D₄O₇.

(Z)-Methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate, CAS: 2093243-16-2, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃NO₄.

4-Methyl-1-piperazinyl-acetyl Nintedanib Amide, CAS: /, stock: 8.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₁N₉O₄.

Desmethyl 5-Methoxycarbonyl Nintedanib (Nintedanib Impurity B), CAS: /, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁N₅O₄.

Desmethyl 7-Methoxycarbonyl Nintedanib (Nintedanib Impurity C), CAS: /, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁N₅O₄.

Desmethyl Nintedanib Carboxylic Acid (Nintedanib Impurity A), CAS: /, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₉N₅O₅.

Dimethyl 2-Oxoindoline-3,6-dicarboxylate, CAS: /, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₅.

N-[4-[[(Z)-(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)phenylmethyl]amino]phenyl]-N,4-dimethyl-1-piperazineacetamide, CAS: 262366-32-5, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁N₅O₂.

Nintedanib Demethyl-O-glucuronic Acid, CAS: 1352789-50-4, stock: 4.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₉N₅O₁₀.

Nintedanib Demethyl-O-glucuronic Acid-d3, CAS: /, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₆D₃N₅O₁₀.

Nintedanib Demethyl-O-β-D-glucuronic Acid Methyl Ester, CAS: /, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₁N₅O₁₀.

Nintedanib Demethyl-O-β-D-glucuronic Acid Methyl Ester 2,3,4-Triacetate, CAS: /, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₇N₅O₁₃.

Nintedanib Demethyl-O-β-D-glucuronic Acid Methyl Ester 2,3,4-Triacetate-D3, CAS: /, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₄₄D₃N₅O₁₃.

Nintedanib Demethyl-O-β-D-glucuronic Acid Methyl Ester-D3, CAS: /, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₃₈D₃N₅O₁₀.

Nintedanib Dimer Impurity, CAS: /, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₅₂N₈O₈.

4-[2-(4-Nitro-1H-imidazol-1-yl)ethyl]morpholine, CAS: 6497-78-5, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₄O₃.

Nilvadipine, CAS: 75530-68-6, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉N₃O₆.

Nilvadipine-d3, CAS: 95326-14-0, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₃N₃O₆.

Nilutamide, CAS: 63612-50-0, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀F₃N₃O₄.

Nilutamide-d6, CAS: 1189477-66-4, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄D₆F₃N₃O₄.

(E)-3-(3-(Dimethylamino)acryloyl)pyridine 1-Oxide, CAS: /, stock: 6.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₂.

3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)-aniline, CAS: 943320-48-7, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈F₃N₃.

3-(2,4-Dimethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline, CAS: /, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂F₃N₃.

3-(4-Ethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline, CAS: /, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂F₃N₃.

3-Acetylpyridine N-Oxide, CAS: 14188-94-4, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

4-(2-Pyridinyl)-2-pyrimidinamine, CAS: 66521-65-1, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₄.

4-(3-Pyridinyl)-2-pyrimidinamine, CAS: 66521-66-2, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₄.

4-Desmethyl-4-ethylimidazolyl Nilotinib, CAS: /, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄F₃N₇O.

4-Methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl]amino-N-(5-(3-oxo-4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamine, CAS: 2139382-75-3, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₂F₃N₇O₂.

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoyl Chloride, CAS: 1205540-17-5, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃ClN₄O.

Nifurtimox, CAS: 23256-30-6, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₅S.

Nifurtimox-d4, CAS: /, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₄N₃O₅S.

2-(2-Aminonicotinamido)-N,N-dimethylnicotinamide, CAS: /, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₅O₂.

DUDN, CAS: /, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₆O₄.

DUDN-d6, CAS: /, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₆N₆O₄.

Nicosulfuron, CAS: 111991-09-4, stock: 7.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₆O₆S.

Nicosulfuron-d6, CAS: 1189419-41-7, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₆N₆O₆S.

Terbufos Sulfone, CAS: 56070-16-7, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁O₄PS₃.

[[3-[(Dimethylamino)carbonyl]-2-pyridinyl]sulfonyl]carbamic Acid Ethyl Ester, CAS: 144098-17-9, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃O₅S.

[[3-[(Dimethylamino)carbonyl]-2-pyridinyl]sulfonyl]carbamic Acid Methyl Ester, CAS: 144098-18-0, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₅S.

2-(3-Pyridyl)-2-oxazoline, CAS: 40055-37-6, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O.

2-[(Pyridin-3-ylcarbonyl)-2-[(pyridin-3-ylcarbonyl)ethyl]amino]ethyl Nitrate, CAS: 1798026-96-6, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₅O₅.

6-Hydroxy Nicorandil, CAS: 113743-17-2, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O₅.

6-Hydroxy Nicorandil-d4, CAS: /, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₄N₃O₅.

N-(2-Hydroxyethyl)nitotinamide, CAS: 6265-73-2, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₂.

N-(2-Hydroxyethyl)nitotinamide-d4, CAS: /, stock: 2.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₄N₂O₂.

Nicorandil, CAS: 65141-46-0, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O₄.

Nicorandil N-Oxide, CAS: 107833-98-7, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O₅.

Nicorandil-d4, CAS: 1132681-23-2, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₄N₃O₄.

p-Nicorandil, CAS: 65141-47-1, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃O₄.

(+)-Cyclazocine, CAS: 7313-87-3, stock: 1.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO.

(+)-Cyclazocine-d3, CAS: /, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂D₃NO.

(+/-)-2-Methylnicotine, CAS: 64114-31-4, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

(+/-)-6-Methylnicotine, CAS: 101540-79-8, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

(+/-)-Iso Myosmine, Technical Grade, CAS: 53844-46-5, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂.

(-)-Cyclazocine, CAS: 7313-86-2, stock: 5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO.

(-)-Cyclazocine-d3, CAS: /, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂D₃NO.

(-)-Nicotine Ditartrate, CAS: 65-31-6, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₂O₁₂.

(1R,2S)-anti-Nicotine N’-Oxide Hydrate, CAS: /, stock: 7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O • H  ₂O.

(2R)-1-Methyl-2-phenylpyrrolidine, CAS: 58166-84-0, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N.

(2R)-1-Methyl-2-phenylpyrrolidine-D3, CAS: /, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₃N.

(2S)-1-Methyl-2-phenylpyrrolidine, CAS: 58166-86-2, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N.

(2S)-1-Methyl-2-phenylpyrrolidine-D3, CAS: /, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₃N.

(2S)-N’-Nitrosonornicotine, CAS: 16543-55-8, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃O.

(2S)-N’-Nitrosonornicotine-d4, CAS: 1426174-36-8, stock: 8.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₄N₃O.

(±)-N-Ethoxycarbonylnornicotine, CAS: 74245-32-2, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂.

(R)-(+)-Anatabine, CAS: 126454-22-6, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

(R)-N’-Nitrosonornicotine, CAS: 61601-78-3, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃O.

(R)-N’-Nitrosonornicotine-d4, CAS: /, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₄N₃O.

(R)-Nicotine-d3 N-β-D-Glucuronide, CAS: /, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉D₃N₂O₆.

(R)-Nornicotine, CAS: 7076-23-5, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.

(R)-Nornicotine-d4, CAS: 1259761-67-5, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₄N₂.

(R,S)-1-Methyl-3-nicotinoylpyrrolidine, CAS: 125630-26-4, stock: 5.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O.

(R,S)-Anatabine, CAS: 2743-90-0, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

(R,S)-Anatabine Tartrate (2:3), CAS: /, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂N₄O₁₈.

(R,S)-Anatabine-2,4,5,6-d4, CAS: 1020719-11-2, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₄N₂.

(R,S)-Anatabine-2,4,5,6-d4 (Major), CAS: 1020719-11-2, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₄N₂.

(R,S)-N-Ethyl Nornicotine, CAS: 86900-39-2, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

(R,S)-N-Nitroso Anabasine-d4, CAS: 1020719-68-9, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₄N₃O.

(R,S)-N’-Nitrosonornicotine-13C6, CAS: /, stock: 2.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₆H₁₁N₃O.

(R,S)-Nornicotine, CAS: 5746-86-1, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.

(R,S)-Nornicotine (1.0 mg/mL in Methanol), CAS: 5746-86-1, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.

(R,S)-Nornicotine-13C6, CAS: /, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₆H₁₂N₂.

(R,S)-Nornicotine-d4, CAS: 66148-18-3, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₄N₂.

(R,S)-Nornicotine-d4 (100 ug/mL in Methanol), CAS: 66148-18-3, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₄N₂.

(RS)-3-Bromo Nornicotine, CAS: 71719-06-7, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrN₂.

(S)-(-)-Anatabine, CAS: 581-49-7, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

(S)-1-Methyl-d3-nicotinium Iodide, CAS: /, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁D₃H₁₄N₂I.

(S)-1-Methylnicotinium Iodide, CAS: 21446-46-8, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₂I.

(S)-1’-Methyl-d3-nicotinium Iodide, CAS: /, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁D₃H₁₄N₂I.

(S)-1’-Methylnicotinium Iodide, CAS: 5959-86-4, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₂I.

(S)-2-Iodonicotine, CAS: 872315-70-3, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃IN₂.

(S)-5-Methylnicotine, CAS: 77629-31-3, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

(S)-6-Chloro-4-iodonicotine, CAS: 913264-28-5, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClIN₂.

(S)-6-Chloro-5-iodonicotine, CAS: 909193-59-5, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClIN₂.

(S)-6-Chloronicotine, CAS: 112091-17-5, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂.

(S)-6-Hydroxy Nicotine, CAS: 10516-09-3, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

(S)-6-Iodonicotine, CAS: 853737-18-5, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃IN₂.

(S)-6-Methoxynicotine, CAS: 224569-41-9, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

(S)-Anabasine, > 98% ee, CAS: 494-52-0, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

(S)-Anabasine-15N, CAS: /, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N¹⁵N.

(S)-Nicotine-d3 N-β-D-Glucuronide, CAS: /, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉D₃N₂O₆.

(S)-Nornicotine, CAS: 494-97-3, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.

(S)-Nornicotine-d4, CAS: 92761-98-3, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₄N₂.

1,​5,​6,​7,​8,​9-​Hexahydro-​5,​9-​methanoimidazo[4,​5-​h]​[3]​benzazepine hydrochloride, CAS: 230615-10-8, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₃•(HCl).

1-(Phenylmethyl)-5-(3-pyridinyl)-2-pyrrolidinone, CAS: 134415-17-1, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O.

1-Benzothiophene-3-carbonyl Chloride, CAS: 39827-12-8, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅OSCl.

1-Methyl-1H-pyrrole-2-carbaldehyde, CAS: 1192-58-1, stock: 2.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NO.

1-Methyl-3 (hydroxy- (3-pyridyl) methyl) Pyrrolidine (Mixture of Diastereomers), CAS: 887407-08-1, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

1-Methyl-3-(3’-pyridylcarbonyl-1,2’,3’,4’,5’,6’-13C6-pyrrolidinone, CAS: 1189492-36-1, stock: 10g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₆H₁₂N₂O₂.

2,6-Bis(benzyloxy)-3-bromopyridine, CAS: 16727-47-2, stock: 5.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆BrNO₂.

2-Chloro-5-(1-methyl-2-pyrrolidinyl)pyridine, CAS: 185510-30-9, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂.

2-Cyanopyridine, CAS: 100-70-9, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂.

2-Hydroxysaclofen, CAS: 117354-64-0, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO₄S.

2-Methyl Myosmine, CAS: 65719-03-1, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

2-Methyl Nornicotine, CAS: 64114-19-8, stock: 5.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl Ester, CAS: 74936-72-4, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₆.

(+/-)-Nipecotic Acid, CAS: 498-95-3, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.

3,5-Bis(3,4-dihydro-2H-pyrrol-5-yl)pyridine, CAS: /, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃.

(±)-Nipecotic Acid, CAS: 60252-41-7, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.

3-(4-Formylaminobutyryl)pyridine-d4, CAS: /, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₄N₂O₂.

Dehydro Nicardipine Hydrochloride, CAS: 1216817-27-4, stock: 6.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈ClN₃O₆.

m-Nifedipine, CAS: 21881-77-6, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂O₆.

(R)-Imazamox, CAS: 221298-64-2, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₄.

(S)-Imazamox, CAS: 355838-61-8, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₄.

3-(4-Methylaminobutyryl)pyridine-1,2’,3’,4’,5’,6’-13C6, Dihydrochloride, CAS: 1246819-72-6, stock: 6.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₁₆Cl₂N₂O.

Methyl 2-Methyl-6-(3-nitrophenyl)-4-oxo-2-cyclohexene-1-carboxylate, CAS: 87625-92-1, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₅.

Methyl 4-Methyl-6-(3-nitrophenyl)-2-oxo-cyclohex-3-enyl Carboxylate, CAS: /, stock: 4.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₅.

3-Picoline 1-Oxide, CAS: 1003-73-2, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NO.

3-Picoline-d6 1-Oxide, CAS: /, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₆NO.

1-Methyl-nicotinamide Iodide, CAS: 6456-44-6, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉IN₂O.

1-Methylnicotinamide-d3 Iodide, CAS: /, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₃IN₂O.

3-Pyridine-d4-acetic Acid, CAS: 1035439-74-7, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃D₄NO₂.

3-Pyridinecarboxaldehyde, CAS: 500-22-1, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO.

2,3,5-Trichloroisonicotinic Acid, CAS: 406676-18-4, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂NO₂Cl₃.

3-Pyridinecarboxaldehyde-d4, CAS: 258854-80-7, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₄NO.

3-Pyridylacetic Acid Hydrochloride, CAS: 6419-36-9, stock: 3.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈ClNO₂.

2,3,6-Trifluoroisonicotinic Acid, CAS: 675602-92-3, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂NO₂F₃.

2,3-Dibromoisonicotinic Acid, CAS: 1020056-98-7, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂Br₂.

3-Pyridylacetic Acid-d6, CAS: 1190005-72-1, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HD₆NO₂.

2,3-Dichloro-5-(trifluoromethyl)isonicotinic Acid, CAS: 1135283-33-8, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂NO₂F₃Cl₂.

2,3-Dichloroisonicotinic Acid, CAS: 184416-84-0, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂Cl₂.

4-(2-Pyrrolidinyl)pyridine, CAS: 128562-25-4, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.

4-(3-Pyridinyl)-2-pyrrolidinone, CAS: 55656-99-0, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O.

1,3-Bis(4-nitrophenyl)urea, CAS: 587-90-6, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀N₄O₅.

2,4-Dichloro-5,6-dimethyl Nicotinic Acid Ethyl Ester 1-Oxide, CAS: 1329488-60-9, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁Cl₂NO₃.

2,4-Dihydroxy-5,6-dimethyl Nicotinic Acid Ethyl Ester, CAS: 77629-51-7, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₄.

4-(Methyl-d3-amino)-1-(3-pyridyl)-1-butanone Dihydrochloride, CAS: 1189727-40-9, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃D₃Cl₂N₂O.

1,3-Bis(4-nitrophenyl)urea-d8, CAS: 1156508-87-0, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂D₈N₄O₅.

4,6-Dimethyl-2-hydroxypyrimidine, CAS: 108-79-2, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O.

2,5,6-Trichloronicotinic Acid, CAS: 54718-39-7, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂NO₂Cl₃.

2,5-Dibromoisonicotinic Acid, CAS: 942473-59-8, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Br₂NO₂.

4-(Methylamino)-1-(3-pyridyl)-1-butanone Dihydrochloride, CAS: 66093-90-1, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆Cl₂N₂O.

5-Bromo-2-methoxy-4,6-dimethyl-pyrimidine, CAS: 4786-73-6, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉BrN₂O.

2,5-Dibromonicotinic Acid, CAS: 29312-99-0, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Br₂NO₂.

2,5-Dichloro-4,6-dimethylnicotinic Acid, CAS: 142266-66-8, stock: 2.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₂Cl₂.

4-(Methylamino)-1-(3-pyridyl-d4)-1-butanone Dihydrochloride, CAS: 764661-23-6, stock: 9.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂D₄Cl₂N₂O.

Nicarbazine, CAS: 330-95-0, stock: 4.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₆O₆.

2,5-Dichloroisonicotinic acid, CAS: 88912-26-9, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂NO₂.

2,5-Dichloronicotinic Acid, CAS: 59782-85-3, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂Cl₂.

2,5-Difluoroisonicotinic Acid, CAS: 851386-39-5, stock: 5.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂F₂.

2,6-Bis-trifluoromethyl-nicotinic Acid Ethyl Ester, CAS: 1095211-28-1, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₂F₆.

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone N-β-D-Glucuronide, CAS: 350508-26-8, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₈.

2,6-Dichloro-5-fluoronicotinic acid, CAS: 82671-06-5, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Cl₂FNO₂.

2,6-Dichloroisonicotinic Acid, CAS: 5398-44-7, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂NO₂.

2,6-Dichloropyridine-3-carboxylic Acid, CAS: 38496-18-3, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂NO₂.

4-O-(4-Hydroxybutyl)thymidine, CAS: 938078-77-4, stock: 5.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₆.

2,6-Difluoro-nicotinic Acid Methyl Ester, CAS: 117671-02-0, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NO₂F₂.

2,6-Difluoronicotinic acid, CAS: 171178-50-0, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃F₂NO₂.

5-(Hydroxymethyl)-3-pyridinecarboxylic Acid Methyl Ester, CAS: 129747-52-0, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

2,6-Dihydroxyisonicotinic Acid, CAS: 99-11-6, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₄.

2,6-Dimethyl-nicotinic acid hydrochloride, CAS: 100960-91-6, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂ • HCl.

2,6-Dimethylisonicotinic acid, CAS: 54221-93-1, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

2,6-Dimethylnicotinic acid, CAS: 5860-71-9, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

2,​6-​Dibromopyridine-​4-​carboxylic Acid, CAS: 2016-99-1, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Br₂NO₂.

2-((2-Methoxyphenyl)amino)nicotinic Acid, CAS: 114501-02-9, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O₃.

5-Methyl Myosmine, CAS: 102780-52-9, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

2-(1-Pyrrolidinyl)nicotinic Acid, CAS: 690632-36-1, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₂.

2-(1-tert-Butoxycarbonyl-pyrrolidin-3-yloxy)nicotinic Acid, CAS: 1086392-88-2, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₅.

5-Methyl Nornicotine, CAS: 126741-11-5, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

5-Methylnicotine-d3, CAS: 1190016-33-1, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₃N₂.

2-(2,2-Dimethyl-propionylamino)-nicotinic acid, CAS: 125867-25-6, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

2-(2,3-Dihydro-1H-indol-1-yl)isonicotinic Acid, CAS: 1019357-95-9, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₂.

6,7-Dihydro-8(5H)-isoquinolinone, CAS: 21917-88-4, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO.

2-(2,4-Difluorophenyl)isonicotinic acid, CAS: 1258627-10-9, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇F₂NO₂.

2-(2,5-Difluorophenoxy)isonicotinic Acid, CAS: 1199215-67-2, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇NO₃F₂.

6-Hydroxy-N-methyl Myosmine, CAS: 68104-57-4, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O.

6-Methyl Myosmine, CAS: 77629-49-3, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

2-(2-((3-Fluorophenyl)amino)thiazol-4-yl)isonicotinic Acid, CAS: 1797019-23-8, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀FN₃O₂S.

2-(2-Ethoxy-2-oxoethyl)nicotinic Acid, CAS: 35969-51-8, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₄.

6-Methyl Nornicotine, CAS: 90872-72-3, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

2-(2-Ethyl-1-piperidinyl)isonicotinic Acid, CAS: 1094711-00-8, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

2-(2-Methoxybenzylamino)nicotinic Acid, CAS: 1019372-81-6, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂O₃.

8,9-Dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-one, CAS: 75704-24-4, stock: 4.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁Cl₂N₃O.

8-Fluoro-2,3,4,5-tetrahydro-1,5-methano-1H-3-benzazepine-7-carbonitrile, CAS: 328056-66-2, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁FN₂.

2-(3-Methoxycarbonylphenyl)Isonicotinic acid, CAS: 1258627-15-4, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₄.

2-(3-Oxo-1-piperazinyl)isonicotinic Acid, CAS: 1019323-66-0, stock: 6.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₃O₃.

Bis(2-​(dimethylamino)​ethyl) Succinate, CAS: 19249-04-8, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₂O₄.

2-(4-(3-Acetamidophenyl)-1H-pyrazol-1-yl)isonicotinic Acid, CAS: 1798043-17-0, stock: 7.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄N₄O₃.

2-(4-Benzyl-1-piperazinyl)isonicotinic Acid, CAS: 1019373-73-9, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₂.

2-(4-BOC-Aminophenyl)nicotinic acid, CAS: 1261951-56-7, stock: 9.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂O₄.

2-(4-Chlorophenyl)isonicotinic acid, CAS: 500586-44-7, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇F₂NO₂.

2-(4-Fluoro-2-hydroxyphenyl)isonicotinic acid (~90%), CAS: 1261919-94-1, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈FNO₃.

2-(4-Fluorophenoxy)nicotinic Acid, CAS: 54629-13-9, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈NO₃F.

2-(4-Fluorophenyl)nicotinic acid, CAS: 101419-78-7, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈FNO₂.

2-(4-methoxycarbonylphenyl)Isonicotinic acid, CAS: 1258621-89-4, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₄.

Dihydro Nicotyrine (>50%), CAS: 525-74-6, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

Dihydro Nicotyrine-d3, CAS: 1246818-62-1, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₃N₂.

2-(4-Methoxyphenethylamino)nicotinic Acid, CAS: 1019348-36-7, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O₃.

2-(4-Methylphenyl)isonicotinic Acid, CAS: 1226205-64-6, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₂.

Diisopinocampheylborane, CAS: 21947-87-5, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₅B.

Isonicotine, CAS: 92118-22-4, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

2-(4-Morpholinyl)isonicotinic Acid Hydrochloride, CAS: 848580-46-1, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃ • HCl.

2-(4-t-Butylphenyl)isonicotinic Acid, CAS: 1226273-21-7, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₂.

Isonicotine-d3, CAS: 1346601-08-8, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₃N₂.

β-Nicotyrine, CAS: 487-19-4, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂.

2-(Allylamino)nicotinic Acid, CAS: 1019126-98-7, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₂.

2-(Azidomethyl)-3-pyridinecarboxylic Acid, CAS: 1700604-18-7, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₄O₂.

β-Nicotyrine L-Tartrate, CAS: 4315-37-1, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₆.

β-Nicotyrine-13C6, CAS: /, stock: 1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₆N₂.

2-(Carboxymethylamino) Nicotinic Acid, CAS: 1057318-86-1, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₄.

2-(Carboxymethylamino) Nicotinic Acid Diethyl Ester, CAS: 1178176-00-5, stock: 3.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₄.

β-Nicotyrine-d3, CAS: /, stock: 4.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₃N₂.

γ-Oxo-3-pyridinebutanamide, CAS: 61192-49-2, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₂.

2-(Cyclohexyloxy)isonicotinic Acid, CAS: 1019353-19-5, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃.

2-(Difluoromethoxy)isonicotinic Acid, CAS: 1211581-51-9, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NO₃F₂.

LY 288513, CAS: 147523-65-7, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈BrN₃O₂.

2-(Ethoxycarbonyl)isonicotinic Acid, CAS: 142074-49-5, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₄.

2-(Ethylthio)nicotinic Acid, CAS: 27868-76-4, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂S.

2-(Isobutylamino)nicotinic Acid, CAS: 1019461-50-7, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂.

2-(Isopropoxycarbonyl)nicotinic Acid, CAS: 118892-73-2, stock: 4.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₄.

2-(Methylthio)nicotinic Acid Hydrazide, CAS: 232926-33-9, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N₃OS.

Methyl[4-(3-pyridinyl)-3-butenyl]carbamic Acid Ethyl Ester, CAS: 54002-25-4, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

Mixture of  (R,S)-N-Nitroso Anabasine, rac N’-Nitrosonornicotine, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and (S)-N-Nitroso Anatabine (10μg/mL in Acetonitrile), CAS: /, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  1:1:1:1 by weight.

2-(Pentylthio)nicotinic Acid, CAS: 175135-23-6, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂S.

2-(Propylthio)nicotinic Acid, CAS: 175135-22-5, stock: 4.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂S.

Mixture of  (R,S)-N-Nitroso Anabasine, rac N’-Nitrosonornicotine, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and (S)-N-Nitroso Anatabine (1mg/mL in Acetonitrile), CAS: /, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  NA.

Mixture of  (R,S)-N-Nitroso Anabasine-d4, rac N’-Nitrosonornicotine-d4, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-d4 and (S)-N-Nitroso Anatabine-d4 (0.1mg/mL in Acetonitrile), CAS: /, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  1:1:1:1 by weight.

2-(tert-Butoxycarbonylamino)-4-chloronicotinic Acid, CAS: 1021339-32-1, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂O₄Cl.

2-(tert-Butoxycarbonylamino)-6-chloronicotinic Acid, CAS: 1224194-44-8, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₂O₄Cl.

Mixture of  (R,S)-N-Nitroso Anabasine-d4, rac N’-Nitrosonornicotine-d4, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-d4 and (S)-N-Nitroso Anatabine-d4 (1.0mg/mL in Acetonitrile), CAS: /, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  1:1:1:1 by weight.

Mixture of  (R,S)-N-Nitroso Anabasine-d4, rac N’-Nitrosonornicotine-d4 , and 4-(Methylnitrosamino)-1-(3-pyridyl-d4)-1-butanone (1mg/mL in Acetonitrile), CAS: /, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  NA.

2-(Trifluoromethoxy)isonicotinic Acid, CAS: 1221171-98-7, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄NO₃F₃.

2-(Trifluoromethyl) Nicotinic Acid, CAS: 131747-43-8, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄F₃NO₂.

2-(Trifluoromethyl)isonicotinic Acid, CAS: 131747-41-6, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄NO₂F₃.

2-Acetamido-5-bromoisonicotinic Acid, CAS: 871269-03-3, stock: 6.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇BrN₂O₃.

N-Benzyl-3-(4-(methylamino)butyl)pyridin-2-amine, CAS: /, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃N₃.

N-Benzyl-N-methylputrescine, CAS: 221196-25-4, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀N₂.

2-Acetamido-5-chloroisonicotinic Acid, CAS: 944390-08-3, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇ClN₂O₃.

2-Acetyl-isonicotinic acid methyl ester, CAS: 138715-82-9, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₃.

N-Boc (R,S)-Nornicotine, CAS: 1076199-53-5, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₂.

2-Acetylaminoisonicotinic Acid, CAS: 54221-95-3, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C8H8N2O3.

2-Amino Nicotinic Acid, CAS: 5345-47-1, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

2-Amino-4,6-dimethylnicotinic Acid, CAS: 106837-89-2, stock: 2.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₂.

2-Amino-5-(4-fluorophenyl)isonicotinic Acid, CAS: 1214370-50-9, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉FN₂O₂.

N-Formylnornicotine, CAS: 3000-81-5, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O.

2-Amino-5-bromoisonicotinic Acid, CAS: 1000339-23-0, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂Br.

2-Amino-5-bromonicotinic Acid, CAS: 52833-94-0, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrN₂O₂.

N-Methoxy-N-methylnicotinamide-13C6, CAS: /, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₁₀N₂O₂.

2-Amino-5-chloropyridine-3-carboxylic acid, CAS: 52833-93-9, stock: 7.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O₂.

2-Amino-5-fluoronicotinic acid, CAS: 1196154-03-6, stock: 1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅FN₂O₂.

2-Amino-5-iodonicotinic Acid, CAS: 54400-30-5, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂I.

2-Amino-5-methylnicotinic Acid, CAS: 532440-94-1, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

2-Amino-5-phenylnicotinic Acid, CAS: 1196157-56-8, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₂.

2-Amino-6-bromonicotinic Acid, CAS: 1196157-51-3, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂Br.

N-Methyl-D3-pyrrolidine, CAS: 77422-30-1, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈D₃N.

2-Amino-6-chloronicotinic Acid, CAS: 58584-92-2, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O₂.

2-Amino-6-fluoroisonicotinic Acid, CAS: 1393583-50-0, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅FN₂O₂.

N-Methyl-N’-nitrosonornicotinium Iodide, CAS: 53844-48-7, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄IN₃O.

2-Amino-6-methoxy-nicotinic Acid Methyl Ester, CAS: 1227048-93-2, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₃.

2-Amino-6-methoxynicotinic Acid, CAS: 1196156-84-9, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃.

N-Methylbutane-1,4-diamine Dihydrochloride, CAS: 89690-09-5, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₆Cl₂N₂.

N-Methylbutane-1,4-diamine, Dihydrochloride-13C, 15N, CAS: /, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₄N¹⁵N • Cl  ₂H₂.

2-Amino-6-methylnicotinic Acid, CAS: 846021-26-9, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

N-Methylbutane-1,4-diamine, Dihydrochloride-13C, 15N, CAS: /, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₁₂N¹⁵N  •  Cl₂H₂.

2-Aminoisonicotinic Acid Hydrochloride, CAS: 1185560-43-3, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.HCl.

2-Anilinoisonicotinic Acid, CAS: 1019461-36-9, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₂.

N’-Nitrosonornicotine N-D-Glucoside, Acetate Salt (Mixture Of Diastereomers), CAS: /, stock: 7.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₈.

2-Azepan-1-yl-isonicotinic acid hydrochloride, CAS: 1187932-74-6, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂ • HCl.

2-Bromo-3,5-dichloroisonicotinic acid, CAS: 343781-56-6, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂BrCl₂NO₂.

N’-Nitrosonornicotine N-β-D-Glucuronide (Mixture Of Diastereomers) X Hydrate, CAS: 350508-25-7, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₇.

N’-Nitrosonornicotine-5-carboxylic Acid, CAS: 1076199-27-3, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₃O₃.

2-Bromo-3-fluoroisonicotinic Acid, CAS: 1211530-89-0, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂FBr.

2-Bromo-3-methyl-isonicotinic Acid, CAS: 1211583-05-9, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂Br.

N’-Nitrosonornicotine-N-b-D-glucuronide, CAS: 864071-82-9, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₇.

Nicotelline, CAS: 494-04-2, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁N₃.

2-Bromo-4-hydroxynicotinic acid, CAS: 1150561-81-1, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrNO₃.

2-Bromo-5-chloronicotinic acid, CAS: 65550-79-0, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrClNO₂.

Nicotelline-d9 (Major), CAS: /, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂D₉N₃.

2-Bromo-5-fluoroisonicotinic acid, CAS: 885588-12-5, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrFNO₂.

2-Bromo-6-(trifluoromethyl)nicotinic Acid, CAS: 749875-07-8, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₂F₃Br.

2-Bromo-6-chloroisonicotinic Acid, CAS: 1060811-26-8, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂ClBr.

Nicotine N-(4-Deoxy-4,5-didehydro)-β-D-glucuronide, CAS: /, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O₅.

2-Bromo-6-fluoronicotinic Acid, CAS: 1214332-31-6, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂FBr.

2-Bromo-6-methoxynicotinic Acid, CAS: 1009735-25-4, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₃Br.

Nicotine N-D-Glucoside 2,3,4,6-Tetraacetate Bromide Hydrobromide, CAS: /, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄Br₂N₂O₉.

Nicotine N-D-Glucoside Bromide Hydrobromide, CAS: /, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆Br₂N₂O₅.

2-Bromo-6-methyl-nicotinic Acid, CAS: 1060810-09-4, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂Br.

2-Bromoisonicotinic Acid, CAS: 66572-56-3, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄NO₂Br.

Nicotine N-β-D-Glucuronide, CAS: 153536-53-9, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₂O₆.

Nicotine N-β-D-Glucuronide-2,3,4-O-triacetate Bromide, CAS: /, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁BrN₂O₉.

2-Bromonicotinic acid, CAS: 35905-85-2, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrNO₂.

2-Chloro-3-(trifluoromethyl)isonicotinic Acid, CAS: 1227587-24-7, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₂F₃Cl.

Nicotine-d3 N-(4-Deoxy-4,5-didehydro)-β-D-glucuronide, CAS: /, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₃N₂O₅.

2-Chloro-3-aminoisonicotinic Acid, CAS: 58483-94-6, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O₂.

2-Chloro-3-fluoroisonicotinic acid, CAS: 628691-93-0, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClFNO₂.

NIDA 41020, CAS: 502486-89-7, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄Cl₂N₄O₂.

Nornicotine-2-carboxylic Acid, CAS: 06/11/3562, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₂.

2-Chloro-4,6-dimethylnicotinic acid, CAS: 66662-48-4, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.

11-Cyclopropyl-5,11-dihydro-4-(hydroxymethyl)-6H-dipyrido[3,2-b:2’,3’-e][1,4]diazepin-6-one, CAS: 133627-24-4, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₂.

o-Myosmine, CAS: 4593-27-5, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂.

2-Chloro-4-(trifluoromethyl)nicotinic Acid, CAS: 590371-81-6, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₂F₃Cl.

2-Chloro-4-iodonicotinic acid, CAS: 544671-78-5, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClINO₂.

11-Cyclopropyl-5,11-dihydro-4-(hydroxymethyl)-6H-dipyrido[3,2-b:2’,3’-e][1,4]diazepin-6-one-d2, CAS: /, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₂N₄O₂.

Pancuronium Dibromide, CAS: 15500-66-0, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₂N₂O₄ • 2Br.

2-Chloro-4-pivalamidonicotinic Acid, CAS: 1021339-24-1, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClN₂O₃.

2-Chloro-4-trimethylsilanylethynyl-nicotinic acid methyl ester, CAS: 470463-44-6, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClNO₂Si.

12-Hydroxy Nevirapine 12-O-β-D-Glucuronide, CAS: 245500-95-2, stock: 6.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₄O₈.

R-(+)-Nicotine, CAS: 25162-00-9, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

2-Chloro-5,6-dimethyl Nicotinic Acid, CAS: 120003-75-0, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.

2-Chloro-5,6-dimethyl-4-methoxy Nicotinic Acid Methyl Ester, CAS: 1329833-74-0, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClNO₃.

2,6-Dichloro-N-[2-chloro-4-methyl-3-pyridinyl]-3-pyridinecarboxamide, CAS: 1798004-92-8, stock: 5.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈Cl₃N₃O.

2-Amino Nevirapine, CAS: 284686-15-3, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₅O.

Monohydroxy Netupitant, CAS: 910808-12-7, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂F₆N₄O₂.

R-(+)-Nicotine Di-p-toluoyl-D-tartrate Salt, CAS: 68935-27-3, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂N₂O₈.

rac 2-Chloro Nicotine, CAS: 871894-35-8, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂.

2-Chloro-5-(trifluoromethoxy)isonicotinic Acid, CAS: 1221171-77-2, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₃F₃Cl.

2-Chloro-5-fluoro-6-methoxynicotinic acid, CAS: 943025-86-3, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClFNO₃.

2-Amino Nevirapine-d3, CAS: 1346605-12-6, stock: 3.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂D₃N₅O.

2-Chloro-N-[2-(cyclopropylamino)-4-methyl-3-pyridinyl]-3-pyridinecarboxamide, CAS: 284686-19-7, stock: 4.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅ClN₄O.

Monohydroxy Netupitant-d6, CAS: /, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆D₆F₆N₄O₂.

N-Desmethyl Netupitant, CAS: 290296-72-9, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀F₆N₄O.

2-Chloro-5-fluoroisonicotinic acid, CAS: 884494-74-0, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClFNO₂.

2-Chloro-5-fluoronicotinic acid, CAS: 38186-88-8, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClFNO₂.

2-Hydroxy Nevirapine, CAS: 254889-31-1, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₂.

2-Hydroxy Nevirapine 2-O-β-D-Glucuronide, CAS: 245500-91-8, stock: 8.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₄O₈.

N-Desmethyl Netupitant-d6, CAS: /, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄D₆F₆N₄O.

Netupitant, CAS: 290297-26-6, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂F₆N₄O.

rac 5-(3-Pyridyl)tetrahydro-2-furanone, CAS: 20971-79-3, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

rac 5-(3-Pyridyl)tetrahydro-2-furanone-d3, CAS: /, stock: 9.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆D₃NO₂.

2-Chloro-5-nitronicotinic acid, CAS: 42959-38-6, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClN₂O₄.

2-Chloro-5-phenylisonicotinic acid, CAS: 1214323-23-5, stock: 2.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClNO₂.

2-Hydroxy Nevirapine-d3, CAS: 1329834-05-0, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₃N₄O₂.

2-Nitro Nevirapine, CAS: 284686-16-4, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N₅O₃.

Netupitant N-Oxide, CAS: 910808-11-6, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂F₆N₄O₂.

Netupitant N-Oxide-d6, CAS: /, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆D₆F₆N₄O₂.

rac N’-Nitrosonornicotine 5’-Acetate(Mixture of Diastereomers), CAS: 68743-65-7, stock: 10g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₃.

rac N’-Nitrosonornicotine-d4, CAS: 66148-19-4, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₄N₃O.

2-Chloro-5-phenylnicotinic acid, CAS: 117449-73-7, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClNO₂.

2-Chloro-6-(trifluoromethyl)nicotinic acid, CAS: 280566-45-2, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃ClF₃NO₂.

2-Nitro Nevirapine-d3, CAS: /, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₃N₅O₃.

3-Bromo Nevirapine, CAS: 284686-21-1, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃BrN₄O.

Netupitant-d6, CAS: /, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆D₆F₆N₄O.

rac N’-Nitrosonornicotine-d4 (0.1 mg/mL in Methanol), CAS: 66148-19-4, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₄N₃O.

rac N’-Nitrosonornicotine-d4 (1.0 mg/mL in Acetonitrile), CAS: 66148-19-4, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₄N₃O.

2-Chloro-6-hydroxynicotinic acid, CAS: 38025-90-0, stock: 1.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₃.

2-Chloro-6-methoxyisonicotinic Acid, CAS: 15855-06-8, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₃Cl.

3-Ethenyl Nevirapine, CAS: 284686-22-2, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₄O.

3-Formyl Nevirapine, CAS: 174532-77-5, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₄O₂.

rac N’-Nitrosonornicotine-d4 with (R,S)-N-Nitroso Anabasine-d4 (1:1) (Solution in Acetonitrile 1mg/mL), CAS: /, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₄N₃O.

rac-2-Amino Nicotine, CAS: 32726-84-4, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₃.

2-Chloro-6-methylnicotinic acid, CAS: 30529-70-5, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₂.

2-Chloroisonicotinic Acid, CAS: 6313-54-8, stock: 8.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₂.

3-Hydroxy Nevirapine, CAS: 174532-82-2, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₂.

3-Hydroxy Nevirapine 3-O-β-D-Glucuronide, CAS: 245500-93-0, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₄O₈.

rac-2-Hydroxy Nicotine, CAS: 2055-24-5, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

2-Chloronicotinic Acid, CAS: 2942-59-8, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₂.

2-Cyano-4-pyridinecarboxylic Acid Ethyl Ester, CAS: 58481-14-4, stock: 4.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₂.

3-Hydroxy Nevirapine-d3, CAS: 1346602-85-4, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₃N₄O₂.

4-Carboxy Nevirapine, CAS: 245501-02-4, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₄O₃.

rac-5-Methylnicotine, CAS: 82111-06-6, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

2-Cyano-4-pyridinecarboxylic Acid Methyl Ester, CAS: 94413-64-6, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O₂.

2-Cyclopropylisonicotinic Acid, CAS: 1216171-07-1, stock: 1.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

6-Chloro-2-cyclopropylamino-N-[2-chloro-4-methyl-3-pyridinyl]-3-pyridinecarboxamide, CAS: 1797987-49-5, stock: 5.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄Cl₂N₄O.

8-Hydroxy Nevirapine, CAS: 254889-32-2, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₂.

2-Cyclopropylnicotinic Acid, CAS: 1244761-65-6, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

2-Ethoxy-5-fluoroisonicotinic Acid, CAS: 1809157-96-7, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NO₃F.

8-Hydroxy Nevirapine 8-O-β-D-Glucuronide, CAS: 245500-97-4, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₄O₈.

9-Chloro Nevirapine, CAS: 1796928-56-7, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃ClN₄O.

2-Ethoxyisonicotinic Acid, CAS: 91940-86-2, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

2-Ethoxynicotinic Acid, CAS: 35969-54-1, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

BIRG 613 BS, CAS: 287980-85-2, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₄O.

BIRG 613 BS-d7, CAS: /, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₇N₄O.

2-Ethylnicotinic Acid, CAS: 3421-76-9, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

2-Fluoro-4-iodonicotinic acid, CAS: 884494-51-3, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃FINO₂.

BIRG 616 BS, CAS: 287980-84-1, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₄O.

BIRH 414, CAS: 133627-17-5, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₄O.

rac-N’-Nitroso Nornicotine, CAS: 80508-23-2, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃O.

rac-N’-Nitroso Nornicotine (1.0 mg/mL in Acetonitrile), CAS: 80508-23-2, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃O.

2-Fluoro-4-iodonicotinic acid methyl ester, CAS: 884494-84-2, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅FINO₂.

2-Fluoro-5-methylnicotinic Acid, CAS: 1042986-00-4, stock: 1.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂F.

N-(2-Chloro-4-methyl-3-pyridinyl)-2-(cyclopropyl-d5-amino)-3-pyridine-carboxamide, CAS: 1184978-88-8, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₅ClN₄O.

N-Cyclopropyl-4-methyl-3-nitro-2-pyridinamine, CAS: 284686-17-5, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃O₂.

rac-N’-Nitroso Nornicotine (1.0 mg/mL in Methanol), CAS: 80508-23-2, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃O.

rac-N’-Nitrosonornicotine 1-N-Oxide, CAS: 1314916-69-2, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃O₂.

2-Fluoro-6-(pyrrolidin-1-yl)isonicotinic acid, CAS: 1228665-96-0, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁FN₂O₂.

2-Fluoro-6-(pyrrolidin-1-yl)nicotinic Acid, CAS: 1203499-55-1, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁FN₂O₂.

N-[5-Bromo-2-(cyclopropylamino)-4-methyl-3-pyridinyl]-2-chloro-3-pyridinecarboxamide, CAS: 284686-20-0, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄BrClN₄O.

N2-Cyclopropyl-4-methyl-2,3-pyridinediamine, CAS: 284686-18-6, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃.

rac-N’-Nitrosonornicotine-13C6 1-N-Oxide, CAS: /, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₆H₁₁N₃O₂.

rac-N’-Nitrosonornicotine-d4 1-N-Oxide, CAS: /, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₄N₃O₂.

2-Fluoronicotinic Acid, CAS: 393-55-5, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄FNO₂.

2-Hydrazinonicotinic Acid, CAS: 462068-09-3, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃O₂.

Nevirapine, CAS: 129618-40-2, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O.

Nevirapine Dimer, CAS: 1391054-30-0, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆N₈O₂.

rac-Nicotine, CAS: 22083-74-5, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

rac-Nicotine 1-Oxide, CAS: 23113-16-8, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

2-Hydroxy Nicotinic Acid, CAS: 609-71-2, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₃.

2-Hydroxy-5-(4-t-butylphenyl)isonicotinic acid, CAS: 1261954-99-7, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₃.

Nevirapine-12-(n-proylidenyl), CAS: 284686-27-7, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₄O.

Nevirapine-12-(n-proylidenyl-d5), CAS: /, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃D₅N₄O.

rac-Nicotine-1,2’,3’,4’,5’,6’-13C6, CAS: 1189715-49-8, stock: 6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₁₄N₂.

rac-Nicotine-13CD3, CAS: 909014-86-4, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₁D₃N₂.

2-Hydroxy-5-iodo-nicotinic Acid Methyl Ester, CAS: 116387-40-7, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₃I.

2-Hydroxy-5-nitronicotinic acid, CAS: 05/07/6854, stock: 4.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₅.

Nevirapine-d3, CAS: 1051419-24-9, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁D₃N₄O.

rac-Nicotine-1’-oxide, CAS: /, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

rac-Nicotine-2’,3’,3’-d3, CAS: 1189681-48-8, stock: 2.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₃N₂.

2-Hydroxy-5-phenylnicotinic acid, CAS: 10177-08-9, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

2-Hydroxy-6-methylnicotinic acid, CAS: 38116-61-9, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

rac-Nicotine-d3, CAS: 69980-24-1, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₃N₂.

rac-Nicotine-d3 N-β-D-Glucuronide, CAS: /, stock: 8.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉D₃N₂O₆.

2-Isopropoxynicotinic Acid, CAS: 1016690-39-3, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₃.

2-Mercaptonicotinic acid, CAS: 38521-46-9, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₂S.

rac-Nicotine-d4, CAS: 350818-69-8, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₄N₂.

rac-Nornicotine Bitartrate, CAS: /, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₂O₁₂.

2-Methoxy-3-pivalamidoisonicotinic acid, CAS: 705291-48-1, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₄.

2-Methoxy-5-(4-t-butylphenyl)nicotinic acid, CAS: 1261994-19-7, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₃.

rac-ortho-Nicotine Diperchlorate, CAS: 147663-86-3, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆Cl₂N₂O₈.

rac-trans 3’-Acetylthiomethyl Nicotine, CAS: 1217716-10-3, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂OS.

2-Methoxy-5-methylnicotinic acid, CAS: 1227594-72-0, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

2-Methoxy-5-nitro-nicotinic Acid, CAS: 1020635-54-4, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₅.

rac-trans 3’-Hydroxymethylnicotine, CAS: 71771-91-0, stock: 5.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O.

2-Methoxy-5-pyridinecarboxylic Acid, CAS: 66572-55-2, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

2-Methoxy-6-(pyrrolidin-1-yl)nicotinic acid, CAS: 1228665-72-2, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

rac-trans 3’-Hydroxymethylnicotine Hemisuccinate, CAS: 1207282-59-4, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O₄.

rac-trans 3’-Hydroxymethylnicotine Hemisuccinate N-Hydroxysuccinimide Ester, CAS: 1207282-60-7, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃N₃O₆.

2-Methoxyisonicotinic acid, CAS: 105596-63-2, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

2-Methoxynicotinic Acid, CAS: 16498-81-0, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

rac-trans 3’-Thiomethyl Nicotine Dihydrochloride, CAS: /, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈Cl₂N₂S.

2-Methyl Nicotinic Acid, CAS: 3222-56-8, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

2-Methyl-5-(trifluoromethyl)nicotinic Acid, CAS: 1211581-65-5, stock: 7.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆NO₂F₃.

rac-trans-Nicotine-1’-oxide-d3, CAS: /, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₃N₂O.

RuBi-Nicotine, CAS: 1256362-30-7, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₄Cl₂N₈Ru.

2-Methyl-6-(trifluoromethyl)nicotinic Acid, CAS: 261635-93-2, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆NO₂F₃.

2-Methylcyclopentanone, CAS: 1120-72-5, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O.

2-Morpholinoisonicotinic Acid, CAS: 295349-64-3, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

S-(-)-Nicotine Di-p-Toluoyl-D-Tartrate Salt, CAS: 68935-26-2, stock: 7.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂•C₂₀H₁₈O₈.

2-Morpholinonicotinic Acid, CAS: 423768-54-1, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

2-Nitronicotinic Acid, CAS: 33225-72-8, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₄.

S-(-)-Nicotine-Δ1’(5’)-iminium Diperchlorate Salt, CAS: 71014-67-0, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄Cl₂N₂O₈.

2-Nitropyridine-4-carboxylic Acid, CAS: 33225-74-0, stock: 6.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₄.

2-Phenoxynicotinic Acid, CAS: 35620-71-4, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

2-Phenylisonicotinic Acid, CAS: 55240-51-2, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₂.

2-Pyrrolidin-1-yl-isonicotinic acid hydrochloride, CAS: 1187932-62-2, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₂ • HCl.

(2E)-N-​(4-​Chloro-​3-​cyano-​7-​ethoxy-​6-​quinolinyl)​-​2-butenamide, CAS: 1403831-79-7, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄ClN₃O₂.

2-[(4-Trifluoromethyl)phenyl]-6-methyl Nicotinic Acid, CAS: 883241-16-5, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀F₃NO₂.

2-[3,4-Dihydro-2(1H)-isoquinolinyl]-isonicotinic Acid, CAS: 1019375-24-6, stock: 5.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂O₂.

N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide, CAS: 848133-76-6, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂ClN₃O₂.

3,5-Dichloroisonicotinic acid, CAS: 13958-93-5, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂NO₂.

3,5-Difluoroisonicotinic acid, CAS: 903522-29-2, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃F₂NO₂.

Neratinib, CAS: 698387-09-6, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₉ClN₆O₃.

Neratinib-d6, CAS: 1259519-18-0, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₃D₆ClN₆O₃.

3,5-Pyridinedicarboxylic Acid, CAS: 499-81-0, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NO₄.

3,6-Dihydro Risperidone, CAS: 168906-58-9, stock: 6.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅FN₄O₂.

3-((2-Trifluoromethyl)benzyl)amino)isonicotinic Acid, CAS: 1522626-06-7, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁F₃N₂O₂.

3-((tert-Butoxycarbonyl)amino)isonicotinic Acid, CAS: 179024-65-8, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₄.

3-((tert-Butoxycarbonylamino)methyl)-5-methoxyisonicotinic Acid, CAS: 1138444-21-9, stock: 10g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₅.

3-(2,2-Dimethyl-propionylamino)isonicotinic Acid, CAS: 86847-91-8, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

[4-Chloro-4-(3-pyridinyl)butyl]methylcarbamic Acid Ethyl Ester, CAS: 73130-52-6, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉ClN₂O₂.

3-(3-Hydroxymethylphenyl)isonicotinic acid, CAS: 1261991-78-9, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₃.

3-(4-Fluorophenyl)isonicotinic acid, CAS: 1214348-98-7, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈FNO₂.

2-Amino-3-benzoyl-5-chloro-α-(propylthio)benzeneacetamide, CAS: 1881270-48-9, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉ClN₂O₂S.

3-(4-Hydroxyphenyl)isonicotinic acid, CAS: 1258625-94-3, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

3-(4-methoxyphenyl)isonicotinic acid, CAS: 1258618-34-6, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₃.

3-Amino Isonicotinic Acid, CAS: 7579-20-6, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

2-Amino-3-benzoyl-α-(methylthio)benzeneacetamide, CAS: 78281-61-5, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆N₂O₂S.

2-Amino-3-benzoyl-α-(propylthio)benzeneacetamide, CAS: 173262-94-7, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O₂S.

3-Amino-2,6-dichloroisonicotinic Acid, CAS: 58484-01-8, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄Cl₂N₂O₂.

3-Amino-2-methoxyisonicotinic Acid, CAS: 870997-81-2, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃.

2-[[4-(Dimethylamino)phenyl](methylthio)methylene]propanedinitrile, CAS: 98190-48-8, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃S.

3-Amino-5-methoxyisonicotinic acid, CAS: 82673-73-2, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃.

3-Amino-6-chloroisonicotinic Acid, CAS: 58483-95-7, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClN₂O₂.

3-Amino-isonicotinic Acid Ethyl Ester, CAS: 14208-83-4, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₂.

3-Amino-isonicotinic acid ethyl ester hydrochloride, CAS: 306936-11-8, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₂ • HCl.

3-Aminoisonicotinic Acid Methyl Ester, CAS: 55279-30-6, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

3-Boronoisonicotinic Acid, CAS: 1072946-05-4, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆BNO₄.

3-Bromoisonicotinic Acid, CAS: 13959-02-9, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄NO₂Br.

3-Chloro-2-methoxyisonicotinic Acid, CAS: 1211584-06-3, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₃.

3-Chloroisonicotinic acid, CAS: 88912-27-0, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₂.

3-Cyano-5-methoxyisonicotinic acid, CAS: 1138444-09-3, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O₃.

3-Cyanoisonicotinic Acid, CAS: 1060802-59-6, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₂O₂.

3-Fluoroisonicotinic acid, CAS: 393-53-3, stock: 2.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄FNO₂.

3-Iodoisonicotinic Acid, CAS: 57842-10-1, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄INO₂.

3-Methoxy-5-(phenylcarbamoyl)isonicotinic acid, CAS: 1087659-19-5, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₄.

3-Nitroisonicotinic Acid, CAS: 59290-82-3, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₄.

3-Phenylisonicotinic Acid, CAS: 104096-15-3, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₂.

3-Pyridazinecarboxylic Acid, CAS: 2164-61-6, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₂.

4,6-Dichloro-2-methylnicotinic Acid, CAS: 693286-31-6, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NO₂Cl₂.

4,6-Dichloro-5-fluoronicotinic Acid, CAS: 154012-18-7, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Cl₂FNO₂.

4,6-Dichloronicotinic acid, CAS: 73027-79-9, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂NO₂.

4,6-Dihydroxynicotinic Acid, CAS: 5466-62-6, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₄.

4-(4-Cyanophenyl)nicotinic acid, CAS: 1261943-53-6, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈N₂O₂.

4-(4-Fluorophenyl)nicotinic acid, CAS: 32923-72-1, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈FNO₂.

4-(Furan-2-yl)nicotinic acid, CAS: 1261961-41-4, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₃.

4-(Piperidin-1-yl)nicotinic Acid, CAS: 1023816-94-5, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₂.

4-(Trifluoromethyl)-3-Pyridinecarboxylic Acid, CAS: 158063-66-2, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄F₃NO₂.

4-Amino-2-bromonicotinic Acid, CAS: 1060809-71-3, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrN₂O₂.

4-Amino-6-chloronicotinic Acid, CAS: 1060811-65-5, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂Cl.

4-Amino-6-fluoronicotinic Acid, CAS: 1242336-78-2, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂F.

4-Amino-6-methoxynicotinic Acid, CAS: 1060806-76-9, stock: 4.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₃.

4-Amino-6-methylnicotinic Acid, CAS: 127915-50-8, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

4-Aminonicotinic Acid, CAS: 7418-65-7, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

4-Aminonicotinic Acid Dihydrochloride, CAS: 1138011-19-4, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.• 2[HCl].

4-Bromo-2,6-dichloro-5-fluoro-3-pyridinecarboxylic Acid, CAS: 1526945-64-1, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HBrCl₂FNO₂.

4-Bromo-2-chloronicotinic Acid, CAS: 1060805-68-6, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂ClBr.

4-Bromonicotinic acid, CAS: 15366-62-8, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrNO₂.

4-Chloro-2-methylpyridinecarboxylic Acid, CAS: 914219-06-0, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₂.

4-Chloro-5-(trifluoromethyl)nicotinic Acid, CAS: 1211520-84-1, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃ClF₃NO₂.

4-Chloro-6-methylnicotinic Acid, CAS: 1060805-95-9, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂Cl.

4-Chloronicotinic Acid, CAS: 10177-29-4, stock: 2.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₂.

4-Formylnicotinic Acid, CAS: 395645-41-7, stock: 9.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅NO₃.

4-Hydroxy-3-pyridinecarboxylic Acid Hydrochloride Salt, CAS: /, stock: 7.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₃ (HCl).

4-Hydroxy-6-methylnicotinic acid, CAS: 67367-33-3, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

4-Hydroxynicotinic Acid, CAS: 609-70-1, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₃.

4-Methoxynicotinic acid, CAS: 10177-31-8, stock: 8.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

4-Methylnicotinic Acid, CAS: 3222-50-2, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

4-Methylnicotinic Acid Hydrochloride, CAS: 94015-05-1, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂ • HCl.

4-Phenylnicotinic Acid, CAS: 103863-14-5, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₂.

4-Pyridazinecarboxylic Acid, CAS: 50681-25-9, stock: 1.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₂O₂.

4-Pyridinecarboxylic Acid Ethyl Ester, CAS: 1570-45-2, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

4-Pyridoxic Acid, CAS: 82-82-6, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₄.

4-Pyridoxic Acid-d3, CAS: 1435934-03-4, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆D₃NO₄.

4-[(2,2-Dimethylpropanoyl)amino]nicotinic Acid, CAS: 125867-31-4, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

5,6-Dibromonicotinic Acid, CAS: 29241-64-3, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂Br₂.

5,6-Dichloronicotinic acid, CAS: 41667-95-2, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₂NO₂.

5,6-Dimethoxynicotinic acid, CAS: 76470-34-3, stock: 8.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₄.

5,6-Dimethyl-4-methoxy Nicotinic Acid Methyl Ester, CAS: 1314982-27-8, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

5,6-Dimethyl-4-methoxy Nicotinic Acid Methyl Ester 1-Oxide, CAS: 1251762-02-3, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₄.

5,6-Dimethyl-nicotinic Acid Methyl Ester, CAS: 1174028-18-2, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

5-(2,4-Difluorophenyl)nicotinic acid, CAS: 887973-46-8, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇F₂NO₂.

5-(2-(Methylthio)phenyl)nicotinic Acid, CAS: 1261964-02-6, stock: 9.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₂S.

5-(3,4-Dichlorophenyl)nicotinic acid, CAS: 926255-89-2, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇Cl₂NO₂.

5-(3,5-Dichlorophenyl)nicotinic acid, CAS: 887973-53-7, stock: 4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇Cl₂NO₂.

5-(3,5-Dimethylphenyl)nicotinic acid, CAS: 1048486-24-3, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂.

5-(3-(Methylsulfonyl)phenyl)nicotinic Acid, CAS: 1261973-40-3, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₄S.

5-(3-Aminophenyl)nicotinic Acid, CAS: 1261995-87-2, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₂.

5-(3-Benzyloxyphenyl)nicotinic acid, CAS: 893740-67-5, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅NO₃.

5-(3-Carboxyphenyl)nicotinic acid, CAS: 1261976-89-9, stock: 4.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉NO₄.

5-(3-Chloro-4-methoxyphenyl)nicotinic acid, CAS: 1261960-17-1, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀ClNO₃.

5-(3-Chloro-4-methylphenyl)nicotinic acid, CAS: 1261934-19-3, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀ClNO₂.

5-(3-Chlorophenyl)nicotinic acid, CAS: 375853-95-5, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClNO₂.

5-(3-Fluoro-4-methylphenyl)nicotinic acid, CAS: 1261946-42-2, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀FNO₂.

5-(3-Hydroxyphenyl)nicotinic acid, CAS: 1181452-05-0, stock: 4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

5-(3-Methoxyphenyl)nicotinic Acid, CAS: 97000-30-1, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₃.

5-(4-Benzyloxyphenyl)nicotinic acid, CAS: 893739-18-9, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅NO₃.

5-(4-Carboxy-3-fluorophenyl)nicotinic acid, CAS: 1258613-93-2, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈FNO₄.

5-(4-Chloro-2-methoxyphenyl)nicotinic acid, CAS: 1261980-32-8, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀ClNO₃.

5-(4-Chloro-3-methylphenyl)-6-hydroxynicotinic acid, CAS: 1262006-39-2, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀ClNO₃.

5-(4-Chlorophenyl)-6-hydroxynicotinic acid, CAS: 1262010-75-2, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClNO₃.

5-(4-Chlorophenyl)nicotinic Acid, CAS: 187999-33-3, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈NO₂Cl.

5-(4-Ethylphenyl)nicotinic acid, CAS: 1048308-04-8, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₂.

5-(4-Fluoro-3-methoxyphenyl)nicotinic acid, CAS: 1261934-09-1, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀FNO₃.

5-(4-Fluorophenyl)nicotinic acid, CAS: 364064-17-5, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈FNO₂.

5-(4-Hydroxyphenyl)nicotinic acid, CAS: 1181566-40-4, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

5-(4-t-Butylphenyl)nicotinic acid, CAS: 893738-16-4, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₂.

5-(5-Oxopyrrolidin-2-yl)nicotinic Acid Methyl Ester, CAS: /, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₃.

5-(Ethoxycarbonyl)-2-(hydroxymethyl-6-methyl-4-(3-nitrophenyl)nicotinic Acid(Nitrendipine Impurity), CAS: 89267-43-6, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₇.

5-(Methoxycarbonyl)nicotinic Acid, CAS: 5027-65-6, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₄.

5-(Methoxycarbonyl)nicotinic Acid Potassium Salt, CAS: 27247-34-3, stock: 9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆KNO₄.

5-(Methylamino)nicotinic acid, CAS: 91702-88-4, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

5-(Trifluoromethyl)nicotinic Acid, CAS: 131747-40-5, stock: 3.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄NO₂F₃.

5-Acetamidonicotinic acid, CAS: 82817-65-0, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₃.

5-Amino-2-bromoisonicotinic Acid, CAS: 1242336-80-6, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrN₂O₂.

5-Amino-2-chloronicotinic Acid, CAS: 42959-39-7, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂Cl.

5-Amino-2-methoxy-nicotinic Acid Methyl Ester, CAS: 122433-51-6, stock: 8.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₃.

5-Amino-2-methylnicotinic Acid, CAS: 1092286-36-6, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

5-Aminonicotinic acid, CAS: 24242-19-1, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

5-Borononicotinic acid, CAS: 913836-03-0, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆BNO₄.

5-Bromo-2-(methylthio)nicotinic Acid, CAS: 1220422-10-5, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂SBr.

5-Bromo-2-chloroisonicotinic acid, CAS: 886365-31-7, stock: 2.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrClNO₂.

5-Bromo-2-chloronicotinic acid, CAS: 29241-65-4, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrClNO₂.

5-Bromo-2-ethoxynicotinic Acid, CAS: 393184-78-6, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NO₃Br.

5-Bromo-2-fluoroisonicotinic Acid, CAS: 1214377-40-8, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂FBr.

5-Bromo-2-fluoronicotinic acid, CAS: 29241-66-5, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrFNO₂.

5-Bromo-2-hydroxynicotinic acid, CAS: 104612-36-4, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrNO₃.

5-Bromo-2-methoxy-isonicotinic acid, CAS: 886365-22-6, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrNO₃.

5-Bromo-2-methoxynicotinic acid, CAS: 54916-66-4, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrNO₃.

5-Bromo-2-methylnicotinic Acid, CAS: 351003-02-6, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂Br.

5-Bromo-2-morpholinonicotinic Acid, CAS: 1017783-03-7, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₂O₃Br.

5-Bromo-4-hydroxynicotinic Acid, CAS: 1052114-83-6, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrNO₃.

5-Bromo-6-chloronicotinic acid, CAS: 29241-62-1, stock: 2.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrClNO₂.

5-Bromo-6-hydroxynicotinic acid, CAS: 41668-13-7, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrNO₃.

5-Bromo-6-methoxynicotinic Acid, CAS: 1186194-46-6, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₃Br.

5-Bromo-6-methylnicotinic Acid, CAS: 1190862-72-6, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂Br.

5-Bromo-6-pyrrolidin-1-yl-nicotinic Acid, CAS: 1187930-16-0, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₂O₂Br.

5-Bromopyridine-3-carboxylic Acid, CAS: 20826-04-4, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrNO₂.

5-Bromopyridine-3-carboxylic Acid-D3, CAS: /, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₃BrNO₂.

5-Chloro-2,3-dimethoxyisonicotinic acid, CAS: 1305324-74-6, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₄.

5-Chloro-2-fluoronicotinic Acid, CAS: 884494-57-9, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂FCl.

5-Chloro-2-hydroxy-6-methylnicotinic Acid, CAS: 117449-75-9, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₃Cl.

5-Chloro-2-hydroxynicotinic acid, CAS: 38076-80-1, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₃.

5-Chloro-2-methoxynicotinic acid, CAS: 54916-65-3, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₃.

5-Chloro-6-fluoronicotinic Acid, CAS: 38185-57-8, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂FCl.

5-Chloro-6-hydroxy-nicotinic Acid Methyl Ester, CAS: 1214365-99-7, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₃Cl.

5-Chloro-6-hydroxynicotinic acid, CAS: 54127-63-8, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₃.

5-Chloro-6-methoxynicotinic Acid, CAS: 884494-85-3, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₃Cl.

5-Chloronicotinic Acid, CAS: 22620-27-5, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClNO₂.

5-Cyano-6-methylnicotinic Acid, CAS: 1216866-96-4, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O₂.

5-Cyanonicotinic acid, CAS: 887579-62-6, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₂O₂.

5-Fluoro-2-methoxynicotinic acid, CAS: 884494-82-0, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆FNO₃.

5-Fluoro-2-pivalamidonicotinic acid, CAS: 1228666-46-3, stock: 9.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃FN₂O₃.

5-Fluoronicotinic acid, CAS: 402-66-4, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄FNO₂.

5-Formyl Nicotinic Acid Methyl Ester, CAS: 03/06/6221, stock: 2.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₃.

5-Hydroxy Nicotinic Acid, CAS: 27828-71-3, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₃.

5-Methoxy-4-methylnicotinic Acid, CAS: 1211535-00-0, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

5-Methoxynicotinic Acid, CAS: 20826-03-3, stock: 8.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

5-Methyl-2-pivalamidonicotinic Acid, CAS: 1203499-02-8, stock: 9.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₃.

5-Methylnicotinic Acid, CAS: 3222-49-9, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

5-Nitro Nicotinic Acid, CAS: 2047-49-6, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₄.

5-Phenylnicotinic acid, CAS: 10177-12-5, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₂.

6,6’-Dithiodinicotinic Acid, CAS: 15658-35-2, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂O₄S₂.

6-(1H-1,2,4-Triazol-1-yl)nicotinic Acid, CAS: 281232-20-0, stock: 9.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₄O₂.

6-(1H-Imidazol-1-yl)nicotinic Acid, CAS: 216955-75-8, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇N₃O₂.

6-(2,2,2-Trifluoroethoxy)nicotinic Acid, CAS: 175204-90-7, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆NO₃F₃.

6-(2,2-Dimethyl-propionylamino)-nicotinic acid, CAS: 898561-66-5, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₃.

6-(2,4-Difluorophenyl)nicotinic acid, CAS: 505082-74-6, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇F₂NO₂.

6-(3,4-Methylenedioxyphenyl)nicotinic acid, CAS: 887976-73-0, stock: 2.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉NO₄.

6-(3,5-Dichlorophenyl)nicotinic acid, CAS: 887976-70-7, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇Cl₂NO₂.

6-(3-((tert-Butyldimethylsilyloxy)methyl)pyrrolidin-1-yl)-2-fluoronicotinic Acid, CAS: 1228666-21-4, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇N₂O₃FSi.

6-(3-Fluorophenyl)nicotinic acid, CAS: 582325-22-2, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈FNO₂.

6-(Acetoxymethyl)-4-methoxy-5-methyl Nicotinic Acid Methyl Ester, CAS: 1329633-58-0, stock: 5.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₅.

6-(Chloromethyl)-4-methoxy-5-methyl Nicotinic Acid Methyl Ester, CAS: 120003-81-8, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClNO₃.

6-(Cyclopropylmethoxy)nicotinic Acid, CAS: 1019546-29-2, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃.

6-(Hydroxymethyl)-4-methoxy-5-methyl Nicotinic Acid Methyl Ester, CAS: 1251762-18-1, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₄.

6-(Methoxycarbonyl)nicotinic Acid, CAS: 17874-76-9, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₄.

6-(Methylsulfonyl)nicotinic Acid, CAS: 1186663-34-2, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₄S.

6-Acetamidonicotinic Acid, CAS: 21550-48-1, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈N₂O₃.

6-Amino Nicotinic Acid, CAS: 3167-49-5, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

6-Amino-5-bromonicotinic Acid, CAS: 180340-69-6, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₂O₂Br.

6-Amino-5-iodonicotinic acid, CAS: 543740-89-2, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅IN₂O₂.

6-​Chloro-​2-​ethylaminonicotinic Acid, CAS: 1092523-21-1, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉ClN₂O₂.

6-Bromo-2-chloronicotinic acid, CAS: 1060815-67-9, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃BrClNO₂.

6-Bromo-2-methoxynicotinic Acid, CAS: 1060806-62-3, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₃Br.

6-Bromo-2-methylnicotinic Acid, CAS: 1060805-97-1, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂Br.

6-Bromo-4-chloronicotinic Acid, CAS: 1060808-92-5, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂ClBr.

6-Bromo-4-methylnicotinic Acid, CAS: 1060804-74-1, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂Br.

6-Bromo-5-methylnicotinic Acid, CAS: 901300-51-4, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆NO₂Br.

6-Bromo-5-pivalamidonicotinic acid, CAS: 1142192-31-1, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrN₂O₃.

6-Bromomethyl-nicotinic acid ethyl ester, CAS: 178264-57-8, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO₂.

6-Bromonicotinic acid ethyl ester, CAS: 132334-98-6, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO₂.

6-Chloro-2-(trifluoromethoxy)nicotinic Acid, CAS: 1221171-91-0, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₃F₃Cl.

6-Chloro-2-fluoronicotinic Acid, CAS: 1211578-46-9, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃NO₂FCl.

6-Chloro-4-formyl-nicotinic Acid, CAS: 1031433-06-3, stock: 10g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄NO₃Cl.

6-Chloro-4-methoxy Nicotinic Acid, CAS: 716362-10-6, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₃.

6-Chloro-4-trifluoromethylnicotinic Acid, CAS: 261635-77-2, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃ClF₃NO₂.

6-Chloro-5-(methoxymethoxy)nicotinic Acid, CAS: /, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₄.

6-Chloro-5-(trifluoromethyl)nicotinic Acid, CAS: 1110782-41-6, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃NO₂F₃Cl.

6-Chloro-5-cyanonicotinic Acid, CAS: 1206969-20-1, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃N₂O₂Cl.

6-Chloro-5-methoxynicotinic acid, CAS: 915107-39-0, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₃.

6-Chloro-5-nitronicotinic acid, CAS: 03/10/7477, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃ClN₂O₄.

6-Chloro-5-nitronicotinic Acid Methyl Ester, CAS: 59237-53-5, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClN₂O₄.

6-Chloronicotinic Acid Ethyl Ester, CAS: 49608-01-7, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.

6-Cyanonicotinic Acid, CAS: 70165-31-0, stock: 1.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₂O₂.

6-Cyclopropyl-2-hydroxynicotinic Acid, CAS: 1135283-67-8, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₃.

6-Fluoro-2-methylnicotinic acid, CAS: 884494-97-7, stock: 3.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆FNO₂.

6-Fluoronicotinic Acid, CAS: 403-45-2, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄FNO₂.

6-Fluoronicotinic acid methyl ester, CAS: 1427-06-1, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆FNO₂.

6-Hydrazinonicotinic acid, CAS: 133081-24-0, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₃O₂.

6-Hydroxy Nicotinic Acid, CAS: 5006-66-6, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₃.

6-Hydroxy-5-methoxynicotinic acid, CAS: 1171919-98-4, stock: 5.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₄.

6-Hydroxy-5-nitronicotinic acid, CAS: 6635-31-0, stock: 8.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₅.

6-Hydroxy-5-phenylnicotinic Acid, CAS: 1214389-46-4, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

6-Iodo-nicotinic Acid, CAS: 13054-02-9, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄NO₂I.

6-Isopropoxy-5-methylnicotinic Acid, CAS: 1011558-18-1, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₃.

6-Isopropoxynicotinic Acid, CAS: 223127-05-7, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₃.

6-Methoxy-5-methylnicotinic Acid, CAS: 1211531-94-0, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

6-Methyl Nicotinic Acid, CAS: 3222-47-7, stock: 4.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

6-Methyl-5-nitronicotinic Acid, CAS: 1523570-93-5, stock: 9.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₄.

6-Methylnicotinamide, CAS: 6960-22-1, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O.

6-Methylnicotinamide Iodide, CAS: /, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈IN₂O.

6-Morpholinonicotinic Acid, CAS: 120800-52-4, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₃.

6-Nitro-5-hydroxy Nicotinic Acid, CAS: 59288-43-6, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₅.

6-Phenoxynictinic Acid, CAS: 51362-38-0, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

6-Phenylnicotinic Acid, CAS: 29051-44-3, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₂.

6-Trifluoromethyl Nicotinic Acid, CAS: 231291-22-8, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄F₃NO₂.

6-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl] Nicotinic Acid Methyl Ester, CAS: 153559-92-3, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇NO₃.

6-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl] Nicotinic Acid Methyl Ester, CAS: 153559-50-3, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁NO₂.

6-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl] Nicotinic Acid Methyl Ester, CAS: 153559-44-5, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₂.

6-[4,5-Dimethyl-2-thiazolyl]aminonicotinic Acid, CAS: 1273946-12-5, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁N₃O₂S.

8-Chloroquinoline-2-carboxylic Acid, CAS: 915922-73-5, stock: 5.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆NO₂Cl.

Acifran, CAS: 72420-38-3, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O₄.

Arecaidine Hydrochloride, CAS: 6018-28-6, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂ClNO₂.

Arecoline, CAS: 63-75-2, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₂.

AZD 1283, CAS: 919351-41-0, stock: 2.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₄O₅S.

Benzyl 6-aminonicotinate, CAS: 935687-49-3, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂N₂O₂.

3-(Dimethylamlno)phenol-d6, CAS: /, stock: 1.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₆NO.

Bovine NMNAT1 (Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1) ELISA Kit (96T), CAS: /, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3-(tert-Butyldimethylsilyloxy)aniline-N,N,N-trimethyl-d9 Sulfate, CAS: /, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉D₉NOSi⁺ • CH ₂D₃O₄S⁻.

Nor Neostigmine, CAS: 16088-19-0, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂.

Cyclopropylacetic Acid, CAS: 5239-82-7, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₂.

Nor Neostigmine-d6, CAS: /, stock: 5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₆N₂O₂.

Ethyl 2,4-Dihydroxy-6-methylnicotinate, CAS: 10350-10-4, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₄.

Ethyl 2-Aminopyridine-3-carboxylate, CAS: 13362-26-0, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O₂.

Ethyl 2-Fluoropropionate, CAS: 349-43-9, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉FO₂.

Ethyl 4,6-Dichloronicotinate, CAS: 40296-46-6, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇Cl₂NO₂.

Ethyl 4-Hydroxynicotinate, CAS: 57905-31-4, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

Ethyl 5-bromo-2-methylnicotinate, CAS: 129477-21-0, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrNO₂.

Ethyl 5-Bromopyridine-3-carboxylate-D3, CAS: /, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₃BrNO₂.

Ethyl Nicotinate, CAS: 614-18-6, stock: 1.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

Ethyl Nicotinate-1,2’,3’,4’,5’,6’-13C6 Hydrochloride Salt, CAS: 1346604-87-2, stock: 6.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₁₀ClNO₂.

Ethyl Nicotinate-d4, CAS: 66148-16-1, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₄NO₂.

Fumaric Acid Monomethyl Ester, CAS: 2756-87-8, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆O₄.

Fumaric Acid Monomethyl Ester-d3, CAS: 1616345-41-5, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃D₃O₄.

Fumaric Acid Monomethyl Ester-d5, CAS: 1616345-45-9, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅HD₅O₄.

Gentianine, CAS: 439-89-4, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO₂.

Guvacine Hydrochloride, CAS: 6027-91-4, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀ClNO₂.

Guvacine-2,2,5,5-D4 Hydrochloride, CAS: /, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅D₄NO₂ • (HCl).

Guvacoline Hydrobromide, CAS: 17210-51-4, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂BrNO₂.

Hexyl Nicotinoate, CAS: 23597-82-2, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

Human NMNAT1 (Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Imazamox, CAS: 114311-32-9, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₄.

Imazapic, CAS: 104098-48-8, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₃.

1,’1-Thiocarbonyldi-2(1H)-pyridone, CAS: 102368-13-8, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈N₂O₂S.

Isonicotinamide, CAS: 1453-82-3, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O.

Isonicotinamide-d4, CAS: 1219799-40-2, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂D₄N₂O.

Neamine Disulfate Salt, CAS: /, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₃₀N₄O₁₄S₂.

Isonicotinic Acid, CAS: 55-22-1, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₂.

Isonicotinic Acid Allyl Ester, CAS: 25635-24-9, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

Isonicotinic Acid-d4, CAS: 53907-55-4, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₄NO₂.

Human Neopterin ELISA Kit (96T), CAS: /, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

L-Monapterin, CAS: 2277-42-1, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₄.

Isonipecotic Acid, CAS: 498-94-2, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁NO₂.

Neomycin B Sulfate, CAS: 28002-70-2, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₆N₆O₁₃ • x(SO ₄H₂).

Sheep Neopterin ELISA Kit (96T), CAS: /, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Methyl 2,6-Dichloronicotinate, CAS: 65515-28-8, stock: 7.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₂NO₂.

Methyl 2,6-Dichloropyridine-4-carboxylate, CAS: 42521-09-5, stock: 4.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₂NO₂.

Methyl 2-(chloromethyl)nicotinate, CAS: 177785-14-7, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO₂.

Methyl 2-Aminoisonicotinate, CAS: 07/03/6937, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

Methyl 2-Aminonicotinate, CAS: 14667-47-1, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

Methyl 2-Methylnicotinate, CAS: 65719-09-7, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

Methyl 3-bromoisonicotinate, CAS: 59786-31-1, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrNO₂.

Methyl 4,​6-​Dibromonicotinate, CAS: 1364663-27-3, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Br₂NO₂.

Methyl 4-Chloromethylnicotinic Acid Hydrochloride, CAS: 1159826-53-5, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈NO₂Cl  •  HCl.

Methyl 4-Hydroxynicotinate, CAS: 67367-24-2, stock: 8.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

(S)-(+)-p-Toluenesulfinamide, CAS: 188447-91-8, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NOS.

Methyl 4-Methylnicotinate, CAS: 33402-75-4, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

Methyl 5-Carboxy-N-phenyl-2-1H-pyridone, CAS: 77837-09-3, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₃.

Methyl 5-Hydroxynicotinate, CAS: 30766-22-4, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

Methyl 5-Methylnicotinate, CAS: 29681-45-6, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

Methyl 6-Aminopyridine-3-carboxylate, CAS: 36052-24-1, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

Methyl 6-Chloronicotinate, CAS: 73781-91-6, stock: 9.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₂.

Methyl 6-Methylnicotinate, CAS: 5470-70-2, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

Methyl Isonicotinate, CAS: 08/09/2459, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

Methyl Isonicotinate N-Oxide, CAS: 3783-38-8, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₃.

Methyl Isonicotinate-13C3, CAS: /, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₃H₇NO₂.

Methyl Nicotinate, CAS: 93-60-7, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

Morniflumate, CAS: 65847-85-0, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀F₃N₃O₃.

Mouse Nmnat1 (Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1) ELISA Kit (96T), CAS: /, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N,N-Diethylnicotinamide (Nikethamide), CAS: 59-26-7, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O.

N-(Hydroxymethyl)nicotinamide, CAS: 3569-99-1, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

N-Ethylnicotinamide, CAS: 4314-66-3, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂O.

N-Methyl-4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinamine, CAS: 290297-25-5, stock: 9.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₄.

N-Methylnicotinamide-d4, CAS: /, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄D₄N₂O.

NAADP Tetrasodium Salt, CAS: /, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₆Na₄O₁₈P₃.

Nicergoline, CAS: 27848-84-6, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆BrN₃O₃.

Nicocodine (1.0 mg/mL in Acetonitrile), CAS: 3688-66-2, stock: 4.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₂O₄.

Nicotinic Acid 2-Aminoethyl Ester Dihydrochloride, CAS: 87330-70-9, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂Cl₂N₂O₂.

Nicotinic Acid 2-Diethylamino-Ethyl Ester, CAS: 3099-52-3, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₂.

Nicotinic Acid 2-Diethylamino-Ethyl Ester Citrate Hydrate, CAS: /, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O₂.C₆H₈O₇ • H ₂O.

Nicotinic Acid Acyl-β-D-glucuronide, CAS: 24719-73-1, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₈.

Nicotinic Acid Methyl Ester 5-N-Methylnitrone, CAS: 1159977-53-3, stock: 6.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₃.

Nicotinic Acid N-Hydroxysuccinimide Ester, CAS: 78348-28-4, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O₄.

Nicotinic Acid Riboside, CAS: 17720-18-2, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₆.

Nicotinic Acid Riboside Methyl Ester Triflate, >90%, CAS: /, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆F₃NO₉S.

Nicotinic Acid Riboside-d4 Methyl Ester Triflate, CAS: /, stock: 8.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂D₄F₃NO₉S.

Nicotinic Acid-13C1 (~1% unlabeled), CAS: 57987-14-1, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³CH₅NO₂.

Nicotinic Acid-13C6,d4 N-Hydroxysuccinimide Ester, CAS: 1209457-55-5, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₄D₄N₂O₄.

Nicotinic Acid-d4 Riboside, CAS: /, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₄NO₆.

Nicotinoyl Chloride Hydrochloride, CAS: 20260-53-1, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅Cl₂NO.

Niflumic Acid, CAS: 4394-00-7, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉F₃N₂O₂.

Niflumic Acid-d5 (Major), CAS: 1794811-58-7, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₄D₅F₃N₂O₂.

NSC 14613, CAS: 91396-88-2, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₃O.

Nudifloric Acid Methyl Ester, CAS: 6375-89-9, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₃.

p-Chlonixin, CAS: 36752-40-6, stock: 9.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁ClN₂O₂.

Picolinamide, CAS: 1452-77-3, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O.

Tazarotenic Acid Sulfone, CAS: 603952-63-2, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₄S.

21-Hydroxyoligomycin A, CAS: 102042-09-1, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₇₄O₁₂.

Tazarotenic Acid Sulfone-d8, CAS: /, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₉D₈NO₄S.

Trigonelline, CAS: 535-83-1, stock: 1.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

Valeric Acid, CAS: 109-52-4, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

Valeric Acid-d9, CAS: 115871-50-6, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅HD₉O₂.

2-((3-Hydroxy(phenyl)methyl)benzyl)(methyl)amino)ethanol, CAS: /, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₂.

N-Desmethyl Nefopam, CAS: 46868-19-3, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO.

N-Desmethyl Nefopam-D5, CAS: /, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₅NO.

Nefopam, CAS: 13669-70-0, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO.

Nefopam Hydrochloride, CAS: 23327-57-3, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClNO.

Nefopam N-β-D Glucuronide, CAS: /, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClNO.

Nefopam N-Oxide, CAS: 66091-32-5, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.

Nefopam-d3 Hydrochloride, CAS: 1346603-30-2, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₃ClNO.

Nefopam-d3 N-Oxide, CAS: 1346603-50-6, stock: 6.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₃NO₂.

Tilidine Impurity D Hydrochloride, CAS: 24811-92-5, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂ •  HCl.

1-(3-Bromopropyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-d5, CAS: /, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₆BrN₃O₂.

1-(3-Chlorophenyl)piperazine, CAS: 6640-24-0, stock: 3.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂.

1-(3-Chlorophenyl)piperazine Hydrochloride, CAS: 13078-15-4, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄Cl₂N₂.

1-(3-Chlorophenyl)piperazine-d8, CAS: 1189923-43-0, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅D₈ClN₂.

1-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-4-(2-phenoxyethyl)-1,2,4-triazolidine-3,5-dione, CAS: 153707-88-1, stock: 1.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClN₅O₃.

2,4-Dihydro-5-[1-(methoxymethoxy)ethyl]-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one, CAS: 98159-88-7, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₄.

2-(Methoxymethoxy)propanehydrazide, CAS: 98159-92-3, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂O₃.

2-Chloro-4-piperazin-1-ylphenol Dihydrochloride, CAS: /, stock: 3.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅Cl₃N₂O.

2-Chloro-4-piperazin-1-ylphenol-d8, CAS: 1246817-03-7, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅D₈ClN₂O.

4-(2-Phenoxyethyl)-5-ethyl-1,2,4-triazol-3-one, CAS: 95885-13-5, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃O₂.

Hydroxy Nefazodone Dihydrochloride, CAS: /, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄Cl₃N₅O₃.

Hydroxy Nefazodone-d6 Hydrochloride, CAS: 1330260-82-6, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇D₆Cl₂N₅O₃.

Methoxymethoxy Nefazodone, CAS: 1346604-95-2, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆ClN₅O₄.

Nebramine Hydrochloride, CAS: /, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₆N₄O₅ . (ClH)ₓ.

Nebramine Sulfate, CAS: /, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₆N₄O₅  xH₂SO₄.

(+)-Nebivolol, CAS: 118457-15-1, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

(+)-Nebivolol O-β-D-Glucuronide(Mixture of 2 Diastereomers), CAS: /, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃F₂NO₁₀.

(+)-Nebivolol-d4 Hydrochloride, CAS: /, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₄ClF₂NO₄.

(-)-Nebivolol, CAS: 118457-16-2, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

(-)-Nebivolol O-β-D-Glucuronide(Mixture of 2 Diastereomers), CAS: /, stock: 6.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃F₂NO₁₀.

(-)-Nebivolol-d4 Hydrochloride, CAS: /, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₄ClF₂NO₄.

(1’R,2R)-2-[(1’,2’-O-Isopropylidene)dihydroxyethyl]-6-fluorochroman-4-one, CAS: 797054-18-3, stock: 6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅FO₄.

(1’R,2S)-2-[(1’,2’-O-Isopropylidene)dihydroxyethyl]-6-fluorochroman-4-one, CAS: 797054-19-4, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅FO₄.

(1’S,2R)-2-[(1’,2’-O-Isopropylidene)dihydroxyethyl]-6-fluorochroman-4-one, CAS: 797054-21-8, stock: 3.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅FO₄.

(1’S,2S)-2-[(1’,2’-O-Isopropylidene)dihydroxyethyl]-6-fluorochroman-4-one, CAS: 797054-20-7, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅FO₄.

(1R)-1-((2S)-6-Fluoro-4-Hydroxychroman-2-yl)ethane-1,2-diol, CAS: /, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃FO₄.

(2S,αR)-α-(Aminomethyl)-6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol, CAS: 303176-42-3, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄FNO₂.

(E)-(4R)-4,5-Isopropylidene-dioxy-1-(2-hydroxy-5-fluorophenyl)propenone, CAS: 797054-17-2, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅FO₄.

(E)-(4S)-4,5-Isopropylidene-dioxy-1-(2-hydroxy-5-fluorophenyl)propenone, CAS: 797054-16-1, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅FO₄.

(R)-1-((S)-6-fluorochroman-2-yl)ethane-1,2-diyl bis(4-methylbenzenesulfonate), CAS: /, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅FO₇S₂.

(R)-1-((S)-Chroman-2-yl)-2-(phenylamino)ethanol Hydrochloride(Mixture of 4 Diastereomers), CAS: /, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClNO₂.

(R,R,S,R)-Nebivolol, CAS: 920275-20-3, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇F₂NO₃.

(R,R,S,R)-Nebivolol Hydrochloride-d4, CAS: /, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃D₄F₂NO₃.

(R,R,S,S)-Nebivolol, CAS: 1360598-84-0, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

(R,S,R,S)-Nebivolol, CAS: 119365-24-1, stock: 4.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

(R,S,S,S)-Nebivolol Hydrochloride, CAS: 920299-33-8, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆ClF₂NO₄.

(S)-2-(Benzyl((S)-2-((R)-chroman-2-yl)-2-hydroxyethyl)amino)-1-((S)-chroman-2-yl)ethanol Oxalate(Nebivolol Impurity)(Mixture of Diastereomers), CAS: /, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₅NO₈.

(S,R,R,S)-Nebivolol, CAS: 119365-23-0, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

(S,R,S,R)-Nebivolol, CAS: /, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

(S,S,S,S)-Nebivolol, CAS: 119365-28-5, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

1,2:5,6-Di-O-isopropylidene-D-mannitol, CAS: 1707-77-3, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₆.

1-(5-Fluoro-2-hydroxyphenyl)-2-(triphenylphosphoranylidene)ethanone, CAS: 797054-15-0, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀FO₂P.

1-[(6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)carbonyl]piperidine, CAS: 878208-57-2, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈FNO₂.

4-Hydroxy Nebivolol Hydrochloride-d4(Mixture of Diastereomers), CAS: /, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₄ClF₂NO₅.

4-Hydroxy Nebivolol, Hydrochloride Hydrate(Mixture of Diastereomers), CAS: /, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈ClF₂NO₆.

4-tert-Butyldimethylsilyloxy Nebivolol (Mixture of Diastereomers), CAS: 1287115-86-9, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉F₂NO₅Si.

4-tert-Butyldimethylsilyloxy-6-fluoro-2-formyl-3,4-dihydro-2H-1-benzopyran (Mixture of Diastereomers), CAS: 1286400-05-2, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃FO₃Si.

4-tert-Butyldimethylsilyloxy-6-fluoro-2-hydroxymethyl-3,4-dihydro-2H-1-benzopyran (Mixture of Diastereomers), CAS: 1286156-10-2, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅FO₃Si.

4-tert-Butyldimethylsilyloxy-6-fluoro-2-oxiranyl-3,4-dihydro-2H-1-benzopyran (Mixture of Diastereomers), CAS: 1286582-56-6, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅FO₃Si.

5-Fluoroindan, CAS: 37530-82-8, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉F.

6-Fluoro-3,4-dihydro-2-(2-oxiranyl)-2H-1-benzopyran-d2 (Mixture of Diastereomers), CAS: 1246820-42-7, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉D₂FO₂.

6-Fluoro-3,4-dihydro-α-[[(benzyl)amino]methyl]-2H-1-benzopyran-2-methanol-d2(Mixture of Diastereomers), CAS: 1285866-07-0, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₂FNO₂.

6-Fluorochroman, CAS: 82070-01-7, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉FO.

Defluoro Nebivolol(Mixture of Diastereomers), CAS: 129101-34-4, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆FNO₄.

Desfluoro FAM Nebivolol (Mixture of Enantiomers), CAS: /, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆FNO₄.

Didefluoro Nebivolol(Mixture of Diastereomers), CAS: 129101-33-3, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇NO₄.

H-NBH (Mixture of Diastereomers)(R,S,R,R + R,R,R,R), CAS: /, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

α-(Aminomethyl)-6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol (Mixture of Diastereomers), CAS: 897661-66-4, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄FNO₂.

N-Benzyl (-)-Nebivolol, CAS: 1199945-26-0, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁F₂NO₄.

N-Nitroso Nebivolol (Mixture of Diastereomers), CAS: 1391051-68-5, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄F₂N₂O₅.

Nebivolol, CAS: 99200-09-6, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

Nebivolol (Mixture of Enantiomers)(S,R,S,R + R,S,R,S), CAS: /, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

Nebivolol Hydrochloride, CAS: 152520-56-4, stock: 9.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄ • HCl.

Nebivolol O-β-D-Glucuronide(Mixture of 4 Diastereomers), CAS: /, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃F₂NO₁₀.

R74714, CAS: 119365-25-2, stock: 6.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

rac 6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol, CAS: 99199-62-9, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁FO₂.

rac N-Benzyl Nebivolol, CAS: 929706-85-4, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁F₂NO₄.

rac N-Benzyl Nebivolol-d4, CAS: 1246814-48-1, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇D₄F₂NO₄.

rac Nebivolol Hydrochloride, CAS: 169293-50-9, stock: 4.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆ClF₂NO₄.

rac Nebivolol-d4 (Major), CAS: 1219407-55-2, stock: 9.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁D₄F₂NO₄.

rac Nebivolol-d8, CAS: 1219166-00-3, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₈F₂NO₄.

rac Nebivolol-d8 Hydrochloride, CAS: /, stock: 5.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₈ClF₂NO₄.

rac-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic Acid, CAS: 99199-60-7, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉FO₃.

rac-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic Acid Ethyl Ester, CAS: 99199-61-8, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃FO₃.

rac-6-Fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic Acid Methyl Ester, CAS: 874649-82-8, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁FO₃.

rac-6-Fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic Acid, CAS: 105300-40-1, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇FO₄.

rac-6-Fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic Acid Methyl Ester, CAS: 134102-10-6, stock: 6.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉FO₄.

rel-(S,R,S,S)-Nebivolol Hydrochloride, CAS: 1338823-20-3, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₅F₂NO₄.

1-Methyl-4-[5-(2-methylsulfamoylethyl)-1H-indol-3-yl]pyridinium Chloride(Naratriptan Impurity), CAS: /, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClN₃O₂S.

2,2-Bis-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonic Acid Methylamide, CAS: 1346604-16-7, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₁N₅O₂S.

4-[1,5-Bis-(2-methylsulfamoylethyl)-1H-indol-3-yl]-1-methylpyridinium Chloride(Naratriptan impurity), CAS: /, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇ClN₄O₄S₂.

N-Methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)-N-(2-(N-methylsulfamoyl)ethyl)ethanesulfonamide, CAS: /, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂N₄O₄S₂.

Naratriptan Hydrochloride, CAS: 143388-64-1, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆ClN₃O₂S.

Naratriptan Impurity F, CAS: /, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇ClN₄O₄S₂.

Naratriptan N-Methiodide, CAS: /, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈IN₃O₂S.

Naratriptan N-Methiodide-13CD3, CAS: 220495-95-4, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³CH₂₅D₃IN₃O₂S.

Naratriptan-d3 Hydrochloride, CAS: 1190021-64-7, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃D₃ClN₃O₂S.

(2S)-Narirutin, CAS: 14259-46-2, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂O₁₄.

4-Morpholineethanol, CAS: 622-40-2, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₂.

4-Morpholineethanol-d4, CAS: 1185052-90-7, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₄NO₂.

6-Prenyl-rac-naringenin, CAS: 68682-01-9, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₅.

Naringenin 4’-O-β-D-Glucuronide(Mixture of Diastereomers), CAS: 1237479-04-7, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₁₁.

Naringenin 4’-O-β-D-Glucuronide Sodium Salt(Mixture of Diastereomers), CAS: /, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉NaO₁₁.

Naringenin 7-O-β-D-Glucuronide Methyl Ester, CAS: 1985597-72-5, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₁₁.

Naringenin 7-O-β-D-Glucuronide Sodium Salt (Mixture of Diastereomers), CAS: /, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉NaO₁₁.

Anirolac, CAS: 66635-85-6, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₄.

Naringin Hydrate, CAS: 132203-74-8, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂O₁₄•xH₂O.

Calix[8]arene, CAS: 82452-93-5, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₄₈O₈.

Demethyl Naproxen Sulfate, CAS: 1246819-61-3, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂O₆S.

rac 8-Prenylnaringenin, CAS: 68682-02-0, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₅.

α-Phenyl-2-piperidineacetonitrile, CAS: 500780-11-0, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂.

Osmundacetone, CAS: 37079-84-8, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₃.

rac-Naproxen Methyl Ester-13C,d3, CAS: /, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³CH₁₃D₃O₃.

rac-Naproxen-13C3, CAS: /, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³C₃H₁₄O₃.

Napropamid, CAS: 15299-99-7, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₂.

Napropamid-13C6, CAS: /, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³C₆H₂₁NO₂.

Naphazoline Hydrochloride, CAS: 550-99-2, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄N₂ • HCl.

Naphazoline Nitrate, CAS: 5144-52-5, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₃.

(3S,3’S)-3,3’-[(2-Iodo-1,3-phenylene)bis(oxy)]bis[2-methylenebutanenitrile], CAS: /, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅IN₂O₂.

1,2-Acenaphthylenedione, CAS: 82-86-0, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆O₂.

1,2-Naphthoquinone (90%), CAS: 524-42-5, stock: 3.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆O₂.

11-Bromoundecanoic Acid, CAS: 01/05/2834, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁BrO₂.

2,3-Dichloro-5,8-dihydroxy-1,4-naphthoquinone, CAS: 14918-69-5, stock: 1.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄Cl₂O₄.

2,3-Dichloro-5-nitro-1,4-naphthoquinone, CAS: 22360-86-7, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₃NO₄Cl₂.

2-(1-Hydroxyethyl)acrylonitrile, CAS: 19362-94-8, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇NO.

2-(Bromomethyl)-1,4-naphthoquinone, CAS: 50371-30-7, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇BrO₂.

2-Cyano-1-methyl-2-propen-1-yl Methyl Ester Carbonic Acid, CAS: 474418-69-4, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NO₃.

2-Hydroxy-3-cyclohexyl-1,4-naphthoquinone, CAS: 4042-30-2, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₃.

2-[[1-[(1,4-Dimethoxy-3-methyl-2-naphthalenyl)methyl]-2-methyl-2-propen-1-yl]thio]-acetic Acid Methyl Ester, CAS: 99347-76-9, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆O₄S.

(4S)-(3’,4’-Dichlorophenyl)-3,4-dihydro-1,2-epoxy-1-O-triethylsilyl-1-naphthol, CAS: 1217528-57-8, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆Cl₂O₂Si.

(R)-(+)-5,5’,6,6’,7,7’,8,8’-Octahydro-1,1’-bi-2-naphthol, CAS: 65355-14-8, stock: 8.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₂.

(R)-(-)-1,1’-Binaphthyl-2,2’-diyl Hydrogen Phosphate, CAS: 39648-67-4, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃O₄P.

(R)-(-)-6,6’-Dibromo-1,1’-bi-2-naphthol, CAS: 65283-60-5, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂Br₂O₂.

(R)-3,3’-Dibromo-1,1’-bi-2-naphthol, CAS: 111795-43-8, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂Br₂O₂.

(S)-(+)-1,1’-Binaphthyl-2,2’-diyl Hydrogen Phosphate, CAS: 35193-64-7, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃O₄P.

(S)-(-)-5,5’,6,6’,7,7’,8,8’-Octahydro-1,1’-bi-2-naphthol, CAS: 65355-00-2, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₂.

(S)-3,3’-Dibromo-1,1’-bi-2-naphthol, CAS: 119707-74-3, stock: 4.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂Br₂O₂.

(S)-6,6’-Dibromo-1,1’-bi-2-naphthol, CAS: 80655-81-8, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂Br₂O₂.

1,1’-Methylenedi-2-naphthol, CAS: 1096-84-0, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆O₂.

1-(1,3-Dithiolan-2-yl)-2-naphthol, CAS: 261704-36-3, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂OS₂.

1-(2-Nitroethyl)-2-naphthol, CAS: 96853-41-7, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂ H₁₁NO₃.

Aurofusarin, CAS: 13191-64-5, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₁₈O₁₂.

1-(2-Thiazolylazo)-2-naphthol, CAS: 1147-56-4, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉N₃OS.

1-Acenaphthenol, CAS: 06/07/6306, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O.

Bcl-2 Inhibitor II, YC137, CAS: 810659-53-1, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁N₃O₆S₂.

1-Amino-2-naphthol Hydrochloride, CAS: 1198-27-2, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO • HCl.

1-Amino-2-naphthol-4-sulfonic Acid, CAS: 116-63-2, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO₄S.

cis-4-(4-Chlorophenyl)-1-acetylcyclohexane, CAS: /, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇ClO.

1-Iodo-2-naphthol, CAS: 2033-42-3, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇OI.

1-Naphthol 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: 18404-55-2, stock: 9.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄O₁₀.

1-Naphthol β-D-Glucuronide Sodium Salt, CAS: 83833-12-9, stock: 3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NaO₇.

1-Naphthol-4-sulfonic Acid Sodium Salt, CAS: 6099-57-6, stock: 4.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NaO₄S.

Napabucasin, CAS: 83280-65-3, stock: 5.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈O₄.

1-Naphthol-5-sulfonic Acid, CAS: 117-59-9, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄S.

1-Naphthol-8-sulfonic Acid, CAS: 117-22-6, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₄S.

1-Naphthol-D7 β-D-Glucuronide Sodium Salt, CAS: /, stock: 9.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈D₇NaO₇.

1-Naphthyl Phosphate, CAS: 1136-89-6, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₄P.

trans-2-Methyl-3-(5’-carboxy-3’-methyl-2’-pentenyl)-1,4-naphthoquinone, CAS: 34185-71-2, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₄.

trans-4-(4-Chlorophenyl)-1-acetylcyclohexane, CAS: 91161-85-2, stock: 1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇ClO.

1-Nitroso-2-naphthol, CAS: 131-91-9, stock: 9.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₂.

1-o-Tolueneazo-2-naphthol, CAS: 2646-17-5, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄N₂O.

1-[(1E)-2-Nitroethenyl]-2-naphthalenol, CAS: 1454257-23-8, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO₃.

2,4-Dibromo-1-naphthol, CAS: 2050-49-9, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆OBr₂.

trans-Trideuteromethyl-3-(5′-carboxy-3′-methyl-2’-pentenyl)-1,4-naphthoquinone-5,6,7,8-D4, CAS: /, stock: 6.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₁D₇O₄.

2-Amino-1-Naphthol Hydrochloride, CAS: 41772-23-0, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO • HCl.

2-Diazo-1-naphthol-5-sulfonic Acid Sodium Salt, CAS: 2657-00-3, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅N₂NaO₄S.

2-Diazo-1-naphthol-5-sulfonyl Chloride, CAS: 3770-97-6, stock: 1.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅ClN₂O₃S.

2-Naphthol-6,8-disulfonic Acid, CAS: 118-32-1, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₇S₂.

2-Naphthyl Caprylate, CAS: 10251-17-9, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O₂.

2-Nitro-1-naphthol, CAS: 607-24-9, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₃.

3,4-Dihydro-7-methoxy-1-naphthol Acetate, CAS: 20176-04-9, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₃.

3-(2-Piperidinyl)-2-naphthol Hydrochloride, CAS: 1049742-74-6, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO •  HCl.

3-(Aminomethyl)-2-naphthol, CAS: 1181563-65-4, stock: 1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO.

3-Amino-2-naphthol, CAS: 5417-63-0, stock: 9.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO.

4-(4-Nitrophenylazo)-1-naphthol, CAS: 5290-62-0, stock: 2.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁N₃O₃.

(+)-Naltrexone Hydrochloride, CAS: 114274-32-7, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₄ • HCl.

4-(Trifluoromethoxy)benzyl Alcohol, CAS: 1736-74-9, stock: 6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇F₃O₂.

4-Amino-1-naphthol Hydrochloride, CAS: 5959-56-8, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO • HCl.

(10α, 8β)-Dihydroxy Naltrexone, CAS: /, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₆.

4-Amino-2-methyl-1-naphthalenol Hydrochloride, CAS: 130-24-5, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂ClNO.

(4R,4aS,6S,6aR,11bS)-6-Carboxy-3-(cyclopropylmethyl)-1,2,3,4,4a,5,6,6a-octahydro-4a,6,8-trihydroxy-3-methyl-4,11-methanobenzofuro[3’,2’:2,3]cyclopenta[1,2-c]pyridinium Bromide, CAS: 1005411-72-2, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆BrNO₆.

(10β, 8β)-Dihydroxy Naltrexone, CAS: /, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₆.

(5α)-17-(Cyclopropylmethyl)-4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-6-oxomorphinanium Iodide, CAS: 1360001-83-7, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈INO₄.

(5α)-4,5-Epoxy-14-hydroxy-2-iodo-3-methoxy-17-(2-propen-1-yl)-morphinan-6-one Cyclic 1,2-Ethanediyl Acetal, CAS: /, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆INO₅.

4-Chloro-1-naphthol, CAS: 604-44-4, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇ClO.

4-Nitro-1-naphthol, CAS: 605-62-9, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₃.

4-Phenyl-3-buten-2-ol, CAS: 17488-65-2, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

(5α,17S)-3-(Acetyloxy)-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-17-methyl-6-oxomorphinanium Bromide (1:1), CAS: 1252784-80-7, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈BrNO₅.

5,6,7,8-Tetrahydro-2-naphthol, CAS: 1125-78-6, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

10-Hydroxy Naltrexone-d3, CAS: /, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀D₃NO₅.

1-Chloro Naltrexone, CAS: /, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂ClNO₄.

17-(Cyclopropylmethyl)-6,7,8,14-tetradehydro-4,5-epoxy-3-hydroxy-6-methoxy-17-methylmorphinanium Chloride, CAS: 1253206-60-8, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆NO₃.

17-(Cyclopropylmethyl)-7,8-didehydro-6,14-epidioxy-4,5-epoxy-3-hydroxy-6-methoxy-17-methyl-morphinanium Chloride, CAS: /, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆ClNO₅.

17-Methylnaltrexone Bromide, CAS: 916045-21-1, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆BrNO₄.

(5α)-4,5-Epoxy-14-hydroxy-3-methoxy-6-oxomorphinan-17-carboxylic Acid 1,1-Dimethylethyl Ester, CAS: 742075-03-2, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇NO₆.

7-Amino-1,2,3,4-tetrahydronaphthol, CAS: 214698-03-0, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

7-Anilino-1-naphthol-3-sulfonic Acid, CAS: 119-19-7, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₄S.

(5α,6β)-4,5-Epoxy-6-[[(2E)-3-(3-furanyl)-1-oxo-2-propenyl]methylamino]-14-hydroxy-3-methoxymorphinan-17-carboxylic Acid 1,1-Dimethylethyl Ester, CAS: 742075-09-8, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₆N₂O₇.

(5α,6β)-4,5-Epoxy-6-[[(2E)-3-(3-furanyl)-1-oxo-2-propenyl]methylamino]-14-hydroxy-3-methoxymorphinan-17-carboxylic Acid 9H-Fluoren-9-ylmethyl Ester, CAS: 742075-11-2, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₃₈N₂O₇.

(5α,6β)-4,5-Epoxy-6-[[(2E)-3-(3-furanyl)-1-oxo-2-propenyl]methylamino]-3,14-dihydroxymorphinan-17-carboxylic Acid 9H-Fluoren-9-ylmethyl Ester, CAS: 742075-13-4, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₆N₂O₇.

2-(4-Bromophenyl)-acetamidine, CAS: 59104-21-1, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉BrN₂.

1-(Naphthalen-1-yloxy)-3-(piperazin-1-yl)propan-2-ol, CAS: 75375-26-7, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O₂.

2-Chloro Naltrexone, CAS: /, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂ClNO₄.

2-Chloro-10-hydroxynaltrexone, CAS: 619331-76-9, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂ClNO₅.

8-Amino-2-naphthol, CAS: 118-46-7, stock: 4.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO.

2-(4-(2-Hydroxy-3-(naphthalen-1-yloxy)propyl)piperazin-1-yl)phenol, CAS: 133347-36-1, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₃.

8-Bromo-1,2,3,4-tetrahydro-1-naphthalenol, CAS: 838821-08-2, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁BrO.

3-(4-(2-Methoxyphenyl)piperazin-1-yl)propane-1,2-diol, CAS: 117067-06-8, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₃.

2-Hydroxy-3-O-methylnaltrexone, CAS: 67829-18-9, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₅.

2-Phenylacetamidine, CAS: 5504-24-5, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀N₂.

Naftopidil, CAS: 57149-07-2, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₃.

Naftopidil Dihydrochloride, CAS: 57149-08-3, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀Cl₂N₂O₃.

2-Phenylacetamidine-d5, CAS: /, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₅N₂.

Naftopidil Hydrochloride, CAS: 1164469-60-6, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₃ • HCl.

Naftopidil-d3, CAS: /, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅D₃N₂O₃.

alpha-Naphthol Orange, CAS: 523-44-4, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁N₂NaO₄S.

alpha-Naphthol Orange (13C6), CAS: /, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₆H₁₁N₂NaO₄S.

alpha-Naphtholbenzein, CAS: 145-50-6, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₁₈O₂.

3-O-Methylnaltrexone Ethylene Ketal, CAS: 197242-23-2, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉NO₅.

alpha-Naphtholphthalein, CAS: 596-01-0, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈O₄.

Dihydronaftazone O-β-D-Glucuronide, CAS: 173321-33-0, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₈.

Dihydronaftazone-d4 O-β-D-Glucuronide, CAS: /, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₄N₃O₈.

Cyclopentane, CAS: 287-92-3, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀.

7,8-Didehydro Naloxone (1.0 mg/mL in Acetonitrile), CAS: 26451-92-3, stock: 7.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NO₄.

Heptafluoronaphthalen-2-ol, CAS: 727-49-1, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀HF₇O.

IPA 3, CAS: 42521-82-4, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄O₂S₂.

β-Naphthol Violet, CAS: 7143-21-7, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉N₃Na₂O₉S₂.

7-Bromo-4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride, CAS: /, stock: 9.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁BrClNO₄.

7-Bromonaltrexone Iodide, CAS: /, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅BrINO₄.

Mordant black 11, CAS: 1787-61-7, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₂N₃NaO₇S.

N-Bromophthalimide, CAS: 2439-85-2, stock: 6.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄NO₂Br.

Naphthol AS Nonanoate, CAS: 10523-82-7, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉NO₃.

N,O-Dimethyl-Naltrexone Bromide, CAS: 1005410-37-6, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈BrNO₄.

Naphthol AS-BI β-D-glucuronide, CAS: 37-87-6, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂BrNO₉.

Naphthol AS-BI Sulphate Potassium Salt, CAS: 1680-70-2, stock: 3.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃BrKNO₆S.

Naphthol AS-CL Phosphate, CAS: 18228-16-5, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅ClNO₆P.

Naphthol AS-D Chloroacetate, CAS: 35245-26-2, stock: 2.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆NO₃Cl.

Naphthol AS-E Acetate, CAS: 84100-15-2, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄ClNO₃.

Naloxone, CAS: 465-65-6, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₄.

Naphthol AS-E Phosphate, CAS: 18228-17-6, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃ClNO₅P.

Naloxone (1.0 mg/mL in Methanol), CAS: 465-65-6, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₄.

Naphthol AS-MX Acetate, CAS: 4569-00-0, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉NO₃.

Naphthol AS-MX Phosphate, CAS: 1596-56-1, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈NO₅P.

N-Methyl N-(3-Butenyl) Noroxymorphone Bromide, CAS: /, stock: 8.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄BrNO₄.

N-Methyl N-(3-Butenyl) Noroxymorphone Bromide-d3, CAS: /, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃BrNO₄.

(4S)-2-((2-Ethoxy-1-naphthamido)methyl)-5,5-dimethylthiazolidine-4-carboxylic Acid, CAS: 940306-33-2, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₄S.

Naphthol AS-OL Acetate, CAS: 7128-79-2, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇NO₄.

N-Methyl Naltrexone Bromide, CAS: 73232-52-7, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆BrNO₄.

N-Methyl Naltrexone-d3 Bromide, CAS: /, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₃BrNO₄.

Nafcillin Penilloic Acid (Mixture of Diastereomers), CAS: 940306-31-0, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₂O₆S.

Naphthol AS-TR Phosphate, CAS: 2616-72-0, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅ClNO₅P.

N-Methyl Naltrexone-O-ethyl Carbonate, CAS: /, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀BrNO₆.

N-Methyl-O-methylcyclopropyl-Naltrexone Bromide, CAS: 1055877-40-1, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂BrNO₄.

Nafcillin Penilloic Acid Methyl Ester, CAS: /, stock: 6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆N₂O₆S.

Naphthol Yellow S Hydrate, CAS: 846-70-8, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄N₂Na₂O₈S • xH  ₂O.

Naphthol-AS-CA, CAS: 137-52-0, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄NO₃Cl.

Nalmefene, CAS: 55096-26-9, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₃.

Nalmefene-d3, CAS: /, stock: 6.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂D₃NO₃.

Orange G, CAS: 1936-15-8, stock: 5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂N₂O₇S₂ • 2Na.

Naloxone Hydrochloride, CAS: 357-08-4, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂ClNO₄.

Para Red, CAS: 02/10/6410, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁N₃O₃.

Naltrexone, CAS: 16590-41-3, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₄.

Naloxone Hydrochloride Dihydrate, CAS: 51481-60-8, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆ClNO₆.

Para Red-d4, CAS: 1185235-75-9, stock: 4.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₇D₄N₃O₃.

Para-Naphthol Duloxetine, CAS: 949095-98-1, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NOS.

Naltrexone (1.0 mg/mL in Methanol), CAS: 16590-41-3, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₄.

Potassium 1-(2,3-Epoxypropoxy)-4-naphthol Sulfate, CAS: 95648-12-7, stock: 3.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁KO₆S.

Naloxone-d5, CAS: 1261079-38-2, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₅NO₄.

Naloxone-d5 (100 ug/mL in Methanol), CAS: 1261079-38-2, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₅NO₄.

Sodium 2-Naphthol-7-sulfonate, CAS: 135-55-7, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NaO₄S.

Norbinaltorphimine Dihydrochloride Salt, CAS: 113158-34-2, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₄₅Cl₂N₃O₆.

Naltrexone Hydrochloride, CAS: 16676-29-2, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄ClNO₄.

Naltrexone-d3, CAS: 1261080-26-5, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀D₃NO₄.

Sulfur Dichloride, CAS: 10545-99-0, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Cl₂S.

Naltrexone-d3 (100 ug/mL in Methanol), CAS: 1261080-26-5, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀D₃NO₄.

Naltrexone-O-ethyl Carbonate, CAS: 836602-51-8, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇NO₆.

(1-Naphthalenylmethyl)[(tetrahydro-2-furanyl)methyl]-propanedioic Acid Diethyl Ester, CAS: 85068-37-7, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₅.

Nafronyl, CAS: 31329-57-4, stock: 7.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃NO₃.

Nafronyl-d4, CAS: 1215649-28-7, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉D₄NO₃.

Tetrahydro-α-(1-naphthalenylmethyl)-2-furanpropanoic Acid, CAS: 25379-26-4, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀O₃.

(±)-2’-Methylpropranolol Hydrochloride, CAS: 15230-34-9, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₂ •HCl.

1-(tert-Butylamino)-3-(1-naphthyloxy)-2-propanol, CAS: 2116-22-5, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₂.

De(2,3-dihydroxy) Nadolol, CAS: 33841-03-1, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇NO₂.

De(2,3-dihydroxy) Nadolol Hydrochloride, CAS: 15148-92-2, stock: 6.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₈ClNO₂.

De(2,3-dihydroxy) Nadolol-d9 Hydrochloride, CAS: /, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₉NO₂ .HCl.

(S)-(-)-Nadifloxacin, CAS: 154357-42-3, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁FN₂O₄.

(S)-(-)-Nadifloxacin-O-sulfate, CAS: 1544562-94-8, stock: 9.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁FN₂O₇S.

Nadifloxacin, CAS: 124858-35-1, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁FN₂O₄.

Nadifloxacin-d9, CAS: /, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₂D₉FN₂O₄.

2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione, CAS: 1218942-37-0, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉ClN₄O₂.

2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione-d3, CAS: /, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆D₃ClN₄O₂.

2-Acetyl Phenothiazine, CAS: 6631-94-3, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NOS.

5,12-Dihydroquinoxalino[2,3-b]quinoxaline (~90%), CAS: 531-46-4, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₄.

5-Methoxy-2-methyl-1,4-naphthoquinone, CAS: 22266-99-5, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀O₃.

5-Methoxy-2-methyl-1,4-naphthoquinone-d3, CAS: /, stock: 1.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₃O₃.

5-Methoxy-2-methyl-α-naphthol, CAS: 79795-25-8, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

5-Methoxy-2-methyl-α-naphthol-d3, CAS: /, stock: 3.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉D₃O₂.

Bovine BLVRB (Flavin reductase (NADPH)) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine CBR1 (Carbonyl reductase [NADPH] 1) ELISA Kit (96T), CAS: /, stock: 7.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(((7-Methylocta-2,6-dien-1-yl)oxy)methyl)benzene, CAS: /, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O.

Bovine FDXR (NADPH:adrenodoxin oxidoreductase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine NDOR1 (NADPH-dependent diflavin oxidoreductase 1) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(+)-(1R,2S)-1,2-Dihydro-1,2-naphthalenediol, CAS: 51268-88-3, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂.

(+)-Aphidicolin, CAS: 38966-21-1, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₄.

Hexamethylenetetramine, CAS: 100-97-0, stock: 8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂N₄.

(+)-Valerianol, CAS: 20489-45-6, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O.

(+/-)-2-Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene Hydrobromide, CAS: 13575-86-5, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂ •HBr.

Hexamethylenetetramine-d12, CAS: 23304-08-7, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₁₂N₄.

Methenamine Mandelate, CAS: 587-23-5, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₄O₃.

(-)-(1S,2R)-1,2-Dihydro-1,2-naphthalenediol, CAS: 90365-29-0, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂.

(-)-Nafadotride, CAS: 173429-65-7, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₃O₂.

(-)-Rugulosin, CAS: 21884-45-7, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₂O₁₀.

(1,2,5,6-Tetramethyl-d6)naphthalene, CAS: /, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀D₆.

(1R,2R)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid, CAS: 642995-15-1, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₄.

5-(Acetylimino)-4,5-dihydro-4-methyl-1,3,4-thiadiazole-2-sulfonic Acid, CAS: 1312679-00-7, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃O₄S₂.

(1R,4S)-1,2,3,4-Tetrahydro-1,4-epoxynaphthalene-1-carboxylic Acid, CAS: 1244954-14-0, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

(1RS)-1-(6-Methoxy-2-naphthyl)ethanol (Naproxen Impurity K), CAS: 77301-42-9, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₂.

5-(Acetylimino)-4,5-dihydro-4-methyl-1,3,4-thiadiazole-2-sulfonic Acid-d3, CAS: 1795143-17-7, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₃N₃O₄S₂.

Bis(5-acetylamino-4-methyl-1,3,4-thiadiazole-2-sulfonyl)amine, CAS: /, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₇O₆S₄.

Diphenyleneiodonium Chloride, CAS: 4673-26-1, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClI.

(1S)-N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-1,2,3,4-tetrahydro-1-naphthalenecarboxamide, CAS: /, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O.

Bis(5-acetylamino-4-methyl-1,3,4-thiadiazole-2-sulfonyl)amine-d6, CAS: /, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₆N₇O₆S₄.

Methazolamide, CAS: 554-57-4, stock: 8.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈N₄O₃S₂.

Diphenyleneiodonium Sulfate, CAS: 4510-83-2, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈I•1/2SO₄.

(1S)-N-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-1,2,3,4-tetrahydro-1-naphthalenecarboxamide, CAS: 177793-79-2, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O.

Methazolamide-d3, CAS: 1795133-31-1, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₃N₄O₃S₂.

Methazolamide-d3, CAS: /, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₃N₄O₃S₂.

(1S)-N-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-1,2,3,4-tetrahydro-1-naphthalenecarboxamide-d1, CAS: 1330266-39-1, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃DN₂O.

(1S)-[1,1’-Binaphthalene]-2,2’-diol, CAS: 18531-99-2, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄O₂.

Methazolamide-d6, CAS: 1795142-30-1, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂D₆N₄O₃S₂.

(1S)​-​[1,​1’-​Binaphthalene]​-​2,​2’-​diylbis[bis[3,​5-​bis(trifluoromethyl)​phenyl]​phosphine, CAS: 220196-32-7, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₂₄F₂₄P₂.

(1S,2S)-1,2-Bis[[[2-(diphenylphosphino)naphthalen-1-yl]carbonyl]amino]cyclohexane, CAS: 205495-66-5, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₄₄N₂O₂P₂.

Human CBR1 (Carbonyl reductase [NADPH] 1) ELISA Kit (96T), CAS: /, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(1S,2S)-2-(Naphthalene-2,3-dicarboximido)cyclohexanecarboxylic Acid, CAS: 642995-16-2, stock: 3.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₄.

(1S,4R)-1,2,3,4-tTetrahydro-1,4-epoxynaphthalene-1-carboxylic Acid, CAS: 1244954-13-9, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₃.

Human NADPH oxidase 5 ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human NOX1 (NADPH oxidase 1) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(2-(4-Fluoronaphthalen-1-yl)phenyl)methanol, CAS: /, stock: 1.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃FO.

(2R)-2-Amino-1,2,3,4-tetrahydro-5,8-dimethoxy-2-naphthalenecarboxylic Acid Methyl Ester-13C, CAS: 1346617-27-3, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃¹³CH₁₉NO₄.

Human NOX1(NADPH oxidase 1) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human NOX4(NADPH oxidase 4) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(2R,3S)-rel-Nadolol-de(N-tert-butyl)methoxy, CAS: /, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₅.

(2R,3S)-rel-Nadolol-N-[(2R,3S)-rel-Nadolol-de(N-tert-butyl)], CAS: /, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₃NO₈.

Human NOXA1 (NADPH oxidase activator 1) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human NOXO1 (NADPH oxidase organizer 1) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(2S,2’S,3R,3’R)-5,5’-((2-hydroxypropane-1,3-diyl)bis(oxy))bis(1,2,3,4-tetrahydronaphthalene-2,3-diol), CAS: /, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₇.

(2S,3R)-rel-5-(3-(((6R,7S)-rel-6,7-Dihydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)oxy)-2-hydroxypropoxy)-1,2,3,4-tetrahydronaphthalene-2,3-diol + (2S,2’S,3R,3’R)-5,5’-((2-Hydroxypropane-1,3-diyl)bis(oxy))bis(1,2,3,4-tetrahydronaphthalene-2,3-diol)(Mixture), CAS: /, stock: 4.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₇.

(3-Methoxynaphthalen-1-yl)boronic acid, CAS: 219834-94-3, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁BO₃.

Methylmethaqualone, CAS: 1915-80-6, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O.

(3S,5S)-Simvastatin Hydroxy Acid Ammonium Salt, CAS: 139893-43-9, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₃NO₆.

(3Z)-4-Hydroxy-4-(6-methoxy-2-naphthalenyl)-3-buten-2-one, CAS: 218768-11-7, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄O₃.

(4-(tert-Butyl)-1,2-phenylene)dimethanol, CAS: 374592-80-0, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₂.

(4-Bromonaphthalen-2-yl)acetonitrile, CAS: 401469-73-6, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈BrN.

(4E,8E,12E,16E)-Ethyl 2-acetyl-5,9,13,17,21-pentamethyl-2-((2E,6E,10E,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaen-1-yl)docosa-4,8,12,16,20-pentaenoate, CAS: /, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₉₀O₃.

(4S)-(3’,4’-Dichlorophenyl)-3,4-dihydro-1-O-triethylsilyl-1-naphthol, CAS: 1217778-10-3, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆Cl₂OSi.

(5E,9E,13E,17E)-6,10,14,18,22-Pentamethyltricosa-5,9,13,17,21-pentaen-2-one, CAS: /, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O.

(5S)-5-Amino-5,6,7,8-tetrahydronaphthalene-2-carbonitrile Hydrochloride, CAS: 1212852-88-4, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂ • HCl.

(all-E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenoic Acid Ethyl Ester, CAS: 65733-07-5, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₈₄O₂.

(±)-3’,4’-Dihydro-1’-hydroxy-7’-methoxy-spiro[cyclopentane-1,2’(1’H)-naphthalene]-1’-acetonitrile, CAS: 51491-09-9, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₂.

β-NADPH Disodium Salt Derivative, CAS: /, stock: 2.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₈Na₂O₂₁P₃⁺.

(±)-cis-Calamenene, CAS: 72937-55-4, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂.

(±)-cis-Calamenene-d7, CAS: /, stock: 8.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅D₇.

β-Nicotinic Acid Mononucleotide, CAS: 321-02-8, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NO₉P.

(±)-δ-Cadinene, CAS: 60305-17-1, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄.

(±)-Shikonin, CAS: 54952-43-1, stock: 5.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₅.

β-Nicotinic Acid Mononucleotide-13C5, CAS: /, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₅H₁₄NO₉P.

β-Nicotinic Acid Mononucleotide-d4, CAS: /, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₄NO₉P.

(E)-1-(4-Methoxystyryl)naphthalene, CAS: 22920-31-6, stock: 9.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O.

(E,E,E)-2-Acetyl-5,9,13,17-tetramethyl-4,8,12,16-octadecatetraenoic Acid Ethyl Ester, CAS: 71668-81-0, stock: 8.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂O₃.

(α)-6-Methoxy-α-methyl-2-naphthaleneacetamide, CAS: 123675-40-1, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NO₂.

Mouse Blvrb (Flavin reductase (NADPH)) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(αR)​-α,​5-​Dimethyl-1-​naphthalenemethanami​ne, CAS: 1344557-18-1, stock: 8.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N.

(βR,δR,1S,2S)-1,2-Dihydro-β,δ,6-trihydroxy-2-methyl-1-naphthaleneheptanoic Acid Sodium Salt(Pravastatin Impurity), CAS: 720666-74-0, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NaO₅.

Mouse Cbr1 (Carbonyl reductase [NADPH] 1) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Cbr2 (Carbonyl reductase [NADPH] 2) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Fdxr (NADPH:adrenodoxin oxidoreductase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Ndor1 (NADPH-dependent diflavin oxidoreductase 1) ELISA Kit (96T), CAS: /, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(R)-(+)-Shikonin, CAS: 517-89-5, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₅.

Mouse Nox1 (NADPH oxidase 1) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Nox1(NADPH oxidase 1) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(R)-(+)-[1,1’-Binaphthalene]-2,2’-diamine, CAS: 18741-85-0, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆N₂.

Mouse Noxa1 (NADPH oxidase activator 1) ELISA Kit (96T), CAS: /, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Noxo1 (NADPH oxidase organizer 1) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(R)-1,2,3,4-Tetrahydro-1-naphthoic Acid, CAS: 23357-47-3, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₂.

(R)-1-(Naphthalene-2-sulfonyl)-piperidine-3-carboxylic Acid, CAS: 1187928-75-1, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₄S.

(R)-2,2’-Bis(methoxymethoxy)-1,1’-binaphthyl, CAS: 173831-50-0, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂O₄.

(R)-2-[[(4-Methoxy-1-naphthalenyl)oxy]methyl]oxirane, CAS: 1217724-80-5, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₃.

(R)-3,3’-Dibromo-5,5’,6,6’,7,7’,8,8’-octahydro-[1,1’-binaphthalene]-2,2’-diol, CAS: 65355-08-0, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀Br₂O₂.

(R)-3’’-Hydroxy Pravastatin Sodium Salt, CAS: 722504-46-3, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₅NaO₈.

(R)-5-Bromo Naproxen, CAS: 92471-85-7, stock: 4.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃BrO₃.

(R)-5-Chloro Naproxen, CAS: 92471-86-8, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃ClO₃.

(R)-6,6’-Dibromo-2,2’-bis(methoxymethoxy)-1,1’-binaphthyl, CAS: 179866-74-1, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀Br₂O₄.

(R)-BINAP, CAS: 76189-55-4, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₃₂P₂.

N-Methylnicotinamide, CAS: 114-33-0, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O.

(R)-Naproxen, CAS: 23979-41-1, stock: 9.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₃.

(R)-Naproxen Acyl-β-D-glucuronide, CAS: 112828-15-6, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₉.

(R)-Naproxen Acyl-β-D-glucuronide Benzyl Ester, CAS: /, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈O₉.

(R)-O-Desmethyl Naproxen, CAS: 123050-98-6, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂O₃.

(R)-Rutheniumdiacetate-(H8-BINAP), CAS: 374067-51-3, stock: 6.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₄₆O₄P₂Ru.

(R,S)-Fmoc-3-amino-3-(naphthalen-2-yl)-propionic Acid, CAS: 269078-81-1, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₃NO₄.

Nicotinamide, CAS: 98-92-0, stock: 4.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O.

Nicotinamide-13C6, CAS: /, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₆N₂O.

Nicotinamide-N-15N, CAS: 113950-01-9, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N¹⁵NO.

(S)-(-)-1-(2-Naphthyl)ethanol, CAS: 27544-18-9, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O.

(S)-(-)-2,2’-Bis(di-p-tolylphosphino)-1,1’-binaphthyl, CAS: 100165-88-6, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₄₀P₂.

(S)-(-)-2,2’-Bis[di-(3,5-dimethylphenyl)phosphino]-1,1’-binaphthyl, CAS: 135139-00-3, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₄₈P₂.

(S)-(-)-3,3’-Dibromo-5,5’,6,6’,7,7’,8,8’-octahydro-1,1’-bi-2,2’-naphthalenediol, CAS: 765278-73-7, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀Br₂O₂.

(S)-1,1’-Binaphthyl-2,2’-Dicarboxylic Acid, CAS: 18531-96-9, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄O₄.

Ormetoprim, CAS: 6981-18-6, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₄O₂.

(S)-1,2,3,4-Tetrahydro-1-naphthalenemethanol, CAS: 151831-52-6, stock: 5.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O.

(S)-1,2,3,4-Tetrahydro-1-naphthoic Acid, CAS: 85977-52-2, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₂.

Ormetoprim-d6, CAS: 1346602-49-0, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₆N₄O₂.

(S)-1-(Naphthalene-2-sulfonyl)-piperidine-3-carboxylic Acid, CAS: 1187928-71-7, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₄S.

(S)-2,2’-Dihydroxy-1,1’-binaphthalene-3,3’-diboronic acid, CAS: 957111-27-2, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆B₂O₆.

(S)-2,2’-Dimethoxy-1,1’-binaphthalene-3,3’-diboronic acid, CAS: 220204-00-2, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀B₂O₆.

(S)-2-[[(4-Methoxy-1-naphthalenyl)oxy]methyl]oxirane, CAS: /, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₃.

Phox-I2, CAS: 353495-22-4, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅N₃O₄.

(S)-3’’-Hydroxy Pravastatin Sodium Salt, CAS: 722504-45-2, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₅NaO₈.

(S)-5-Bromo Naproxen, CAS: 84236-26-0, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃BrO₃.

(S)-5-Chloro Naproxen, CAS: 89617-86-7, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃ClO₃.

(S)-5-Iodo Naproxen, CAS: 116883-62-6, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃IO₃.

(S)-6,6’-Dibromo-2,2’-bis(methoxymethoxy)-1,1’-binaphthalene, CAS: 211560-97-3, stock: 1.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀Br₂O₄.

(S)-7-Methoxy-2-aminotetralin, CAS: 121216-42-0, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO.

(S)-BINAP, CAS: 76189-56-5, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₃₂P₂.

(S)-Methyl 8-Amino-5,6,7,8-tetrahydronaphthalene-2-carboxylate Hydrochloride, CAS: 1246509-73-8, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂ • HCl.

Rat Cbr1 (Carbonyl reductase [NADPH] 1) ELISA Kit (96T), CAS: /, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamide, CAS: 135729-78-1, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O.

(S)-Naproxen, CAS: 22204-53-1, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄O₃.

Rat Fdxr (NADPH:adrenodoxin oxidoreductase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 6.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Nox1 (NADPH oxidase 1) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(S)-Naproxen Acyl-β-D-glucuronide, CAS: 41945-43-1, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₉.

(S)-Naproxen Acyl-β-D-glucuronide Benzyl Ester, CAS: 946517-36-8, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈O₉.

Rat Noxa1 (NADPH oxidase activator 1) ELISA Kit (96T), CAS: /, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

(S)-Naproxen Ethyl Ester, CAS: 31220-35-6, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈O₃.

(S)-Naproxen Ethyl-d5 Ester, CAS: 1346617-42-2, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₅O₃.

(S)-Naproxen Methyl Ester, CAS: 26159-35-3, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₃.

(S)-Naproxen Sodium Salt, CAS: 26159-34-2, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NaO₃.

(S)-Naproxen-d3, CAS: 1094102-82-5, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁D₃O₃.

(S)-Naproxen-d6 Methyl Ester, CAS: 1254693-88-3, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₆O₃.

(S)-O-Desmethyl Naproxen, CAS: 52079-10-4, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂O₃.

(S)-Ru(OAc)2(BINAP), CAS: 261948-85-0, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₃₈O₄P₂Ru.

(S)-Ru(OAc)2(H8-BINAP), CAS: 142962-95-6, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₄₆O₄P₂Ru.

(S)​-​1-​(Naphthalen-​1-​yl)​ethanol, CAS: 15914-84-8, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O.

(Z)-1-(1-Naphthalenyl)ethanone Oxime, CAS: 100485-59-4, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO.

1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene, CAS: 6683-48-3, stock: 2.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂.

Tri-tert-butyl 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetate, CAS: 122555-91-3, stock: 8.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₀N₄O₆.

1,1,4,4,6-Pentamethyl-1,2,3,4-tetrahydronaphthalene-13C4, CAS: 1391053-02-3, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³C₄H₂₂.

1,1,6-Trimethyltetralin, CAS: 475-03-6, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈.

VAS 2870, CAS: 722456-31-7, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂N₆OS.

VAS 3947, CAS: 869853-70-3, stock: 6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₆OS.

1,1’-Azonaphthalene, CAS: 487-10-5, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄N₂.

1,1’-Binaphthyl-2,2’-diyl Hydrogenphosphate, CAS: 35193-63-6, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃O₄P.

1,1’-Dideoxygossylic Acid, CAS: 168787-83-5, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀O₈.

1,2,3,4,4a,9,10,10a-Octahydro-3,7,8-trimethyl-phenanthrene, CAS: 860550-96-5, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄.

CyanoguanidineMetformin Related Compound A USP, CAS: 461-58-5, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₄N₄.

1,2,3,4,5,6,7-Heptachloronaphthalene, CAS: 58863-14-2, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀HCl₇.

1,2,3,4,6,7-Hexachloronaphthalene + 1,2,3,5,6,7-Hexachloronaphthalene (Mixture) (~90%), CAS: /, stock: 3.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂Cl₆ +  C₁₀H₂Cl₆.

1,2,3,4-Tetrahydro-1,2,5-naphthalenetriol, CAS: 1478732-43-2, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

1,2,3,4-Tetrahydro-1,2,8-naphthalenetriol, CAS: /, stock: 6.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

Guanylurea, CAS: 141-83-3, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₆N₄O.

1-Chloro-4-[(3,3-dimethyl-2-methylenecyclopentyl)methyl]benzene-d6, CAS: /, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₆Cl.

1,2,3,4-Tetrahydro-1-naphthoic Acid, CAS: 1914-65-4, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₂.

1,2,3,4-Tetrahydro-1-napthol, CAS: 529-33-9, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀O.

1-[(4-Chlorophenyl)methyl]-2-oxocyclopentanecarboxylic Acid Methyl Ester, CAS: 115851-73-5, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅ClO₃.

1-[(4-Chlorophenyl)methyl]-3,3-dimethyl-2-oxocyclopentanecarboxylic Acid-d6 Methyl Ester, CAS: /, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₆ClO₃.

1,2,3,4-Tetrahydro-2-naphthoic Acid, CAS: 53440-12-3, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₂.

1,2,3,4-Tetrahydro-5-(2-oxiranylmethoxy)-(2R,3S)-rel-2,3-naphthalenediol, CAS: 627081-12-3, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆O₄.

N,N-Dimethylamidino Urea, CAS: 98026-16-5, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀N₄O.

1-[(4-Chlorophenyl)methyl]-3-methyl-2-oxocyclopentanecarboxylic Acid Methyl Ester-d3, CAS: /, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₃ClO₃.

5-[(4-Chlorophenyl)methyl]-2,2-dimethylcyclopentanone-d6, CAS: /, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁D₆ClO.

1,2,3,4-Tetrahydro-5-(2-oxiranylmethoxy)-(2R,3S)-rel-2,3-naphthalenediol-D5, CAS: /, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₅O₄.

Metconazole, CAS: 125116-23-6, stock: 7.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClN₃O.

1,2,3,4-Tetrahydronaphthalene-1-thiol, CAS: 103324-34-1, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂S.

1,2,3,4-Tetrahydronaphthalene-13C6, CAS: /, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₁₂.

(R)-Methadone Hydrochloride (1.0mg/ml in Methanol), CAS: /, stock: 6.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO • (HCl).

Metconazole-d6, CAS: 125116-23-6, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₆ClN₃O.

rac trans-Metconazole-d6, CAS: /, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₆ClN₃O.

1,2,3,4-Tetrahydronaphthalene-13C6, D4, CAS: /, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₈D₄.

1,2,3,4-Tetrahydronaphthalene-2-sulfonyl Chloride, CAS: 102653-21-4, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁O₂SCl.

Yellow 203 Aluminum Lake, CAS: 68814-04-0, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₁NO₈S₂.

1,2,3,6,7,8-HexachloronaphthaleneContains P237980, CAS: 17062-87-2, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂Cl₆.

1,2,3,6,7-Pentachloronaphthalene, CAS: 150224-16-1, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₃Cl₅.

(S)-Methadone Hydrochloride (1.0mg/ml in Methanol), CAS: /, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO.

2-Chloro-N-(chloromethyl)-2’,6’-dimethylacetanilide-d6, CAS: /, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₆Cl₂NO.

1,2,3,7,8-PentachloronaphthaleneContains H290945, CAS: 150205-21-3, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₃Cl₅.

1,2,5,6-Tetrachloronaphthalene, CAS: 67922-22-9, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄Cl₄.

Metazachlor, CAS: 67129-08-2, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆ClN₃O.

Metazachlor 3-Mercaptolactic Acid Conjugate Sulfoxide, CAS: /, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N₃O₅S.

1,2,5,6-Tetramethylnaphthalene, CAS: 2131-43-3, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆.

1,2-Diamino-naphthalene-5-sulfonamide, Hydrochloride, CAS: 1049752-75-1, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClN₃O₂S.

Metazachlor Ethane Sulfonic Acid Sodium Salt, CAS: 1231710-68-1, stock: 5.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₃NaO₄S.

Metazachlor Ethane Sulfonic Acid-d6 Sodium Salt, CAS: /, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀D₆N₃NaO₄S.

1,2-Dichloronaphthalene, CAS: 2050-69-3, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆Cl₂.

Metazachlor Oxalic Acid, CAS: 1231244-60-2, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₃.

1,2-Dihydro Acenaphthylene-13C6, CAS: 189811-57-2, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₈.

1,2-Dihydro-1,1,6-trimethylnaphthalene (>80%), CAS: 30364-38-6, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆.

2-[Di(methyl-d3)amino]-1-propanol, CAS: 97964-90-4, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇D₆NO.

Metazachlor Oxalic Acid-d6, CAS: /, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉D₆N₃O₃.

Metazachlor-13C3, CAS: /, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³C₃H₁₆ClN₃O.

1,2-Dihydronaphthalene, CAS: 447-53-0, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀.

1,2-Dihydroxynaphthalene, CAS: 574-00-5, stock: 5.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₂.

Metazachlor-d6, CAS: 1246816-51-2, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀D₆ClN₃O.

1,2-Naphthalenedicarbonitrile, CAS: 19291-76-0, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆N₂.

1,1’-Iminobis[3-(3,5-xylyloxy)-2-propanol Hydrochloride, CAS: 112072-54-5, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂ClNO₄.

1,3,7-Trichloronaphthalene, CAS: 55720-37-1, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅Cl₃.

1,3-Dihydro-5,6-dichlorobenzo(c)thiophene-S,S-dioxide1,3-dihydro-5,6-dichlorobenzo(c)thiophene-S,S-dioxide, CAS: 87743-20-2, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆Cl₂O₂S.

1,1’-Iminobis[3-(3,5-xylyloxy-d9)-2-propanol Hydrochloride, CAS: /, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄D₁₈ClNO₄.

1,3,5-Tris-[3-(3,5-Dimethylphenoxy)-2-hydroxypropyl]isocyanurate, CAS: /, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₅N₃O₉.

1,3-Dimethyl-2-phenylnaphthalene, CAS: 119264-82-3, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆.

1,3-Dimethylnaphthalene, CAS: 575-41-7, stock: 1.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂.

1,3-Bis-[3-(3,5-Dimethylphenoxy)-2-hydroxypropyl]-5-glycidyl Isocyanurate, CAS: 1392430-17-9, stock: 5.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₅N₃O₈.

1-Amino-3-(3,5-dimethylphenoxy)-2-propanol, CAS: 66766-07-2, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₂.

1,3-Dinitronaphthalene, CAS: 606-37-1, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂O₄.

Metamizole Impurity 2, CAS: /, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃Na₂O₇S₂.

1-Deoxa-1-aza-metaxalone, CAS: /, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂.

1,3-Naphthalenediol, CAS: 132-86-5, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₂.

1-[3-(3,5-Dimethylphenoxy)-2-hydroxypropyl]-3,5-Diglycidyl Isocyanurate, CAS: 1392430-16-8, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₃O₇.

3-(3,5-Dimethylphenoxy)propane-1,2-diol, CAS: 59365-66-1, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆O₃.

1,4,5,8-Naphthalenetetracarboxylic Acid 1,8-Monoanhydride, CAS: 52671-72-4, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆O₇.

1,4,5,8-Naphthalenetetracarboxylic Dianhydride, CAS: 81-30-1, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₄O₆.

1-Cyano-6-(methylsulfonyl)-7-nitro-9H-xanthen-9-one, CAS: /, stock: 1.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈N₂O₆S.

4-((3,5-Dimethylphenoxy)methyl)imidazolidin-2-one, CAS: /, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂.

4-((3,5-Dimethylphenoxy)methyl)imidazolidin-2-one-d9, CAS: /, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₉N₂O₂.

1,4,5,8-Tetramethylnaphthalene, CAS: 2717-39-7, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆.

1,4,6,7-Tetramethylnaphthalene, CAS: 13764-18-6, stock: 6.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆.

1-Cyano-6-(methylsulfonyl)-9H-xanthen-9-one, CAS: /, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉NO₄S.

Metaxalone, CAS: 1665-48-1, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃.

Metaxalone-d6, CAS: 1189944-95-3, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉D₆NO₃.

1,4,6,7-Tetramethylnaphthalene-D3, CAS: /, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆D₃.

1,4-Bis(2-benzoxazolyl)naphthalene, CAS: 5089-22-5, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₄N₂O₂.

N-Benzyl Metaxalone, CAS: /, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₃.

N-Benzyl Metaxalone-d7, CAS: /, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄D₇NO₃.

1,4-Bis(chloromethyl)naphthalene, CAS: 6586-89-6, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀Cl₂.

N-[(Oxazolin-2-on-5-yl)methyl] Metaxalone, CAS: 1392430-18-0, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O₅.

Triglycidyl Isocyanurate, CAS: 2451-62-9, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃O₆.

1,4-Di(methyl-d3)-naphthalene, CAS: 13720-08-6, stock: 8.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₆.

1,4-Dibromonaphthalene, CAS: 83-53-4, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆Br₂.

Isomethadone Hydrochloride (1.0 mg/mL in Methanol), CAS: 5341-49-1, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈ClNO.

Triglycidyl Isocyanurate-d15, CAS: /, stock: 4.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂D₁₅N₃O₆.

1,4-Dibutoxy-2,3-naphthalenedicarbonitrile, CAS: 116453-89-5, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₂.

1,4-Dicyanonaphthalene, CAS: 3029-30-9, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆N₂.

2,2’-[Carbonylbis(thio)]bisethanesulfonic Acid Dipotassium Salt, CAS: /, stock: 4.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈K₂O₇S₄.

2,2’-[Carbonylbis(thio)]bisethanesulfonic Acid-d8 Disodium Salt, CAS: /, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅D₈Na₂O₇S₄.

2-(2-Sulfoethyl)pseudourea, CAS: 25985-57-3, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₈N₂O₃S₂.

1,4-Dimethoxynaphthalene, CAS: 10075-62-4, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

1,4-Dimethyl 1,4-Naphthalenedicarboxylic Acid Ester, CAS: 7487-15-2, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₄.

2-(4,6-Diamino-1,3,5-triazin-2-yl)sulfanylethanesulfonic Acid, CAS: 1391054-56-0, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₅O₃S₂.

2-(4,6-Diamino-1,3,5-triazin-2-yl)sulfanylethanesulfonic Acid-d4, CAS: 1794737-32-8, stock: 3.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₄N₅O₃S₂.

1,4-Dimethylnaphthalene, CAS: 571-58-4, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂.

1,4-Dineopentyloxy-naphthalene, CAS: 957761-01-2, stock: 7.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

2-(4-Amino-1,3,5-triazin-2-yl)sulfanylethanesulfonic Acid Potassium Salt, CAS: 1391054-81-1, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇KN₄O₃S₂.

2-(4-Amino-1,3,5-triazin-2-yl)sulfanylethanesulfonic Acid-d4, CAS: 1794793-34-2, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₄N₄O₃S₂.

1,4-Naphthalenedicarboxylic Acid, CAS: 605-70-9, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈O₄.

1,4-Naphthoquinone, CAS: 130-15-4, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆O₂.

2-Acetylthioethanesulfonic Acid, CAS: 69536-71-6, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉ClO₄S₂.

2-Acetylthioethanesulfonic Acid Sodium Salt, CAS: 76274-71-0, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NaO₄S₂.

1,5-Bis(chloromethyl)naphthalene, CAS: 1733-76-2, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀Cl₂.

(1R)-1-(3,4-Dimethoxyphenyl)-4-hydroxy-2-cyclohexene-1-ethanol 1-(4-Methylbenzenesulfonate), CAS: 866394-50-5, stock: 1.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₆S.

2-Acetylthioethanesulfonic Acid-d4 Sodium Salt, CAS: 1315627-78-1, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃D₄NaO₄S₂.

1,5-Bis[2-(2-hydroxyethoxy)ethoxy]naphthalene, CAS: 136133-14-7, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄O₆.

1,5-Di(methyl-d3)-naphthalene, CAS: 94784-15-3, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₆.

rac α-Methadol-d3, CAS: 1217842-77-7, stock: 7.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆D₃NO.

(4R)-4-(3,4-Dimethoxyphenyl)-4-(2-propen-1-yl)-2-cyclohexen-1-one, CAS: 866394-49-2, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₃.

(7R,8S)-8-(3,4-Dimethoxyphenyl)-8-(2-propen-1-yl)-1,4-dioxaspiro[4.5]decan-7-ol, CAS: 866394-48-1, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆O₅.

2-[2-Sulfo(ethyl-d4)]pseudourea, CAS: 1346602-43-4, stock: 7.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄D₄N₂O₃S₂.

1,5-Diacetoxynaphthalene, CAS: 605-89-0, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₄.

1,5-Diaminonaphthalene, CAS: 2243-62-1, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂.

Mesembrine, CAS: 24880-43-1, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₃.

2-[[(Guanidino)(imino)methyl]sulfanyl]ethanesulfonic Acid, CAS: 1391053-66-9, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀N₄O₃S₂.

2-[[(Guanidino)(imino)methyl]sulfanyl]ethanesulfonic Acid-d4, CAS: 1794941-90-4, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆D₄N₄O₃S₂.

1,5-Diaminonaphthalene-13C6, CAS: /, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³C₆H₁₀N₂.

Mesembrine-d3, CAS: 1346600-05-2, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₃NO₃.

1,5-Diaminonaphthalene-d6, CAS: 1346598-98-8, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄D₆N₂.

1,5-Dibenzoylnaphthalene, CAS: 83-80-7, stock: 1.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₆O₂.

Ethyl Xanthic Acid 2-Sulfoethyl Ester Potassium Salt, CAS: /, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉KO₄S₃.

(R)-Mesopram, CAS: 189940-24-7, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

1,5-Dibromonaphthalene, CAS: 7351-74-8, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆Br₂.

1,5-Dibromonaphthalene-2,6-diol, CAS: 132178-78-0, stock: 9.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆O₂Br₂.

(R)-Mesopram-d7, CAS: 1795787-13-1, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₇NO₄.

(S)-Mesopram, CAS: 1391068-24-8, stock: 5.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

1,5-Dichloronaphthalene, CAS: 1825-30-5, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆Cl₂.

(S)-Mesopram-d7, CAS: 1795786-04-7, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂D₇NO₄.

1,5-Dihydroxytetralin, CAS: 40771-26-4, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₂.

1,5-Diisocyanatonaphthalene, CAS: 3173-72-6, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆N₂O₂.

[R-(E)]-2-Ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine (R-EDDP) (1.0 mg/mL in Methanol), CAS: 106293-55-4, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃N.

(-)-Normacromerine, CAS: 41787-64-8, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₃.

1,5-Dimercaptonaphthalene, CAS: 5325-88-2, stock: 6.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈S₂.

1,5-Dimethoxynaphthalene, CAS: 10075-63-5, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

[S-(E)]-2-Ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine (S-EDDP) (1.0 mg/mL in Methanol), CAS: 106293-57-6, stock: 9.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃N.

(+)-(2R,3S)-1-Methyl-2-(3-pyridinyl)-3-pyrrolidinemethanamine, CAS: 1391361-71-9, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₃.

(+/-)-1-(3-Amino-pyridin-2-yl)ethylamine, CAS: 1270326-64-1, stock: 7.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁N₃.

(-)-Normacromerine-d3, CAS: 1329805-62-0, stock: 8.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄D₃NO₃.

1,5-Dimethylnaphthalene, CAS: 571-61-9, stock: 2.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂.

(-)-trans 3’-Aminomethyl Nicotine, CAS: 272124-60-4, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₃.

(1,3,5-Trimethyl-1H-pyrazol-4-yl)methanamine Hydrochloride, CAS: 1246738-30-6, stock: 8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃N₃.HCl.

1,5-Naphthalenedisulfonic Acid, CAS: 81-04-9, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₆S₂.

1,5-Naphthalenedisulfonic acid tetrahydrate, CAS: 211366-30-2, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₆S₂ • 4(H ₂O).

(1,3-Dimethyl-1H-pyrazol-4-yl)methanamine Dihydrochloride, CAS: 1461713-58-5, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁N₃ • 2[HCl].

(1,3-Thiazol-5-yl)methanamine Dihydrochloride, CAS: 1215372-00-1, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₂S  •  2HCl.

1,5-Naphthalenedisulfonic acid, 3,3’-[carbonylbis[imino(2-methyl-4,1-phenylene)-2,1-diazenediyl]]bis-, sodium salt (1:4), CAS: 3214-47-9, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₄N₆Na₄O₁₃S₄.

1,6,7-Trimethylnaphthalene, CAS: 2245-38-7, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄.

(1,4-Dioxan-2-yl)methanamine Hydrochloride, CAS: 1185156-19-7, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂ • HCl.

(1,5-Dimethyl-1H-pyrrol-2-yl)methanamine Hydrochloride, CAS: 1208744-99-3, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₂ • HCl.

1,6-Dibromo-2-hydroxynaphthalene-3-carboxylic acid, CAS: 1779-10-8, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₆Br₂O₃.

1,6-Dibromo-2-methoxynaphthalene, CAS: 66996-59-6, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈Br₂O.

(1-((4-Methylpiperazin-1-yl)methyl)cyclopropyl)methanamine, CAS: 1015846-52-2, stock: 6.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₁N₃.

(1-(3,4-Dimethoxyphenyl)cyclopropyl)methanamine Hydrochloride, CAS: 1208550-10-0, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂ • HCl.

3-Demethyl Mescaline, CAS: 16046-07-4, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₃.

N-Acetyl Mescaline, CAS: 4593-89-9, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₄.

1,6-Dichloronaphthalene, CAS: 2050-72-8, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆Cl₂.

1,6-Dihydroxynaphthalene, CAS: 575-44-0, stock: 4.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₂.

(1-(3-Bromophenyl)cyclopropyl)methanamine Hydrochloride, CAS: 1211373-43-1, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NBr  •  HCl.

(1-(3-Chlorophenyl)cyclopropyl)methanamine, CAS: 115816-31-4, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NCl.

N-Acetyl Mescaline-d3, CAS: 1329610-11-8, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆D₃NO₄.

PD 144418 Oxalate, CAS: 154131-00-7, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O5.

1,6-Dimethoxynaphthalene, CAS: 3900-49-0, stock: 4.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

1,7-Di(methyl-d3)-naphthalene, CAS: 29636-70-2, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₆.

(1-(4-(Trifluoromethoxy)phenyl)cyclopropyl)methanamine Hydrochloride, CAS: 1209685-75-5, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂NOF₃ • HCl.

(1-(4-Bromophenyl)cyclopropyl)methanamine Hydrochloride, CAS: 1208915-57-4, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NBr  •  HCl.

PD 144418-d7 Oxalate, CAS: /, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₇N₂O₅.

1,7-Dihydroxynaphthalene, CAS: 575-38-2, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₂.

(1-(4-Fluorophenyl)cyclopropyl)methanamine Hydrochloride, CAS: 1209726-03-3, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NF  •  HCl.

(1-(4-Methoxybenzyl)piperidin-4-yl)methanamine, CAS: 117702-38-2, stock: 2.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O.

1,8-Bis(bromomethyl)naphthalene, CAS: 2025-95-8, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀Br₂.

1,8-Bis(chloromethyl)naphthalene, CAS: 50585-29-0, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀Cl₂.

(1-Aminomethylcyclohexyl)dimethylamine, CAS: 41806-09-1, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂.

(1-Benzyl-1H-pyrazol-3-yl)methanamine, CAS: 1005378-65-3, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃.

1,8-Bis-diphenylphosphanyl Naphthalene, CAS: 153725-04-3, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₆P₂.

(1-Benzyl-3-methylpyrrolidin-3-yl)methanamine, CAS: 114373-06-7, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂.

(1-Benzylazetidin-2-yl)methanamine, CAS: 46193-94-6, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

1,8-Diaminonaphthalene, CAS: 479-27-6, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂.

1,8-Dibromonaphthalene, CAS: 17135-74-9, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆Br₂.

(1-Benzylazetidin-3-yl)methanamine, CAS: 1219967-55-1, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

(1-Benzylpiperidin-4-yl)methanamine, CAS: 88915-26-8, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂.

1,8-Dimethylnaphthalene, CAS: 569-41-5, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂.

(1-Butylpiperidin-2-yl)methanamine, CAS: 1019341-68-4, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂N₂.

(1-Cyclohexyl-1H-pyrazol-4-yl)methanamine, CAS: 1199773-51-7, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇N₃.

1,8-Dinitronaphthalene, CAS: 602-38-0, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂O₄.

(1-Cyclopropyl-1H-1,3-benzodiazol-2-yl)methanamine, CAS: 1094220-55-9, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃.

(1-Cyclopropylpropyl)amine, CAS: 219736-10-4, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃N.

1,8-Dinitronaphthalene-d6, CAS: 1346598-02-4, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀D₆N₂O₄.

1,8-Naphthoic Anhydride, CAS: 81-84-5, stock: 5.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆O₃.

(1-Cyclopropylpyrrolidin-3-yl)methanamine, CAS: 1017474-07-5, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆N₂.

(1-Ethyl-1H-1,3-benzodiazol-2-yl)methanamine Hydrochloride, CAS: 1177273-58-3, stock: 9.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃ • HCl.

1,​3-​Di(methyl-​d3)​-naphthalene, CAS: 13720-07-5, stock: 3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₆.

1,​6-​Di(methyl-​d3)​-naphthalene, CAS: 13720-09-7, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₆.

(1-Ethylpiperidin-3-yl)methanamine Dihydrochloride, CAS: 1223210-39-6, stock: 7.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈N₂ • 2[HCl].

1,​6-​Dimethylnaphthalene, CAS: 575-43-9, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂.

1,​7-​Dimethylnaphthalene, CAS: 575-37-1, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂.

3-​Carboxy-​4-​chloro-benzenediazonium Chloride, CAS: 24569-37-7, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClN₂O₂ • HCl.

(1-Methyl-1H-imidazol-2-yl)(3-methylphenyl)methanamine Dihydrochloride, CAS: 1177309-41-9, stock: 4.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃ • 2HCl.

(1-Methyl-1H-imidazol-2-yl)(4-methylphenyl)methanamine Dihydrochloride, CAS: 1216236-39-3, stock: 3.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃ •  2HCl.

1-(1,8-Dihydroxy-3-methyl-naphthalen-2-yl)-ethanone, CAS: 3785-24-8, stock: 6.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂O₃.

3-Descarboxy Olsalazine Methyl Ester, CAS: /, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂N₂O₄.

(1-Methyl-1H-pyrazol-4-yl)(phenyl)methanamine, CAS: 1152547-97-1, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃.

1-(1-Ethoxyethoxy)-4-fluoronaphthalene, CAS: /, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅FO₂.

1-(1-Naphthyl)-2-chloroethane, CAS: 41332-02-9, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁Cl.

(1-Methyl-1H-pyrazol-4-yl)methanamine, CAS: 400877-05-6, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃.

(1-Methyl-1H-pyrazol-4-yl)methanamine Dihydrochloride, CAS: 1185299-72-2, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃ • 2(HCl).

4-Dehydroxy-2-hydroxy Olsalazine Dimethyl Ester, CAS: /, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O₆.

(2S,4R)-2-[(Dimethylamino)carbonyl]-4-hydroxy-1-pyrrolidinecarboxylic Acid-d6 4-Nitrobenzyl Ester, CAS: 1246814-87-8, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₆N₃O₆.

(1-Methyl-1H-pyrazol-4-yl)methanamine Hydrochloride, CAS: 1107601-70-6, stock: 9.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃ • HCl.

(1-Methyl-1H-pyrazol-5-yl)methanamine Dihydrochloride, CAS: 1185299-87-9, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃ • 2HCl.

1-(1-Naphthyl)ethylazide-d3, CAS: 1189510-47-1, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈D₃N₃.

1-(2-(Chloromethyl)phenyl)-4-fluoronaphthalene, CAS: /, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂ClF.

(2S,4R)-2-[(Dimethylamino)carbonyl]-4-[(methylsulfonyl)oxy]-1-pyrrolidinecarboxylic Acid-d6 4-Nitrobenzyl Ester-d6, CAS: 1246818-66-5, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅D₆N₃O₈S.

(2S,4R)-4-Hydroxy-1,2-pyrrolidinedicarboxylic Acid 1-(4-Nitrobenzyl) Ester, CAS: 96034-57-0, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₇.

(1-Methyl-1H-pyrazol-5-yl)methanamine Hydrochloride, CAS: 1185169-37-2, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉N₃ • HCl.

(1-Methyl-3-phenyl-1H-pyrazol-4-yl)methanamine, CAS: 1174310-40-7, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃.

1-(2-aminoethoxy)naphthalene hydrochloride, CAS: 118868-67-0, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO  • HCl.

(2S,4S)-4-(Acetylthio)-2-[(dimethylamino)carbonyl]-1-pyrrolidinecarboxylic Acid 4-Nitrobenzyl Ester-d6, CAS: 1246816-04-5, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₆N₃O₆S.

(2S,4S)-4-Hydroxy-1,2-pyrrolidinedicarboxylic Acid 1-[(4-nitrophenyl)methyl] Ester, CAS: /, stock: 2.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₇.

(1-Methylcyclobutyl)methanamine Hydrochloride, CAS: 1245647-53-3, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃N • HCl.

1-(2-Bromoethyl)naphthalene, CAS: 13686-49-2, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁Br.

((1S,3S,4S)-3-Bromo-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic Acid Hydrate, CAS: 209736-59-4, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄BrO₄S.

2,6-Dimercaptopurine, CAS: 5437-25-2, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄S₂.

4-Nitrobenzyl (4R,5S,6S)-3-[(Diphenylphosphono)oxy]-6-[(R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, CAS: 90776-59-3, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇N₂O₁₀P.

4-Nitrobenzyl (4S,5R,6S)-3-[(diphenylphosphono)oxy]-6-[(R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, CAS: 189188-38-3, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₇N₂O₁₀P.

(1-Methylcyclohexyl)methanamine Hydrochloride, CAS: 1082650-61-0, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇N • HCl.

(1-Methylpiperidin-4-yl)methanamine Dihydrochloride, CAS: 1187582-53-1, stock: 5.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇ClN₂.

1-(2-Nitroprop-1-en-1-yl)naphthalene, CAS: 131981-73-2, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₂.

1-(2-Pyridylazo)-2-naphthol, CAS: 85-85-8, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁N₃O.

((3S,4R)-4-(4-Ethoxyphenyl)-1-methylpiperidin-3-yl)methyl Methanesulfonate, CAS: /, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₄S.

(+)-(1-Oxyl-2,2,5,5-tetramethylpyrrolidin-3-yl)methyl Methanethiosulfonate, CAS: 681034-14-0, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀NO₃S₂.

Meropenem, CAS: 96036-03-2, stock: 1.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁N₃O₈S.

Meropenem Hydrate, CAS: 1465916-43-1, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₅S  • x(H ₂O).

(1-Morpholinocyclohexyl)methanamine, CAS: 64269-03-0, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O.

(1-Phenyl-1H-pyrazol-3-yl)methanamine Hydrochloride, CAS: 1170903-85-1, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₃ •  HCl.

1-(3-Azido-3-phenylpropoxy)naphthalene, CAS: 1776071-89-6, stock: 9.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇N₃O.

1-(3-Fluoro-1-naphthalenyl)-ethanone, CAS: 64977-37-3, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉FO.

Meropenem Sodium Salt, CAS: 211238-34-5, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₃NaO₅S.

Meropenem Trihydrate, CAS: 119478-56-7, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₁N₃O₈S.

(1-Phenylcyclopropyl)methanamine, CAS: 935-42-2, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N.

(1-Phenylpiperidin-3-yl)methanamine, CAS: 1232059-87-8, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(4-Bromophenyl)naphthalene, CAS: 204530-94-9, stock: 4.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁Br.

1-(5-Chloronaphthalenesulfonyl)-1H-hexahydro-1,4-diazepine, Hydrochloride, CAS: 105637-50-1, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈Cl₂N₂O₂S.

(-)-(1-Oxyl-2,2,5,5-tetramethylpyrrolidin-3-yl)methyl Methanethiosulfonate, CAS: 681034-15-1, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀NO₃S₂.

2-Amino-6-mercaptopurine-9-(2’,3’,5’-tri-O-acetyl-β-ribofuranosyl)purine, CAS: 2946-36-3, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉N₅O₇S.

Meropenem-d6 (>90%), CAS: 1217976-95-8, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉D₆N₃O₅S.

N-4-Nitrobenzyloxycarbonyl Meropenem-d6 4-Nitrobenzyl Ester, CAS: 1246815-65-5, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉D₆N₅O₁₁S.

(1-Propylcyclobutyl)methanamine Hydrochloride, CAS: 1384745-74-7, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇N • HCl.

(1-tert-Butyl-3,5-dimethyl-1H-pyrazol-4-yl)methanamine, CAS: 1134497-44-1, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉N₃.

1-(5-Iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4 -diazepine, Hydrochloride, CAS: 110448-33-4, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈ClIN₂O₂S.

1-(5-Methyl-1-naphthalenyl)ethanone, CAS: 67757-61-3, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂O.

2-Mercaptopurine, CAS: 28128-19-0, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄N₄S.

Protected Meropenem, CAS: 96036-02-1, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₅N₅O₁₁S.

R-​(-​)​-​1-​Indanol, CAS: 697-64-3, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O.

(1H-1,2,3-Triazol-4-yl)methanamine Hydrochloride, CAS: 1009101-70-5, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇ClN₄.

(1,4-Dimethoxynaphthalen-2-yl) Methanesulfonothioate, CAS: /, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄O₄S₂.

N-Acetyl Mesalazine-d3, CAS: 1309935-89-4, stock: 7.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆D₃NO₄.

ZM 213689 Disodium Salt (Meropenem impurity)(Mixture of double bond isomers), CAS: /, stock: 5.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃Na₂O₆S.

ZM 213689-d6 Disodium Salt (Meropenem Impurity)(Mixture of double bond isomers), CAS: /, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈D₁₂N₆Na₄O₁₂S₂.

(1H-Benzo[d]imidazol-2-yl)methanamine Dihydrochloride, CAS: 5993-91-9, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃ • 2(HCl).

1-(Bromomethyl)-7-fluoronaphthalene, CAS: 70631-50-4, stock: 6.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈BrF.

(1-Acetoxy-2,2,5,5-tetramethyl-δ-3-pyrroline-3-methyl) Methanesulfonate, CAS: 887352-13-8, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁NO₅S.

(1-Acetoxy-2,2,5,5-tetramethyl-δ-3-pyrroline-3-methyl) Methanethiosulfonate, CAS: 392718-69-3, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁NO₄S₂.

(R)-(-)-Mepivacaine Hydrochloride, CAS: 34333-72-7, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃ClN₂O.

(1H-benzo[d]imidazol-2-yl)methanamine hydrochloride, CAS: 7757-21-3, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃ • HCl.

(1H-Imidazol-2-yl)methanamine Dihydrochloride, CAS: 22600-77-7, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇N₃ • 2(HCl).

1-(Bromomethyl)naphthalene, CAS: 3163-27-7, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉Br.

1-(Chloromethyl)-2,6-dimethylnaphthalene, CAS: 107517-28-2, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃Cl.

(1-Butyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide), CAS: 174899-83-3, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅F₆N₃O₄S₂.

(1-Methanesulfonylpiperidin-2-yl)methanamine Hydrochloride, CAS: 1091613-74-9, stock: 2.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆N₂O₂S  • HCl.

6,8-Dihydroxy-2-methylmercaptopurine, CAS: 14443-37-9, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₄O₂S.

N-Propionyl Mesalazine-d3, CAS: 1330265-97-8, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₃NO₄.

(S)-(+)-Mepivacaine Hydrochloride, CAS: 34333-71-6, stock: 6.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃ClN₂O.

2,3-Dehydro Mepivacaine, CAS: /, stock: 4.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀N₂O.

(1H-Imidazol-4-yl)methanamine hydrochloride, CAS: 66247-84-5, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈ClN₃.

(1H-Indazol-5-yl)methanamine, CAS: 267413-25-2, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃.

1-(Chloromethyl)naphthalene, CAS: 86-52-2, stock: 3.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉Cl.

1-(Methoxymethoxy)naphthalene, CAS: 7382-37-8, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂O₂.

(1-Oxyl-2,2,3,5,5-pentamethyl-∆3-pyrroline-3-methyl) Methanethiosulfonate, CAS: 339072-96-7, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀NO₃S₂.

(1-Oxyl-2,2,5,5-tetraethyl-∆3-pyrroline-3-methyl) Methanethiosulfonate, CAS: /, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆NO₃S₂.

6-Ethylmercaptopurine, CAS: 5417-84-5, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₄S.

2,6-Dimethyl-3-(phenylmethoxy)-aniline, CAS: 70261-50-6, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO.

(1H-Indol-3-yl)methanamine-D4, CAS: 1914139-58-4, stock: 1.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆D₄N₂.

1-(Naphthalene-1-carbonyl)piperazine Hydrochloride, CAS: 1093390-64-7, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O • HCl.

(1-Oxyl-2,2,5,5-tetraethyl-∆3-pyrroline-3-methyl) Methanethiosulfonate-15N, CAS: /, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆¹⁵NO₃S₂.

(1-Oxyl-2,2,5,5-tetraethyl-∆3-pyrroline-3-methyl) Methanethiosulfonate-d20, CAS: /, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆D₂₀NO₃S₂.

(R)-8-Hydroxy Warfarin, CAS: 63740-77-2, stock: 7.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

6-Mercaptopurine Disulfide, CAS: 49808-20-0, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₈S₂.

3-Acetamido-2,4-dimethylphenol, CAS: 100445-95-2, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

3-Hydroxy Mepivacaine, CAS: 37055-90-6, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₂.

(1H-pyrazol-5-yl)methanamine Hydrochloride, CAS: 1196153-72-6, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇N₃ • HCl.

(1H-Pyrrolo[2,3-b]pyridin-6-yl)methanamine, CAS: 1023655-32-4, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₃.

Mephentermine Hydrochloride, CAS: 3978-34-5, stock: 9.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈ClN.

1-(Naphthalene-2-carbonyl)piperazine Hydrochloride, CAS: 1093630-38-6, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₂O • HCl.

(1-Oxyl-2,2,5,5-tetraethyl-∆3-pyrroline-3-methyl) Methanethiosulfonate-d20, 15N, CAS: /, stock: 6.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆D₂₀¹⁵NO₃S₂.

(1-Oxyl-2,2,5,5-tetramethyl-4-(pyridin-3-yl)-2,5-dihydro-1H-pyrrol-3-yl)methyl Methanesulfonate, CAS: /, stock: 3.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N₂O₄S.

(S)-4-Hydroxy Mephenytoin, CAS: 82695-93-0, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₃.

6-Mercaptopurine Hydrochloride-13C,15N2, CAS: /, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₅ClN₂¹⁵N₂S.

6-Mercaptopurine Monohydrate, CAS: 6112-76-1, stock: 5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₄OS.

3-Hydroxy Mepivacaine-d3, CAS: 1346597-79-2, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉D₃N₂O₂.

(1R)-N-((1R)-1-Phenylethyl)-1-[4-(tert-butyldimethylsilyloxymethyl)cyclohexyl]ethan-1-amine, CAS: 672314-45-3, stock: 3.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₁NOSi.

Mephentermine-d3 Hydrochloride, CAS: /, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅D₃ClN.

N-Hydroxymephentermine, CAS: 58670-93-2, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO.

1-(o-Methylstyryl)naphthalene, CAS: 858459-51-5, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆.

1-(p-Methoxystyryl)naphthalene, CAS: 23833-69-4, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O.

(1-Oxyl-2,2,5,5-tetramethyl-∆3-pyrroline-3-methyl) Methanethiosulfonate, CAS: 81213-52-7, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈NO₃S₂.

(1-Oxyl-2,2,5,5-tetramethyl-∆3-pyrroline-3-methyl) Methanethiosulfonate-15N, CAS: 1404308-02-6, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈¹⁵NO₃S₂.

5-(4-(Benzyloxy)phenyl)-5-ethylimidazolidine-2,4-dione, CAS: /, stock: 1.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₂O₃.

6-Mercaptopurine-13C2,15N (major), CAS: 1190008-04-8, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₂H₄N₃¹⁵NS.

4-Chloro Mepivacaine, CAS: /, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₇ClN₂O.